
<html lang="en"     class="pb-page"  data-request-id="440b6913-d9a7-4e33-8071-8accf1195309"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm901902w;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2010.53.issue-14;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives" /></meta><meta name="dc.Creator" content="Cristóbal  de los Ríos" /></meta><meta name="dc.Creator" content="Javier  Egea" /></meta><meta name="dc.Creator" content="José  Marco-Contelles" /></meta><meta name="dc.Creator" content="Rafael  León" /></meta><meta name="dc.Creator" content="Abdelouahid  Samadi" /></meta><meta name="dc.Creator" content="Isabel  Iriepa" /></meta><meta name="dc.Creator" content="Ignacio  Moraleda" /></meta><meta name="dc.Creator" content="Enrique  Gálvez" /></meta><meta name="dc.Creator" content="Antonio G.  García" /></meta><meta name="dc.Creator" content="Manuela G.  López" /></meta><meta name="dc.Creator" content="Mercedes  Villarroya" /></meta><meta name="dc.Creator" content="Alejandro  Romero" /></meta><meta name="dc.Description" content="1,8-Naphthyridine derivatives related to 17 (ITH4012), a neuroprotective compound reported by our research group, have been synthesized. In general, they have shown better inhibition of acetylcholi..." /></meta><meta name="Description" content="1,8-Naphthyridine derivatives related to 17 (ITH4012), a neuroprotective compound reported by our research group, have been synthesized. In general, they have shown better inhibition of acetylcholi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 24, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901902w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901902w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901902w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901902w" /></link>
        
    
    

<title>Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901902w" /></meta><meta property="og:title" content="Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0018.jpeg" /></meta><meta property="og:description" content="1,8-Naphthyridine derivatives related to 17 (ITH4012), a neuroprotective compound reported by our research group, have been synthesized. In general, they have shown better inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) than most tacrine derivatives previously synthesized in our laboratory. The compounds presented an interesting neuroprotective profile in SH-SY5Y neuroblastoma cells stressed with rotenone/oligomycin A. Moreover, compound 14 (ethyl 5-amino-2-methyl-6,7,8,9-tetrahydrobenzo[b][1,8]naphthyridine-3-carboxylate) also caused protection in cells stressed with okadaic acid (OA) or amyloid β 1−42 peptide (Aβ1−42). Interestingly, compound 14 prevented the OA-induced PP2A inhibition, one of the enzymes implicated in τ dephosphorylation. This compound also exhibited neuroprotection against neurotoxicity elicited by oxygen and glucose deprivation in hippocampal slices. Because these stressors caused neuronal damage related to physiopathological hallmarks found in the brain of Alzheimer’s disease (AD) patients, we conclude that compound 14 deserves further in vivo studies in AD models to test its therapeutic potential in this disease." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901902w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901902w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901902w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901902w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901902w&amp;href=/doi/10.1021/jm901902w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 5129-5143</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm9014179" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100429r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Crist%C3%B3bal++de+los+R%C3%ADos">Cristóbal de los Ríos</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Javier++Egea">Javier Egea</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9++Marco-Contelles">José Marco-Contelles</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rafael++Le%C3%B3n">Rafael León</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Abdelouahid++Samadi">Abdelouahid Samadi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isabel++Iriepa">Isabel Iriepa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ignacio++Moraleda">Ignacio Moraleda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Enrique++G%C3%A1lvez">Enrique Gálvez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio+G.++Garc%C3%ADa">Antonio G. García</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manuela+G.++L%C3%B3pez">Manuela G. López</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mercedes++Villarroya">Mercedes Villarroya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alejandro++Romero">Alejandro Romero</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Laboratorio de Radicales Libres y Química Computacional, Instituto de Química Orgánica General, Consejo Superior de Investigaciones Científicas, C/Juan de la Cierva 3, 28006 Madrid, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Servicio de Farmacología Clínica, Hospital Universitario de la Princesa, C/Diego de León 62, 28006 Madrid, Spain</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Departamento de Química Orgánica, Facultad de Farmacia, Universidad de Alcalá de Henares, Ctra. Barcelona, Km. 33.5, 28817, Alcalá de Henares, Spain</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. For C.d.l.R.: phone, +34-91-4972766; fax, +34-91-4973120; e-mail, <a href="/cdn-cgi/l/email-protection#fa998893898e95989b96d49e9f96958988939589ba8f9b97d49f89"><span class="__cf_email__" data-cfemail="4023322933342f22212c6e24252c2f3332292f330035212d6e2533">[email protected]</span></a>. For J.M.-C.: phone, +34-91-5622900; fax, +34-91-5644853; e-mail, <a href="/cdn-cgi/l/email-protection#056c746a663734456c746a622b66766c662b6076"><span class="__cf_email__" data-cfemail="244d554b471615644d554b430a47574d470a4157">[email protected]</span></a></div><div class="corresp-fn" id="fn1">⊥Current Address: Department of Chemistry, University of Cambridge Lensfield Road, Cambridge CB2 1EW, U.K.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901902w&amp;href=/doi/10.1021%2Fjm901902w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 5129–5143</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 24, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 December 2009</li><li><span class="item_label"><b>Published</b> online</span>24 June 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 July 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901902w" title="DOI URL">https://doi.org/10.1021/jm901902w</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5129%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DCrist%25C3%25B3bal%2Bde%2Blos%2BR%25C3%25ADos%252C%2BJavier%2BEgea%252C%2BJos%25C3%25A9%2BMarco-Contelles%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D14%26contentID%3Djm901902w%26title%3DSynthesis%252C%2BInhibitory%2BActivity%2Bof%2BCholinesterases%252C%2Band%2BNeuroprotective%2BProfile%2Bof%2BNovel%2B1%252C8-Naphthyridine%2BDerivatives%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5143%26publicationDate%3DJuly%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901902w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3154</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">53</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901902w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Cristóbal&quot;,&quot;last_name&quot;:&quot;de los Ríos&quot;},{&quot;first_name&quot;:&quot;Javier&quot;,&quot;last_name&quot;:&quot;Egea&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Marco-Contelles&quot;},{&quot;first_name&quot;:&quot;Rafael&quot;,&quot;last_name&quot;:&quot;León&quot;},{&quot;first_name&quot;:&quot;Abdelouahid&quot;,&quot;last_name&quot;:&quot;Samadi&quot;},{&quot;first_name&quot;:&quot;Isabel&quot;,&quot;last_name&quot;:&quot;Iriepa&quot;},{&quot;first_name&quot;:&quot;Ignacio&quot;,&quot;last_name&quot;:&quot;Moraleda&quot;},{&quot;first_name&quot;:&quot;Enrique&quot;,&quot;last_name&quot;:&quot;Gálvez&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;G. García&quot;},{&quot;first_name&quot;:&quot;Manuela&quot;,&quot;last_name&quot;:&quot;G. López&quot;},{&quot;first_name&quot;:&quot;Mercedes&quot;,&quot;last_name&quot;:&quot;Villarroya&quot;},{&quot;first_name&quot;:&quot;Alejandro&quot;,&quot;last_name&quot;:&quot;Romero&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;5129-5143&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901902w&quot;},&quot;abstract&quot;:&quot;1,8-Naphthyridine derivatives related to 17 (ITH4012), a neuroprotective compound reported by our research group, have been synthesized. In general, they have shown better inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) than most tacrine derivatives previously synthesized in our laboratory. The compounds presented an interesting neuroprotective profile in SH-SY5Y neuroblastoma cells stressed with rotenone/oligomycin A. Moreover, compound 14 (ethyl 5-amino-2-methyl-6,7,8,9-tetrahydrobenzo[b][1,8]naphthyridine-3-carboxylate) also caused protection in cells stressed with okadaic acid (OA) or amyloid β 1−42 peptide (Aβ1−42). Interestingly, compound 14 prevented the OA-induced PP2A inhibition, one of the enzymes implicated in τ dephosphorylation. This compound also exhibited neuroprotection against neurotoxicity elicited by oxygen and glucose deprivation in hippocampal slices. Because these stressors caused neuronal damage related to physiopathological hallmarks found in the brain of Al&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901902w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901902w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901902w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901902w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901902w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901902w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901902w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901902w&amp;href=/doi/10.1021/jm901902w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901902w" /></input><a href="/doi/pdf/10.1021/jm901902w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901902w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901902w%26sid%3Dliteratum%253Aachs%26pmid%3D20575555%26genre%3Darticle%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26date%3D2010%26atitle%3DSynthesis%252C%2BInhibitory%2BActivity%2Bof%2BCholinesterases%252C%2Band%2BNeuroprotective%2BProfile%2Bof%2BNovel%2B1%252C8-Naphthyridine%2BDerivatives%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D14%26spage%3D5129%26epage%3D5143%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jmcmar.2010.53.issue-14/production/jmcmar.2010.53.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">1,8-Naphthyridine derivatives related to <b>17</b> (ITH4012), a neuroprotective compound reported by our research group, have been synthesized. In general, they have shown better inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) than most tacrine derivatives previously synthesized in our laboratory. The compounds presented an interesting neuroprotective profile in SH-SY5Y neuroblastoma cells stressed with rotenone/oligomycin A. Moreover, compound <b>14</b> (ethyl 5-amino-2-methyl-6,7,8,9-tetrahydrobenzo[<i>b</i>][1,8]naphthyridine-3-carboxylate) also caused protection in cells stressed with okadaic acid (OA) or amyloid β 1−42 peptide (Aβ<sub>1−42</sub>). Interestingly, compound <b>14</b> prevented the OA-induced PP2A inhibition, one of the enzymes implicated in τ dephosphorylation. This compound also exhibited neuroprotection against neurotoxicity elicited by oxygen and glucose deprivation in hippocampal slices. Because these stressors caused neuronal damage related to physiopathological hallmarks found in the brain of Alzheimer’s disease (AD) patients, we conclude that compound <b>14</b> deserves further in vivo studies in AD models to test its therapeutic potential in this disease.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: 1,4-DHP, 1,4-dihydropyridine; Aβ, amyloid β peptide; ACh, acetylcholine; AChE, acetylcholinesterase; AD, Alzheimer’s disease; APP, amyloid precursor protein; BACE-1, β-site of amyloid precursor protein cleaving enzyme; BDNF, brain-derived neurotrophic factor; BuChE, butyrylcholinesterase; GSK-3β, glucogen synthase kinase 3β; LDH, lactate dehydrogenase; NMDA, <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate; OA, okadaic acid; OGD, oxygen and glucose deprivation; PAS, peripheral anionic binding site; rms, root mean square, VDCC, voltage-dependent calcium channel.</p></div> is an age-related neurodegenerative disease characterized by progressive memory loss, decline in language skills, and loss of function.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Although the etiology of AD is unknown, histopathological hallmarks such as amyloid β (Aβ) deposits,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> τ-protein aggregation,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> oxidative stress,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and low levels of acetylcholine (ACh) have been characterized.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> Currently, there are four drugs for AD approved by regulatory agencies, three cholinesterase inhibitors (rivastigmine, donepezil and galantamine), and a NMDA receptor blocker (memantine).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Cholinesterase inhibitors can reduce AD symptoms by inhibiting acetylcholinesterase (AChE), the enzyme responsible for the hydrolysis of ACh at the synaptic cleft.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This therapeutic strategy is based on the so-called cholinergic hypothesis,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> which suggests that the selective loss of cholinergic neurons in AD results in a deficit of ACh in specific areas of the brain that mediate learning and memory functions.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">There is no agreement in the scientific community about the benefits of the cholinergic therapy.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> However, a renewed interest for AChE inhibitors arose when beneficial effects, not linked to cholinergic neurotransmission, were demonstrated for some of them.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> For instance, galantamine has been described to protect human neuroblastoma cells<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and cortical neurons against Aβ-induced neurotoxicity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Furthermore, donepezil reduced τ-phosphorylation by inhibition of GSK-3β.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In addition, AChE seems to accelerate amyloid fibrils aggregation in the brain, forming stable complexes with Aβ;<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> this action involves the peripheral anionic binding site (PAS) of AChE.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> These effects, together with the fact that AD pathogenesis appears to be multifactorial, have led to the current opinion that drugs with moderate activities acting on two or more targets will be more effective than a highly potent and selective drug acting on a single target.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The multitarget approach<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> includes tacrine−donepezil hybrids as Aβ aggregation inhibitors,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> coumarin or tacrine derivatives that inhibit both AChE and β-site APP cleaving enzyme (BACE1),<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> and highly potent neuroprotectant rasagiline−rivastigmine hybrids,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> among many others.</div><div class="NLM_p">During the past decade, we have devoted our effort to the design and synthesis of multitarget compounds and their biological evaluation as potential drugs for AD, based on the juxtaposition of the structures of tacrine and 1,4-dihydropyridines (1,4-DHPs). Up to now, we have described the synthesis and biological evaluation of 4<i>H</i>-pyranopyridines,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> 1,8-naphthyridines,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and 1,4-dihydro[1,8]naphthyridines<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>).</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0001.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Selected Tacrine−1,4-DHP Hybrids Described in Previous Papers</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0002.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. 1,8-Naphthyridines Based on the Juxtaposition of an AChE Inhibitor (Tacrine) and a 1,4-Dihydropyridine (Nifedipine)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Tacrine (9-amino-1,2,3,4-tetrahydroacridine) was the first AChE inhibitor (AChEI) described,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> while 1,4-DHPs are selective blockers of the L-type voltage-dependent Ca<sup>2+</sup> channel (VDCC, Ca<sub>V</sub>1.1−1.4).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> 1,4-DHPs have exerted neuroprotection in several in vivo models of ischemia and neurodegeneration.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> The hybrid compounds prepared in our laboratory have shown inhibitory activity of AChE and potent L-type VDCC blockade.<a onclick="showRef(event, 'ref29 ref34'); return false;" href="javascript:void(0);" class="ref ref29 ref34">(29, 34)</a> Additionally, they were able to protect neuroblastoma cells against various toxic stimuli, such as Aβ, veratridine, Ca<sup>2+</sup> overload, H<sub>2</sub>O<sub>2</sub>, and thapsigargin.<a onclick="showRef(event, 'ref29 ref35'); return false;" href="javascript:void(0);" class="ref ref29 ref35">(29, 35)</a> One of them, the derivative <b>17</b> (ITH4012, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> induced expression of the antiapoptotic protein Bcl-2 and the neurotrophic factor BDNF, activities that could be mediating its neuroprotective actions. Compound <b>17</b> was the most potent AChEI of its family but 4-fold less active than tacrine.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Docking studies suggested that the aromatic substituent at C4 of <b>17</b> might hinder passing through the gorge to reach the catalytic binding site of AChE.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> These computational data prompted the design of a series of compounds lacking an aromatic substituent at C4 (X = H; Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>), thus favoring their accommodation into the AChE catalytic binding site and potentiating the inhibitory activity of cholinesterase enzymes. Therefore, we present in this paper the synthesis and pharmacological evaluation of novel 1,8-naphthyridine derivatives, analogues to compound <b>17</b> without substitution at C4. This implies an important modification from all of our previous studies. Thus, this series of compounds has been designed to find the first structural hits for further optimization, like cycloalkane-fused ring expansion or contraction (<i>n</i> = 0, 1, 2, 3; Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>) or the change in the carboxylic ester alkyl chain (R = Me, Et). Together with the synthesis and inhibitory activity on cholinesterase enzymes, we describe here the neuroprotective properties in two different models of cell death related to AD pathology, as well as their modulating activity of VDCCs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">For the synthesis of 1,8-naphthyridine precursors, we started from the conveniently substituted 2-pyridinones (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), prepared as described by Abu-Shanab and co-workers.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Following the experimental procedure described for the synthesis of <b>2</b>, a mixture of <b>2</b> (17%) and the methyl ester derivative <b>1</b> as major compound (55%) was obtained. Compound <b>1</b> was presumably formed by transesterification process with methanol, generated in the reaction of ethyl acetoacetate with dimethylformamide dimethyl acetal. Compound <b>2</b> was chemoselectively prepared using dimethylformamide diethyl acetal instead, with medium yield (48%). As shown in the literature, we had scarcely studied structure−activity relationships by modifications at the alkyl ester.<a onclick="showRef(event, 'ref26 ref27 ref29 ref34'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref29 ref34">(26, 27, 29, 34)</a> Therefore, we considered using both methyl and ethyl esters to synthesize new 1,8-naphthyridine derivatives.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0003.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Naphthyridine Precursors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Me<sub>2</sub>NCH(OMe)<sub>2</sub>, DMF, room temp, 24 h; (b) Me<sub>2</sub>NCH(OEt)<sub>2</sub>, DMF, room temp, 24 h; (c) NH<sub>2</sub>COCH<sub>2</sub>CN, NaH, DMF, room temp, 24 h; (d) POCl<sub>3</sub>, reflux, 48 h; (e) benzylamine, MeOH, room temp, 4 days; (f) CF<sub>3</sub>SO<sub>3</sub>H, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 2 h.</p></p></figure><div class="NLM_p">From the 2-pyridinone derivatives <b>1</b> and <b>2</b>, chlorination with phosphorus oxychloride<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> followed by aromatic nucleophilic substitution with benzylamine<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and subsequent deprotection of the amine<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> yielded both methyl and ethyl esters of 6-amino-5-cyano-2-methylpyridine-3-carboxylic acids <b>7</b> and <b>8</b> in good yields from commercial materials (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Next, Friedländer reaction<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> with the corresponding cycloalkanone, under standard conditions (AlCl<sub>3</sub>, 1,2-dichloroethane, reflux)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> provided compounds <b>9</b>−<b>16</b> with the desired 1,8-naphthyridine structure (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), with yields from medium to excellent. These molecules have been conveniently characterized by their analytical and NMR spectroscopic data.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0004.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the 1,8-Naphthyridine Derivatives <b>9</b>−<b>16</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Biology. AChE/BuChE Inhibitory Activity</h3><div class="NLM_p">Compounds <b>9</b>−<b>16</b> were evaluated as inhibitors of AChE from both <i>Electrophorus electricus</i> (eeAChE) and human erythrocytes (hAChE) and of BuChE from equine serum, following Ellman’s method<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compared to the eeAChE inhibitory activity of related compounds,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> compounds <b>9</b>−<b>16</b> were at least 10-fold more potent than those bearing an aryl substituent at C4, confirming our hypothesis that aryl substituents at C4 were barely accommodated into the catalytic binding site of AChE.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Thus, from a previous molecular modeling study with <b>17</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and the X-ray structure of eeAChE,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> we propose compound <b>14</b> could be well-accommodated between Trp86 and Tyr337 of eeAChE, generating a π−π stacking interaction. This conformation would be facilitated by a hydrogen bond between protonated aromatic nitrogen and the carbonyl group of His447. In agreement with previous studies from our laboratory,<a onclick="showRef(event, 'ref27 ref34'); return false;" href="javascript:void(0);" class="ref ref27 ref34">(27, 34)</a> the cyclohexene moiety was the hit for an optimal inhibition of eeAChE. Replacement of the ethyl by a methyl ester slightly modified the eeAChE inhibitory activity, either improving or lowering the inhibitory activity of eeAChE (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Inhibition experiments using hAChE showed IC<sub>50</sub> data in the micromolar range, between 1 and 2.1 μM, except for the cyclohexane-fused ethyl ester derivative <b>14</b>, which inhibited hAChE with an IC<sub>50</sub> of 0.78 μM. It is interesting to note how the cycloalkane ring expansion or contraction diminished the inhibitory activity by approximately 2-fold (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The reason for the enzymatic selectivity of these compounds, about 10-fold more active eeAChEI than hAChEI, could be due to some structural differences, such as eeAChE being a flexible tetramer,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> while human erythrocyte AChE is presented in globular dimers,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> or because they show different rate of glycosylation.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Although some authors have not found any differences in the catalytic behavior of both enzymes,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> there are several papers describing a differential inhibitory activity for eeAChE and human erythrocytes AChE with physostigmine, organophosphorus, and carbamate analogues.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> Otherwise, the fact that these compounds were better inhibitors of eeAChE, an enzyme structurally related to the brain enzyme,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> than the peripheral human erythrocyte AChE could be beneficial for a potential further clinical development, taking into account that many of the side effects of AChE inhibitors are due to the inhibition of the peripheral enzyme.</div><div class="NLM_p">Inhibition of eqBuChE by compounds <b>9</b>−<b>16</b> showed IC<sub>50</sub> values in a wide concentration range, between 0.49 and 36 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Fixing the cycloalkane, methyl esters were better BuChEI than ethyl esters. Thus, cycloheptane-fused derivatives <b>11</b> and <b>15</b> appeared to be the best inhibitors, with IC<sub>50</sub> of 0.49 and 2.1 μM, respectively. This result could be explained by the fact that BuChE possesses a more open catalytic site. In this manner, ring expansion improved the inhibitory activity because of a better accommodation of cycloheptane-fused derivatives into the catalytic site of BuChE. Compound <b>11</b>, the most potent BuChE inhibitor, was 100-fold less potent than tacrine. Also, it was 1.7-fold and 24-fold more potent than donepezil and galantamine, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Thus, the potencies to inhibit BuChE were in the order tacrine > compound <b>11</b> > donepezil > galantamine. In spite of the lesser potency of these 1,8-naphthyridines compared to tacrine, it is worth noting that compounds <b>9</b>−<b>16</b> had better activities than 4-aryl-substituted naphthyridine derivatives previously synthesized in our laboratory.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The poor inhibitory activity of BuChE found in previously described compounds could be a consequence of discarding either methyl ester or cycloheptene-fused derivatives in the chemical design of our tacrine−1,4-DHP hybrid compounds.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of AChE from both <i>Electrophorus electricus</i> (eeAChE<i>)</i> and Human Erythrocytes (hAChE) and of BuChE from Equine Serum (eqBuChE) by 1,8-Naphthyridines <b>9</b>−<b>16</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R, <i>n</i></th><th class="colsep0 rowsep0" align="center">eeAChE</th><th class="colsep0 rowsep0" align="center">eqBuChE</th><th class="colsep0 rowsep0" align="center">hAChE</th><th class="colsep0 rowsep0" align="center">selectivity<br /></br>eqBuChE/eeAChE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tacrine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.027 ± 0.002</td><td class="colsep0 rowsep0" align="left">0.0052 ± 0.0002</td><td class="colsep0 rowsep0" align="left">0.10 ± 0.01</td><td class="colsep0 rowsep0" align="center">0.193</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">donepezil</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.0134 ± 0.0009</td><td class="colsep0 rowsep0" align="left">0.84 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.0082 ± 0.0004</td><td class="colsep0 rowsep0" align="center">62.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">galantamine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.56 ± 0.06</td><td class="colsep0 rowsep0" align="left">12 ± 1</td><td class="colsep0 rowsep0" align="left">0.60 ± 0.04</td><td class="colsep0 rowsep0" align="center">21.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">R = Me, <i>n</i> = 1</td><td class="colsep0 rowsep0" align="left">0.12 ± 0.01</td><td class="colsep0 rowsep0" align="left">5 ± 1</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.2</td><td class="colsep0 rowsep0" align="center">41.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">R = Me, <i>n</i> = 2</td><td class="colsep0 rowsep0" align="left">0.093 ± 0.005</td><td class="colsep0 rowsep0" align="left">3.4 ± 0.3</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.1</td><td class="colsep0 rowsep0" align="center">36.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">R = Me, <i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">0.36 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.49 ± 0.03</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.3</td><td class="colsep0 rowsep0" align="center">1.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">R = Me, <i>n</i> = 4</td><td class="colsep0 rowsep0" align="left">0.25 ± 0.03</td><td class="colsep0 rowsep0" align="left">4.07 ± 0.07</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.2</td><td class="colsep0 rowsep0" align="center">16.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">R = Et, <i>n</i> = 1</td><td class="colsep0 rowsep0" align="left">0.35 ± 0.04</td><td class="colsep0 rowsep0" align="left">39 ± 7</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.2</td><td class="colsep0 rowsep0" align="center">111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">R = Et, <i>n</i> = 2</td><td class="colsep0 rowsep0" align="left">0.060 ± 0.006</td><td class="colsep0 rowsep0" align="left">12 ± 1</td><td class="colsep0 rowsep0" align="left">0.78 ± 0.08</td><td class="colsep0 rowsep0" align="center">200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">R = Et, <i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">0.31 ± 0.02</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.2</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.3</td><td class="colsep0 rowsep0" align="center">6.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">R = Et, <i>n</i> = 4</td><td class="colsep0 rowsep0" align="left">0.40 ± 0.02</td><td class="colsep0 rowsep0" align="left">5.3 ± 0.3</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.2</td><td class="colsep0 rowsep0" align="center">13.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">5.0 ± 0.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">6.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the mean ± SEM of quadruplicates of at least three independent experiments.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Kinetic Study of AChE Inhibition</h3><div class="NLM_p">The mechanism involved in the AChE inhibition by compounds <b>9</b>−<b>16</b> was investigated using compound <b>14</b>, the most potent AChE inhibitor here described (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The type of inhibition was elucidated from the analysis of Lineweaver−Burk reciprocal plots (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) showing both increasing slopes (lower <i>V</i><sub>max</sub>) and intercepts (higher <i>K</i><sub>m</sub>) with higher inhibitory concentration. This suggests a mixed-type inhibition.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The graphical analysis of steady-state inhibition data for compound <b>14</b> is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. A <i>K</i><sub>i</sub> value of 24 ± 3 nM was estimated from the slopes of double reciprocal plots versus compound <b>14</b> concentrations (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, inset).</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Steady-state inhibition of AChE hydrolysis of acetylthiocholine (ATCh) by compound <b>14</b>. Lineweaver−Burk reciprocal plots of initial velocity and substrate concentrations (0.1−1 mM) are presented. Lines were derived from a weighted least-squares analysis of data. Inset: slope of the double reciprocal plots versus [<b>14</b>].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Propidium Iodide Displacement Assay</h3><div class="NLM_p last">Compounds <b>9</b>−<b>16</b> were designed to improve their binding to the AChE catalytic site. To confirm whether our compounds could partially interact with the PAS of AChE, experiments to evaluate the competition with propidium iodide for its binding to this site were performed. Propidium, a selective ligand for the PAS of AChE, exhibits a fluorescence increase upon binding to this site.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Decrease of propidium fluorescence in the presence of the compounds can be interpreted as a displacement of propidium from the PAS. At 1 and 10 μM, compounds <b>9</b>−<b>16</b> did not show a significant ability to displace propidium from the PAS of AChE (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). At 10 μM, although compound <b>10</b> reduced propidium iodide binding by 16%, it seems that compounds <b>9</b>−<b>16</b> would preferentially bind to the catalytic binding site rather than to the PAS of AChE.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Effects of Compounds <b>9</b>−<b>16</b> on Ca<sup>2+</sup> Entry Elicited by K<sup>+</sup> Depolarization of SH-SY5Y Cells</h3><div class="NLM_p">Since Ca<sup>2+</sup> ions are involved in neuronal death in AD,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> we first studied whether compounds <b>9</b>−<b>16</b> had any effect on Ca<sup>2+</sup> entry induced by K<sup>+</sup> depolarization in Fluo-4/AM-loaded SH-SY5Y human neuroblastoma cells. Cells were incubated in the presence of compounds <b>9</b>−<b>16</b> at 1 μM for 10 min and then stimulated with a concentrated solution of KCl so that the final K<sup>+</sup> concentration in the medium was 70 mM. At 3 μM, the 1,4-DHP nifedipine caused 46% inhibition of K<sup>+</sup>-evoked [Ca<sup>2+</sup>]<sub>c</sub> increase. Most compounds had no effect on Ca<sup>2+</sup> uptake (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Only compound <b>12</b> significantly blocked Ca<sup>2+</sup> entry by 20% (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> also shows the time course of [Ca<sup>2+</sup>]<sub>c</sub> changes in cells treated with nifedipine or with compound <b>14</b>, as an example of those compounds unable to inhibit [Ca<sup>2+</sup>]<sub>c</sub> increases. The absence of Ca<sup>2+</sup> channel regulatory activity of these new compounds in comparison to previous analogues was expected, since the 1,4-DHP moiety, which is believed to confer such activity, is absent.<a onclick="showRef(event, 'ref26 ref34'); return false;" href="javascript:void(0);" class="ref ref26 ref34">(26, 34)</a> As shown in Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>, substituent X used to be an aryl ring, while it is a hydrogen in compounds <b>9</b>−<b>16</b>. Hence, they are not tacrine-1,4-DHP hybrids any longer.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of compounds <b>12</b> and <b>14</b> on [Ca<sup>2+</sup>]<sub>c</sub> increase induced by high K<sup>+</sup> in SH-SY5Y neuroblastoma cells. Experiments were performed in Fluo-4-loaded cells (<i>n</i> = 4). The curves are representative examples of the averaged time course of [Ca<sup>2+</sup>]<sub>c</sub> in control conditions and in the presence of <b>12</b>, <b>14</b> (at 1 μM), or nifedipine at 3 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Effects of Compounds <b>9</b>−<b>16</b> on Cell Viability</h3><div class="NLM_p last">Before evaluating the neuroprotective properties of these compounds, we tested whether compounds <b>9</b>−<b>16</b> exerted cytotoxic effects by themselves in human SH-SY5Y neuroblastoma cell line by measuring lactate dehydrogenese (LDH) release as a parameter of cell death. All compounds were studied by incubation of cells with compounds at 1 μM for 24 h. In all cases, LDH release was not statistically significant with respect to the DMSO group. Therefore, compounds <b>9</b>−<b>16</b> were not toxic at the concentration we are using to analyze their neuroprotective effects (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Neuroprotective Effect of Compounds <b>9</b>−<b>16</b> against Rotenone/Oligomycin A Induced Cell Death</h3><div class="NLM_p">Rotenone and oligomycin A block complexes <b>I</b> and <b>V</b>, respectively, of the mitochondrial electron transport chain, thus disrupting ATP synthesis.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The exposure of SH-SY5Y cells to a mixture of rotenone plus oligomycin A (Rot/Olig) constitutes a good model of oxidative stress having its origin in mitochondria; it elicits neurotoxicity and allows the evaluation of potential neuroprotective drugs used to treat AD patients, which inhibit AChE, such as galantamine, donepezil, and rivastigmine. Hence, the neuroprotective effect of compounds <b>9</b>−<b>16</b> against this toxic stimulus was evaluated with the method of the LDH release<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> at 1 μM on SH-SY5Y neuroblastoma cells, exposed to 30 μM rotenone plus 10 μM oligomycin-A for 24 h. The results, shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, indicate that these compounds efficiently protected against oxidative stress in the same range as well-known reference antioxidants such as melatonin (MEL) and <i>N</i>-acetylcysteine (NAC).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Most of the compounds produced approximately a 30% decrease in cell death induced by Rot/Olig (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Compounds <b>12</b> and <b>14</b> reduced cell death by 42% and 48%, respectively, while 4-phenyl-substituted analogue <b>17</b> protected by 27% (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The good profile of these compounds as neuroprotectants against Rot/Olig neurotoxicity is currently an open question that deserves further studies.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. LDH release assay with rotenone/oligomycin A stimulated SH-SY5Y cells in the presence of compounds <b>9</b>−<b>16</b> or the 4-phenyl-substituted analogue <b>17</b>. SH-SY5Y neuroblastoma cells were treated with 1 μM drugs 24 h before and during the incubation period with the toxic stimulus (30 μM rotenone plus 10 μM oligomycin-A, Rot/Olig). The 10 nM melatonin (Mel) and 1 mM <i>N</i>-acetylcysteine (NAC) were used as reference compounds. After exposure to Rot/Olig, cell death was quantified by measuring the LDH released to the media and normalized in each individual experiment as percentage with respect to the maximum LDH released, considered as 100% cell death, and LDH released by nontreated cells, considered as 0% cell death. Data are the means ± SEM of triplicates of seven different cell batches: (∗) <i>p</i> < 0.05 in comparison to control cell death.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Effect of Compounds <b>9</b>−<b>16</b> on Okadaic Acid Induced Cytotoxicity</h3><div class="NLM_p">Okadaic acid (OA), a potent and nonselective inhibitor of Ser/Thr phosphatases, induces τ hyperphosphorylation and cell death in both primary cortical neurons and neuroblastoma cell lines, which leads to subsequent neuronal degeneration, synaptic loss, and memory impairment, resembling AD pathology.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> Although these experimental paradigms are insufficient to characterize the development of AD pathology, they provide a potentially useful tool for determining the role of τ hyperphosphorylation in neuronal death processes.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> In this study, SH-SY5Y cells were incubated with compounds <b>9</b>−<b>16</b> at 1 μM for 24 h before addition of 30 nM OA and co-incubated with OA and the selected compound for an additional 24 h period. Cell viability at the end of this period was evaluated by the MTT reduction method,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Results are expressed as percentage of MTT reduction with respect to nontreated (control) cells; this value was taken as 100% of cell viability. Galantamine (GAL), at 0.3 μM, was used as reference.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Compound <b>17</b> did not protect SH-SY5Y cells against OA. Only compound <b>14</b> protected cells against OA-induced cell death with statistically significant values. Cells treated with compound <b>14</b> were able to reduce MTT by 89% compared to control, having 75% more viability than that found in OA cells. MTT was reduced by 91% compared to control in cells incubated with OA plus GAL. Thus, by comparison to OA cells, GAL afforded 85% protection against OA-elicited toxicity (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. MTT reduction assay in okadaic acid stimulated SH-SY5Y cells in the presence of compounds <b>9</b>−<b>16</b> and the 4-phenyl-substituted analogue <b>17</b>. SH-SY5Y neuroblastoma cells were treated with 1 μM compounds or 0.3 μM galantamine (used as reference compound) 24 h before and during the incubation period with the toxic stimulus (30 nM okadaic acid, 24 h). After this period, cell viability was quantified by evaluating MTT reduction to a formazan salt. Control group was considered as 100% of viability and represents cell viability of cells incubated only with cell culture medium. Data are the mean ± SEM of triplicates of seven different cell batches: (###) <i>p</i> < 0.001, comparing control and okadaic acid-lesioned cells; (∗∗) <i>p</i> < 0.01, comparing to okadaic acid lesioned cells in the absence of drug.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Molecular Modeling Studies on Okadaic Acid Induced Toxicity Prevention by Compound <b>14</b></h3><div class="NLM_p">Molecular field-based similarity is a powerful tool for identifying patterns in bioactive molecules, even when the molecules appear quite dissimilar. To locate the structural commonalities, molecules must be superimposed with respect to their molecular field (steric, electrostatic, etc.). In some cases many possible superpositions of nearly equal similarity can exist; therefore, it is essential that consistent superimpositions be obtained through the use of higher-order similarity relations.</div><div class="NLM_p">In order to understand the good biological data of compound <b>14</b> protecting SH-SY5Y neuroblastoma cells against cell death elicited by OA-induced τ hyperphosphorylation, molecular modeling studies of these two structurally different molecules have been done. We used OA as the 3D template to locate essential features for recognition of ligands that bind to the same receptor. Compound <b>14</b> might exist in amino and imino tautomeric forms, and it is noted that in tautomers <b>14b</b> and <b>14d</b> there is a chiral center (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0009.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Tautomeric Equilibrium for Compound <b>14</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When OA and compound <b>14</b> were compared, a location in OA that has two regions to fit with compound <b>14</b> was found. OA and each of the four tautomers were compared for stereoelectronic congruence on the basis of cyclohexane and aminopyridine rings attachment onto the two tetrahydropyran rings (Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>). The quantitative criterion used for judging the superimposition of the ligands and template is the root means square (rms) distance between selected atoms in the ligand and the paired atoms of the template. The selected atoms are the ones marked by an asterisk in Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>. Tautomer <b>14d</b>, with <i>S</i> configuration, showed the best fit with a rms deviation of 0.188 Å.</div><figure id="cht3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0010.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Structure of Okadaic Acid and Tautomer <b>14d</b> Showing the Regions and the Selected Atoms To Be Aligned</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structural similarities between tautomer <b>14d</b> and OA are depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, where a rigid least-squares fit has been performed. The structural congruences between the cyclohexane and the tetrahydropyran rings, and the aminopyridine ring with the other tetrahydropyran ring are evident from the Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. Moreover, the imino group and two pyridine nitrogens in compound <b>14d</b> are in the same region as O8, O9, and O10 (Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) in OA, respectively.</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Superposition of tautomer <b>14d</b> and okadaic acid. Hydrogen atoms are omitted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To assess the electronic congruence between these two molecules, we have calculated their electrostatic potencial surfaces (EPS) and performed a similarity analysis in the same way as before (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Molecular electrostatic potential surfaces for tautomer <b>14d</b> (left) and okadaic acid (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">At the top of each compound we can recognize a red area corresponding to a region of high electronic density; the same occurs in the region of the imino group (<b>14d</b>) and O8 (OA). Therefore, tautomer <b>14d</b> and OA are congruent in an electrostatic sense in these areas, which can play an important role for the binding to the receptor. On the basis of the molecular modeling studies, we propose that the active conformation of compound <b>14</b> is the tautomer <b>14d.</b></div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Reduction of the OA-Induced PP2A Inhibition by Compound <b>14</b></h3><div class="NLM_p">According to the molecular modeling studies, compound <b>14</b> would be competing with OA for the binding to Ser/Thr phosphatases, e.g., PP2A, preventing OA-induced phosphatases inhibition. Since compound <b>14</b> would be mimicking a portion of OA not essential for its inhibitory activity, the entry of OA to the binding site would be hampered, but Ser/Thr phosphatase-catalyzed τ dephosphorylation would be preserved. PP2A is the most OA-sensitive Ser/Thr phosphatase enzyme.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> To confirm this hypothesis, experiments of PP2A inhibition with OA in the presence of compound <b>14</b> were carried out by the method of the malachite green (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> Immunoprecipitated PP2A was able to release 1.90 ± 0.07 nmol (100 ± 4% control) of inorganic phosphorus to the assay medium. This phosphate generation was significantly reduced in the presence of 30 nM OA (1.31 ± 0.01 nmol, 69 ± 2% control). Under these experimental conditions, compound <b>14</b> significantly prevented the OA inhibitory activity in a concentration-dependent manner. At 1 μM and in the presence of 30 nM OA, compound <b>14</b> increased the inorganic phosphorus release to 1.456 ± 0.004 nmol (77 ± 2% control). This effect was more significant when the concentration of compound <b>14</b> was 10 μM, generating 1.72 ± 0.01 nmol of inorganic phosphorus (91 ± 3% control) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div><figure id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>14</b> on the inhibition of PP2A-derived phosphatase activity induced by OA, measured with the malachite green assay. Immunoprecipitated PP2A from rat brain lysates was treated with vehicle (control), 30 nM OA (maximal inhibition), and 30 nM OA plus <b>14</b> (1 or 10 μM), before adding the threonine phosphopeptide (Lys-Arg-pThr-Ile-Arg-Arg) used as enzymatic substrate. After 10 min, malachite green was added and the enzymatic reaction was allowed 15 min more for color development. After this period, PP2A activity was quantified by measuring color generation at 620 nm. Control group represents the maximal phosphatase activity. Data are the mean ± SEM of triplicates of two different brain lysates: (###) <i>p</i> < 0.001 versus control; (∗) <i>p</i> < 0.05 and (∗∗∗) <i>p</i> < 0.001 in comparison to OA in the absence of drug.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Molecular Docking of Compound <b>14</b> with PP2A</h3><div class="NLM_p">In order to go into depth into the binding mode of compound <b>14</b> compared to OA in PP2A, a molecular docking analysis has been carried out. The blind docking of the <b>14d</b>−PP2A molecules was successful as indicated by the statistically significant scores. An important finding is the location of the binding site, which is situated where we proposed based on superimposition protocol (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).</div><figure id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0014.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (a, left) Molecular docking model of <b>14d</b>−PP2A complex. Yellow portions indicate positions of the pocket. (b, right) Molecular docking model of <b>14d</b>−PP2A complex including okadaic acid (zoom): <b>14d</b> (blue), okadaic acid (red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a> shows the residues involved in the predicted binding site. Hydrogen bond interaction of the ester side chain with Arg214 may strengthen the ligand binding.</div><figure id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0015.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Binding mode of the most stable docked orientation of <b>14d</b> with PP2A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Thus, the computational studies were in accordance with the biological activity found for compound <b>14</b>, with regard to the prevention of OA-induced inhibition of PP2A. Hence, the neuroprotective activity induced by compound <b>14</b> against the toxicity elicited by OA (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) was hypothesized to be due to this down-regulating effect of the OA-induced Ser/Thr phosphatases inhibition.</div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Neuroprotection of Compound <b>14</b> against Aβ-Induced Cytotoxicity</h3><div class="NLM_p">Taking into account the good neuroprotective profile of compound <b>14</b> against models of both τ hyperphosphorylation and oxidative stress, we evaluated whether it was also able to protect against the neurotoxicity evoked by Aβ<sub>1−42</sub>. The 1−42 peptide is the most amyloidogenic isoform of Aβ.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> When SH-SY5Y neuroblastoma cells were exposed to 30 μM Aβ<sub>1−42</sub> for 24 h, cell viability, measured as MTT reduction, decreased significantly (78 ± 2% vs control; Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). We found that compound <b>14</b> was able to increase cell viability in a concentration-dependent manner (0.1−1 μM). When cells were treated with Aβ<sub>1−42</sub> plus compound <b>14</b> at 1 μM for 24 h, viability augmented significantly to 90 ± 1%, which implies 54% more viability than that found in cells treated only with exogenous Aβ<sub>1−42</sub>. Used as reference compound, 10 nM melatonin caused 58% protection.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a></div><figure id="fig10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0016.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. MTT reduction assay in Aβ-lesioned SH-SY5Y neuroblastoma cells in the presence of compound <b>14</b>. Neuroblastoma cells were treated with <b>14</b> (0.1−3 μM) or 10 nM of melatonin (Mel, used as reference) 24 h before and during a 24 h incubation period with 30 μM Aβ<sub>1−42</sub>. After this period, cell viability was quantified by measuring MTT reduction. Control group was considered as 100% and represents cell viability of cells incubated only in culture medium. Data are the mean ± SEM of triplicates of four different cell batches: (##) <i>p</i> < 0.01 versus control; (∗∗) <i>p</i> < 0.01 and (∗∗∗) <i>p</i> < 0.001 in comparison to Aβ<sub>1−42</sub> lesioned cells in the absence of drug.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Neuroprotection Elicited by Compound <b>14</b> in Rat Hippocampal Slices Subjected to Oxygen and Glucose Deprivation</h3><div class="NLM_p">Because compound <b>14</b> exhibited neuroprotective properties against different stressors in neuroblastoma cell cultures, it was of interest to test whether the compound exerted neuroprotection in a more complex model, e.g., the rat hippocampal slice subjected to oxygen and glucose deprivation (OGD) followed by reoxygenation. Thus, 15 min of OGD followed by 2 h reoxygenation produced 35% decrease of cell viability with respect to control slices. We found that compound <b>14</b> was able to increase cell viability in a concentration-dependent manner (1−30 μM), with a maximal protection of 65.5% at 30 μM. This protection was comparable to that of the reference drug galantamine.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> EC<sub>50</sub> for compound <b>14</b> was 6 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>).</div><figure id="fig11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0017.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. MTT reduction assay in rat hippocampal slices subjected to 15 min of OGD and 120 min of reoxygenation in absence (OGD bar) or presence of increasing concentrations (1, 3, 10, and 30 μM) of compound <b>14</b> (see protocol at the top of the figure). Galantamine (GAL, 15 μM) was used as reference. Slices, kept during the same period of time with oxygen and glucose, were run in parallel to define the control condition (Control). MTT reduction in control slices was taken as 100% of tissue viability. Data are the mean ± SEM of six experiments: (###) <i>p</i> < 0.001 comparing control respect to OGD; (∗∗∗) <i>p</i> < 0.001 in comparison to OGD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have synthesized and evaluated a series of 1,8-naphthyridine derivatives related to tacrine and compound <b>17</b>, a neuroprotectant previously reported by our research group. These new compounds were easily prepared by smooth reactions in high yields from readily available precursors. The compounds were dual inhibitors of both AChE and BuChE, with slight selectivity toward AChE inhibition. Cholinesterase inhibition was modulated by tiny modifications of the structure. AChE inhibition was improved in cyclohexene-fused compounds, while BuChE inhibition was better in methyl esters than in ethyl esters, the cycloheptene-fused compound <b>11</b> being the most active. Compared to previous 1,8-naphthyridines reported by our group, removal of the aryl susbtituent at C4 improved both AChE and BuChE inhibition. Only compound <b>12</b> kept the Ca<sup>2+</sup> channel modulating activity (20% blockade) as found in previously described compounds. Furthermore, these 1,8-naphthyridine derivatives showed neuroprotection against oxidative stress elicited by the rotenone/oligomycin A cocktail, but only compound <b>14</b>, the best AChE inhibitor of this series, was able to improve cell viability of SH-SY5Y cells subjected to OA-induced τ hyperphosphorylation. Also, compound <b>14</b> protected SH-SY5Y cells against Aβ<sub>1−42</sub> neurotoxicity in concentration-dependent manner. On the basis of this promising neuroprotective profile, compound <b>14</b> was studied in an experimental preparation that mimics tissue neurodegeneration, the rat hippocampal slices subjected to OGD and reoxygenation, where it protected up to 65.5% against this toxic stimulus, with an EC<sub>50</sub> of 6 μM. As this family of 1,8-naphthyridines scarcely affected Ca<sup>2+</sup> entry, they should exert their neuroprotective actions by a different mechanism, e.g., free radical scavenging. This would explain the neuroprotective profile of compound <b>14</b> in the OGD experiments, as well as Rot/Olig experiments. The fact that compound <b>14</b> also offered neuroprotection against both OA-induced τ hyperphosphorylation and exposure to exogenous Aβ makes us think that its mechanism of action could be located at the beginning of the cascade of events that lead to neurodegeneration. Likely, as hypothesized by computational studies, compound <b>14</b> could be preventing the Ser/Thr phosphatase inhibition. The maintenance of the Ser/Thr phosphatase activity exerted by compound <b>14</b> could have consequences in a neurodegeneration scenario, reducing the generation of neurofibrilary tangles by slowing down the τ hyperphosphorylation. Hence, compound <b>14</b> improves the neuroprotective properties of previous neuroprotectants described by our group, like compound <b>17</b>. For these reasons, compound <b>14</b> (ethyl 4-amino-2-methyl-6,7,8,9-tetrahydrobenzo[<i>b</i>][1,8]naphthyridine-3-carboxylate) can be considered as a new potential neuroprotective drug acting on different models of neurodegeneration, both in neuroblastoma cultures and in cerebral tissues, which deserves a further preclinical investigation and characterization of its mechanism of action. Together with compound <b>14</b>, compound <b>12</b> also presented interesting properties, since it exhibited moderate and dual inhibitory activity of cholinesterases (IC<sub>50</sub> of 0.25 and 4.07 μM to inhibit eeAChE and eqBuChE, respectively), K<sup>+</sup>-evoked Ca<sup>2+</sup> entry blockade, and a 42% protection of SH-SY5Y neuroblastoma cell line against rotenone/oligomycin A neurotoxicity. This pharmacological profile could be interesting taking into account that Ca<sup>2+</sup> channel blockade has been reported to induce neuroprotection in several models of cell death.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> The results of this work are in agreement with the current opinion about the necessity of finding multitarget drugs for the development of AD medicines, like dimebon,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> an antihistaminic and anticholinesterasic drug that was found to preserve mitochondrial function<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> and protected neurons against several neurotoxic stimuli.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Materials</h3><div class="NLM_p last">Melatonin, rotenone, oligomycin A, <i>N</i>-acetylcysteine (NAC), tacrine, nifedipine, dimethyl sulfoxide (DMSO), EDTA, EGTA, leupeptin, PMSF, Aβ protein fragment 1−42, and okadaic acid were purchased from Sigma Aldrich (Madrid, Spain). Galantamine was purchased from Tocris House (Bristol, U.K.). Protease inhibitor cocktail was purchased from Roche (Mannheim, Germany). Fluo-4/AM was purchased from Molecular Probes (Invitrogen, Barcelona, Spain), and PP2A immunoprecipitation phosphatase assay kit was purchased from Millipore (Temecula, CA).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div class="NLM_p last">Reactions were monitored by TLC (thin layer chromatography) using precoated silica gel aluminum plates containing a fluorescent indicator. Detection was done by UV (254 nm) followed by charring with sulfuric−acetic acid spray, 1%, aqueous potassium permanganate solution, or 0.5% phosphomolybdic acid in 95% ethanol. Anhydrous Na<sub>2</sub>SO<sub>4</sub> was used to dry organic solutions during workups, and the removal of solvents was carried out under vacuum with a rotary evaporator. Flash column chromatography was performed using silica gel 60 (230−400 mesh). Melting points were determined in a Stuart SMP-10 apparatus and are uncorrected. IR spectra were obtained in a Bruker IFS60v spectrophotometer. MS spectra were obtained in a QSTAR spectrometer (Applied Biosystems). <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded with a Varian VXR-200S or Bruker AMX-300 spectrometer, using tetramethylsilane as internal standard. All the assignments for protons and carbons were in agreement with 2D COSY, gHSQC, gHMBC, and 1D NOESY spectra. Elemental analyses were used to determine the purity of compounds and carried out on a LECO CHNS-932 apparatus. Positive electrospray HRMS spectra were obtained in an API QSTAR pulsar spectrometer (Applied Biosystems). All the described compounds had ≥95% purity.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Method for the Synthesis of 6(1<i>H</i>)-Pyridinone Derivatives</h3><div class="NLM_p last">In a three-necked round-bottomed flask, a mixture of the corresponding alkyl acetoacetate (1 equiv) and <i>N</i>,<i>N</i>′-dimethylformamide dialkyl acetal (1 equiv) in dry DMF (1 mL/mmol) was stirred at room temperature under argon for 24 h. A mixture of cyanoacetamide (1 equiv) and sodium hydride (2 equiv) in dry DMF (1.4 mL/mmol), previously prepared at 0 °C and stirred at room temperature for 10 min under argon, was added slowly, and the mixture was allowed to stir for 24 h. A solution of ethanol/H<sub>2</sub>O (50:50, 5 mL/mmol) was added, and the resulting mixture was acidified to pH 4 with concentrated HCl and stirred for 24 h. The mixture was filtered to afford a solid with good analytical and spectral data.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Methyl Ester of 5-Cyano-2-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic Acid (<b>1</b>)</h3><div class="NLM_p last">Following the general method for the synthesis of 2(1<i>H</i>)-pyridinone derivatives, reaction of ethyl acetoacetate (6.500 g, 50 mmol) and <i>N</i>,<i>N</i>′-dimethylformamide dimethyl acetal (5.950 g, 50 mmol) in dry DMF (50 mL) afforded after filtration a yellow solid that was assigned to compound <b>1</b> (5.280 g, 55%) with spectral data in accordance with the literature.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Anal. (C<sub>9</sub>H<sub>8</sub>N<sub>2</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Ethyl Ester of 5-Cyano-2-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic Acid (<b>2</b>)</h3><div class="NLM_p last">Following the general method for the synthesis of 2(1<i>H</i>)-pyridinone derivatives, reaction of ethyl acetoacetate (3.797 g, 29.2 mmol) and <i>N</i>,<i>N</i>′-dimethylformamide diethyl acetal (4.295 g, 29.2 mmol) in dry DMF (29 mL) afforded after filtration a yellow solid that was assigned to compound <b>2</b> (2.900 g, 48%) with spectral data in accordance with the literature.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Anal. (C<sub>10</sub>H<sub>10</sub>N<sub>2</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Method for the Synthesis of 6-Chloropyridine Derivatives</h3><div class="NLM_p last">The corresponding 6(1<i>H</i>)-pyridinone was dissolved in POCl<sub>3</sub>, and the mixture was heated under reflux. Ice (40−80 g) was poured into the mixture, and the mixture was neutralized (pH 7) with aqueous ammonia. The resulting solid was filtered and washed with H<sub>2</sub>O. Pure compounds were isolated after desiccation with a vacuum pump.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Methyl Ester of 6-Chloro-5-cyano-2-methylnicotinic Acid (<b>3</b>)</h3><div class="NLM_p last">Following the general method for the synthesis of 6-chloropyridine derivatives, reaction of <b>1</b> (1.000 g, 5.20 mmol) in POCl<sub>3</sub> (10 mL), after 41 h, yielded compound <b>3</b> (1.085 g, 99%) as a yellow solid. IR (KBr) ν 3431, 3074, 2925, 2854, 2238, 1727, 1588, 1535, 1437, 1416, 1282, 1245, 1113, 929, 782 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.39 (s, 1 H, H4), 3.88 (s, 3 H, OCH<sub>3</sub>), 2.81 [s, 3 H, CH<sub>3</sub>(C2)]; <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75.4 MHz) δ 165.7 (C6), 164.6 (CO), 154.3 (C2), 145.1 (C4), 124.7 (C3), 114.5 (CN), 108.6 (C5), 53.4 (OCH<sub>3</sub>), 25.6 [<i>C</i>H<sub>3</sub>(C2)]. MS (API-ES+) <i>m</i>/<i>z</i>: [M + 1]<sup>+</sup> 211.0.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Ethyl Ester of 6-Chloro-5-cyano-2-methylnicotinic Acid (<b>4</b>)</h3><div class="NLM_p last">Following the general method for the synthesis of 6-chloropyridine derivatives, reaction of <b>2</b> (2.000 g, 9.70 mmol) in POCl<sub>3</sub> (10 mL), after 48 h, yielded compound <b>4</b> (2.023 g, 93%) as a yellow solid. IR (KBr) ν 3431, 3063, 2991, 2926, 2850, 2239, 1723, 1582, 1533, 1413, 1370, 1357, 1275, 1241, 1110, 1033, 988, 872, 782 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.43 (s, 1 H, H4), 4.35 (q, 2 H, <i>J</i> = 7.1 Hz, CO<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.80 [s, 3 H, CH<sub>3</sub>(C2)], 1.37 (t, 3 H, <i>J</i> = 7.1 Hz, CO<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75.4 MHz) δ 165.7 (C6), 164.1 (CO), 154.1 (C2), 145.0 (C4), 125.1 (C3), 114.5 (CN), 108.5 (C5), 62.7 (CO<sub>2</sub><i>C</i>H<sub>2</sub>CH<sub>3</sub>), 25.6 [<i>C</i>H<sub>3</sub>(C2)], 14.6 (CO<sub>2</sub>CH<sub>2</sub><i>C</i>H<sub>3</sub>). MS (API-ES+) <i>m</i>/<i>z</i>: [M + 1]<sup>+</sup> 225.1; [M + Na]<sup>+</sup> 247.1.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Method for the Synthesis of Benzyl-Protected Aminopyridine Derivatives</h3><div class="NLM_p last">A mixture of the corresponding 6-chloropyridine (1 equiv) and benzylamine (1−1.2 equiv) in methanol (2 mL/mmol) was stirred at room temperature for several days. The solution was then poured into ice-cold water (10−20 mL/mmol) and kept overnight in a refrigerator. The resulting precipitate was filtered and purified by silica gel flash chromatography using hexane/ethyl acetate mixtures as eluent to give pure compounds.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methyl Ester of 6-(Benzylamino)-5-cyano-2-methylnicotinic Acid (<b>5</b>)</h3><div class="NLM_p last">Following the general method for the synthesis of benzyl-protected aminopyridine derivatives, reaction of <b>3</b> (506 mg, 2.40 mmol) and benzylamine (309 mg, 2.88 mmol) in MeOH (7 mL), after 7 days, yielded compound <b>5</b> (648 mg, 96%) as a white solid. IR (KBr) ν 3354, 3034, 2957, 2223, 1719, 1599, 1580, 1454, 1435, 1325, 1262, 1237, 1210, 1149, 1090, 780, 693 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.28 (s, 1 H, H4), 7.35 (m, 5H, Ph), 5.75 (br, 1 H, NH), 4.79 (d, <i>J</i> = 8.7 Hz, 2 H, CH<sub>2</sub>), 3.86 (s, 3 H, OCH<sub>3</sub>), 2.77 [s, 3 H, CH<sub>3</sub>(C2)]; <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 75.4 MHz) δ 165.1, 164.9 (CO, C6), 157.8 (C2), 145.2 (C4), 139.5 (C1′), 128.4 (C3′), 127.7 (C2′), 127.0 (C4′), 116.1 (C3), 112.8 (CN), 88.1 (C5), 52.0 (CO<sub>2</sub><i>C</i>H<sub>3</sub>), 44.2 (CH<sub>2</sub>N), 25.7 [<i>C</i>H<sub>3</sub>(C2)]. MS (API-ES+) <i>m</i>/<i>z</i>: [M + 1]<sup>+</sup> 282.3, 296.3; [M + Na]<sup>+</sup> 304.3, 318.3.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Ethyl Ester of 6-(benzylamino)-5-cyano-2-methylnicotinic Acid (<b>6</b>)</h3><div class="NLM_p last">Following the general method for the synthesis of benzyl-protected aminopyridine derivatives, reaction of <b>4</b> (225 mg, 1.00 mmol) and benzylamine (129 mg, 1.20 mmol) in MeOH (2 mL), after 4 days, yielded compound <b>6</b> (203 mg, 69%) as a white solid. IR (KBr) ν 3350, 3062, 3032, 2985, 2926, 2903, 2225, 1716, 1600, 1582, 1454, 1403, 1368, 1327, 1258, 1234, 1148, 1109, 1091, 1033, 779, 742, 714, 693, 615 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.29 (s, 1 H, H4), 7.35 (m, 5H, Ph), 5.72 (br, 1 H, NH), 4.79 (d, <i>J</i> = 8.4 Hz, 2 H, CH<sub>2</sub>), 4.32 (q, <i>J</i> = 7.2 Hz, 2 H, CO<sub>2</sub>C<i>H</i><sub><i>2</i></sub>CH<sub>3</sub>), 2.77 [s, 3 H, CH<sub>3</sub>(C2)], 1.37 (t, 3 H, <i>J</i> = 7.2 Hz, CO<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75.4 MHz) δ 166.5, 165.3 (CO, C6), 158.2 (C2), 144.9 (C4), 138.3 (C1′), 129.2 (C3′), 128.4 (C2′), 128.2 (C4′), 116.6 (C3), 114.7 (CN), 89.1 (C5), 61.3 (CO<sub>2</sub><i>C</i>H<sub>2</sub>CH<sub>3</sub>), 45.7 (CH<sub>2</sub>N), 26.4 [<i>C</i>H<sub>3</sub>(C2)], 14.7 (CO<sub>2</sub>CH<sub>2</sub><i>C</i>H<sub>3</sub>). MS (API-ES+) <i>m</i>/<i>z</i>: [M + 1]<sup>+</sup> 296.0; [M + Na]<sup>+</sup> 318.0. Anal. (C<sub>17</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> General Method for the Synthesis of Aminopyridine Derivatives</h3><div class="NLM_p last">Trifluoromethanesulfonic acid (10−13 equiv) was added dropwise to a solution of the corresponding benzyl-protected 6-aminopyridine in anhydrous dichloromethane (8 mL/mmol) under argon at 0 °C. The mixture was then refluxed for 2−3 h, cooled and diluted in water, basified to pH 10 with 10% NaOH, and extracted with dichloromethane. The organic phase was dried over anhydrous sodium sulfate, evaporated, and purified by flash chromatography using hexane and ethyl acetate mixtures as eluent to give pure compounds.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Methyl Ester of 6-Amino-5-cyano-2-methylnicotinic Acid (<b>7</b>)</h3><div class="NLM_p last">Following the general method for the synthesis of aminopyridine derivatives, reaction of <b>5</b> (69 mg, 0.25 mmol) and trifluoromethanesulfonic acid (482 mg, 3.22 mmol) in dichloromethane (2 mL) after 3 h yielded compound <b>7</b> (47 mg, 98%) as a yellow solid. IR (KBr) ν 3387, 3334, 3144, 2224, 1719, 1667, 1598, 1550, 1439, 1340, 1292, 1265, 1170, 1072, 780 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.31 (s, 1 H, H4), 5.55 (br, 2 H, NH<sub>2</sub>), 3.87 (s, 3 H, OCH<sub>3</sub>), 2.73 [s, 3 H, CH<sub>3</sub>(C2)]. MS (API-ES+) <i>m</i>/<i>z</i>: [M + 1]<sup>+</sup> 192.2; [M + Na]<sup>+</sup> 214.0.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Ethyl Ester of 6-Amino-5-cyano-2-methylnicotinic Acid (<b>8</b>)</h3><div class="NLM_p last">Following the general method for the synthesis of aminopyridine derivatives, reaction of <b>6</b> (1.000 g, 3.39 mmol) and trifluoromethanesulfonic acid (5.080 g, 33.88 mmol) in dichloromethane (27 mL) after 2.5 h yielded compound <b>8</b> (679 mg, 98%) as a yellow solid. IR (KBr) ν 3390, 3333, 3140, 2973, 2226, 1719, 1672, 1599, 1549, 1400, 1369, 1338, 1291, 1265, 1172, 1069, 943, 779, 556 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz) δ 8.32 (s, 1 H, H4), 5.50 (br, 2 H, NH<sub>2</sub>), 4.33 (q, <i>J</i> = 7.0 Hz, 2 H, CO<sub>2</sub>C<i>H</i><sub><i>2</i></sub>CH<sub>3</sub>), 2.74 [s, 3 H, CH<sub>3</sub>(C2)], 1.38 (t, 3 H, <i>J</i> = 7.0 Hz, CO<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75.4 MHz) δ 166.5, 165.0 (CO, C6), 159.7 (C2), 145.1 (C4), 116.3, 116.2 (C3, CN), 88.9 (C5), 61.5 (CO<sub>2</sub><i>C</i>H<sub>2</sub>CH<sub>3</sub>), 25.9 [<i>C</i>H<sub>3</sub>(C2)], 14.7 (CO<sub>2</sub>CH<sub>2</sub><i>C</i>H<sub>3</sub>). MS (API-ES+) <i>m</i>/<i>z</i>: [M + 1]<sup>+</sup> 206.0. Anal. (C<sub>10</sub>H<sub>11</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> General Method of Friedländer Reaction for the Synthesis of [1,8]Naphthyridine Derivatives</h3><div class="NLM_p last">Aluminum chloride (1.2−2.2 equiv) was suspended in dry 1,2-dichloroethane (10 mL/mmol) under argon. The corresponding alkyl 6-amino-5-cyano-2-methyl-3-pyridinecarboxylate (1 equiv) and the cycloalkanone (1.2−2.2 equiv) were added. The reaction mixture was heated under reflux (27−49 h). After the reaction was complete (TLC analysis), the mixture was allowed to cool to room temperature and a mixture of THF/H<sub>2</sub>O (2:1) was added. An aqueous solution of 10% NaOH was added dropwise to the mixture until the aqueous solution was basic (pH 9). After being stirred for 30 min, the mixture was extracted three times with dichloromethane. The organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and the solvent was evaporated. The resultant solid was purified by silica gel flash chromatography using methanol/dichloromethane mixtures as eluent to provide pure compounds.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Methyl Ester of 5-Amino-2-methyl-7,8-dihydro-6<i>H</i>-cyclopenta[<i>b</i>][1,8]naphthyridine-3-carboxylic Acid (<b>9</b>)</h3><div class="NLM_p last">This compound was obtained following the general method for the Friedländer reaction. To a stirred suspension of AlCl<sub>3</sub> (93 mg, 0.70 mmol) in dry 1,2-dichloroethane (5 mL) were added methyl 6-amino-5-cyano-2-methyl-3-pyridinecarboxylate <b>7</b> (95 mg, 0.50 mmol) and cyclopentanone (59 mg, 0.70 mmol). Upon the TLC analysis, 33 mg of AlCl<sub>3</sub> (0.25 mmol) and 21 mg of cyclopentanone (0.25 mmol) were added after 28 h of reflux. The reaction was complete at 49 h of total time, yielding compound <b>9</b> (63 mg, 60%) as a yellow solid: mp 255−258 °C; IR (KBr) ν 3317, 3188, 2951, 2844, 1724, 1645, 1601, 1549, 1431, 1358, 1259, 1114, 802, 777 cm<sup>−1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 200 MHz) δ 9.14 (s, 1 H, H4), 7.03 (br, 2 H, NH<sub>2</sub>), 3.89 (s, 3 H, CH<sub>3</sub>O), 3.37 (m, 2 H, H8), 2.91 (m, 2 H, H6), 2.79 [s, 3 H, CH<sub>3</sub>C(2)], 2.10 (m, 2 H, H7); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 50.2 MHz) δ 171.8 (CO), 166.5 (C8a), 158.9 (C2), 157.0 (C9a), 148.1 (C4), 135.8 (C5), 119.5 (C3), 114.1 (C5a), 109.0 (C4a), 52.1 (<i>C</i>H<sub>3</sub>O), 35.1 (C8), 27.5 [<i>C</i>H<sub>3</sub>C(2)], 25.3 (C6), 21.8 (C7). MS (API-ES+) <i>m</i>/<i>z</i>: 258.1 [(M + 1)<sup>+</sup>, 100], 245.1, 205.1, 157.1. Anal. (C<sub>14</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Methyl 5-Amino-2-methyl-6,7,8,9-tetrahydrobenzo[<i>b</i>][1,8]naphthyridine-3-carboxylate (<b>10</b>)</h3><div class="NLM_p last">This compound was obtained following the general method for the Friedländer reaction. To a stirred suspension of AlCl<sub>3</sub> (83 mg, 0.62 mmol) in dry 1,2-dichloroethane (5 mL) were added methyl 6-amino-5-cyano-2-methyl-3-pyridinecarboxylate <b>7</b> (85 mg, 0.44 mmol) and cyclohexanone (61 mg, 0.62 mmol). Upon the TLC analysis, an amount of 30 mg of AlCl<sub>3</sub> (0.22 mmol) was added after 6 h of reflux. Then 30 mg of AlCl<sub>3</sub> (0.22 mmol) and 22 mg of cyclohexanone (0.22 mmol) were added after 21 h of reflux. The reaction was complete at 30 h of total time, yielding compound <b>10</b> (85 mg, 70%) as a yellow solid: mp >300 °C (dark at 185 °C); IR (KBr) ν 3338, 3229, 2941, 2862, 1716, 1620, 1601, 1568, 1543, 1437, 1361, 1284, 1246, 1116, 1070, 802, 779 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz) δ 8.82 (s, 1H, H4), 5.19 (bs, 2H, NH<sub>2</sub>), 3.94 (s, 3H, CH<sub>3</sub>O), 3.07 (m, 2H, H9), 2.95 [s, 3H, CH<sub>3</sub>C(2)], 2.59 (m, 2H, H6), 1.93 (m, 4H, H7, H8); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 75.4 MHz) δ 166.4 (CO), 161.9 (C9a), 159.6 (C2), 154.1 (C10a), 150.9 (C5), 136.0 (C4), 119.7 (C3), 109.9 (C5a), 108.3 (C4a), 52.1 (<i>C</i>H<sub>3</sub>O), 33.4 (C9), 25.2 [<i>C</i>H<sub>3</sub>C(2)], 23.3 (C6), 22.1, 22.0 (C7, C8). MS (API-ES+) <i>m</i>/<i>z</i>: 272 [(M + 1)<sup>+</sup>, 100], 248 (12), 205 (13). Anal. (C<sub>15</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Methyl 5-Amino-2-methyl-7,8,9,10-tetrahydro-6<i>H</i>-cyclohepta[<i>b</i>][1,8]naphthyridine-3-carboxylate (<b>11</b>)</h3><div class="NLM_p last">This compound was obtained following the general method for the Friedländer reaction. To a stirred suspension of AlCl<sub>3</sub> (93 mg, 0.70 mmol) in dry 1,2-dichloroethane (5 mL) were added methyl 6-amino-5-cyano-2-methyl-3-pyridinecarboxylate <b>7</b> (95 mg, 0.50 mmol) and cycloheptanone (78 mg, 0.70 mmol). Upon the TLC analysis, 33 mg of AlCl<sub>3</sub> (0.25 mmol) and 28 mg of cycloheptanone (0.25 mmol) were added after 19h of reflux. The reaction was complete at 27 h of total time, yielding compound <b>11</b> (95 mg, 67%) as a yellow solid: mp 227−233 °C; IR (KBr) ν 3330, 3199, 2918, 2850, 1720, 1651, 1601, 1579, 1543, 1429, 1361, 1346, 1257, 1105, 1082, 810, 779 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz) δ 8.77 (s, 1H, H4), 5.03 (bs, 2H, NH<sub>2</sub>), 3.96 (s, 3H, CH<sub>3</sub>O), 3.19 (m, 2H, H10), 2.96 [s, 3H, CH<sub>3</sub>C(2)], 2.75 (m, 2H, H6), 1.98−1.46 (m, 6H, H7, H8, H9); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 75.4 MHz) δ 169.1 (CO), 166.4 (C10a), 159.0 (C2), 154.5 (C11a), 149.2 (C5), 136.0 (C4), 120.1 (C3), 114.9 (C5a), 109.2 (C4a), 52.0 (OCH<sub>3</sub>), 39.2 (C10), 31.4 (C9), 27.3 (C8), 26.2 (C6), 25.0, 24.9 [<i>C</i>H<sub>3</sub>C(2), C7]. MS (API-ES+) <i>m</i>/<i>z</i>: 286 [(M + 1)<sup>+</sup>, 100], 248 (12), 205 (15). HRMS calcd for C<sub>16</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub> 286.1550 (M + H<sup>+</sup>). Found 286.1544 (M + H<sup>+</sup>).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Methyl 5-Amino-2-methyl-6,7,8,9,10,11-hexahydrocycloocta[<i>b</i>][1,8]naphthyridine-3-carboxylate (<b>12</b>)</h3><div class="NLM_p last">This compound was obtained following the general method for the Friedländer reaction. To a stirred suspension of AlCl<sub>3</sub> (146 mg, 1.10 mmol) in dry 1,2-dichloroethane (8 mL) were added methyl 6-amino-5-cyano-2-methyl-3-pyridinecarboxylate <b>7</b> (150 mg, 0.78 mmol) and cyclooctanone (139 mg, 1.10 mmol). Upon the TLC analysis, 52 mg of AlCl<sub>3</sub> (0.39 mmol) and 50 mg of cyclooctanone (0.39 mmol) were added after 20 h of reflux. The reaction was complete at 28 h of total time, yielding compound <b>12</b> (134 mg, 57%) as a white solid: mp 259−262 °C; IR (KBr) ν 3349, 2923, 2851, 1725, 1713, 1620, 1600, 1571, 1541, 1432, 1361, 1351, 1291, 1260, 1249, 1109, 1093 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz) δ 8.80 (s, 1H, H4), 5.10 (bs, 2H, NH<sub>2</sub>), 3.97 (s, 3H, CH<sub>3</sub>O), 3.15 (m, 2H, H11), 2.98 [s, 3H, CH<sub>3</sub>C(2)], 2.88 (m, 2H, H6), 1.90 (m, 2H, H10), 1.73 (m, 2H, H7), 1.43 (m, 4H, H8, H9); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75.4 MHz) δ 167.6 (CO), 166.5 (C11a), 161.9 (C2), 148.2 (C12a), 146.2 (C5), 134.9 (C4), 121.4 (C3), 114.2 (C5a), 109.0 (C4a), 52.4 (OCH<sub>3</sub>), 36.2 (C11), 30.8 (C10), 27.8 (C7), 26.3, 26.2 (C8, C9), 25.9 [<i>C</i>H<sub>3</sub>C(2)], 24.7 (C6). MS (API-ES+) <i>m</i>/<i>z</i>: 300.3 [(M + 1)<sup>+</sup>, 100], 322.3 [(M + Na)<sup>+</sup>, 13]. Anal. (C<sub>17</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Ethyl 5-Amino-2-methyl-7,8-dihydro-6<i>H</i>-cyclopenta[<i>b</i>][1,8]naphthyridine-3-carboxylate (<b>13</b>)</h3><div class="NLM_p last">This compound was obtained following the general method for the Friedländer reaction. To a stirred suspension of AlCl<sub>3</sub> (91 mg, 0.68 mmol) in dry 1,2-dichloroethane <b>8</b> (5 mL) were added ethyl 6-amino-5-cyano-2-methyl-3-pyridinecarboxylate (100 mg, 0.49 mmol) and cyclopentanone (57 mg, 0.68 mmol). Upon the TLC analysis, 32 mg of AlCl<sub>3</sub> (0.24 mmol) and 20 mg of cyclopentanone (0.24 mmol) were added after 14 and 25 h of reflux. The reaction was complete at 40 h of total time, yielding compound <b>13</b> (91 mg, 69%) as a yellow solid: mp 237−240 °C; IR (KBr) ν 3329, 3176, 2964, 1716, 1657, 1604, 1550, 1433, 1400, 1358, 1252, 1217, 1117, 1086, 1051, 806, 779 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz) δ 8.74 (s, 1H, H4), 4.80 (bs, 2H, NH<sub>2</sub>), 4.44 (q, <i>J</i> = 7.2 Hz, 2H, CO<sub>2</sub>C<i>H</i><sub><i>2</i></sub>CH<sub>3</sub>), 3.16 (t, <i>J</i><sub>7,8</sub> = 7.6 Hz, 2H, H8), 2.98 [s, 3H, CH<sub>3</sub>C(2)], 2.88 (t, <i>J</i><sub>6,7</sub> = 7.6 Hz, 2H, H6), 2.23 (quintet, 2H, <i>J</i><sub>6,7,8</sub> = 7.6 Hz, H7), 1.45 (t, <i>J</i> = 7.2 Hz, 3H, CO<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub><i>3</i></sub>); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 50.2 MHz) δ 171.6 (CO), 166.1 (C8a), 158.7 (C2), 156.9 (C9a), 148.0 (C4), 135.6 (C5), 120.0 (C3), 114.0 (C5a), 109.0 (C4a), 60.8 (O<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 35.0 (C8), 27.5 (C6), 25.2 [<i>C</i>H<sub>3</sub>C(2)], 21.8 (C7), 14.1 (OCH<sub>2</sub><i>C</i>H<sub>3</sub>). MS (API-ES+) <i>m</i>/<i>z</i>: 272.2 [(M + 1)<sup>+</sup>, 100], 258.1 (8), 245.1 (7). Anal. (C<sub>15</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Ethyl 5-Amino-2-methyl-6,7,8,9-tetrahydrobenzo[<i>b</i>][1,8]naphthyridine-3-carboxylate (<b>14</b>)</h3><div class="NLM_p last">This compound was obtained following the general method for the Friedländer reaction. To a stirred suspension of AlCl<sub>3</sub> (112 mg, 0.84 mmol) in dry 1,2-dichloroethane (6 mL) were added ethyl 6-amino-5-cyano-2-methyl-3-pyridinecarboxylate <b>8</b> (123 mg, 0.60 mmol) and cyclohexanone (82 mg, 0.84 mmol). Upon the TLC analysis, 40 mg of AlCl<sub>3</sub> (0.30 mmol) and 30 mg of cyclohexanone (0.30 mmol) were added after 22 h of reflux. The reaction was complete at 31 h, yielding compound <b>14</b> (159 mg, 93%) as a yellow solid: mp 212−215; IR (KBr) ν 3374, 3324, 3182, 2934, 1717, 1664, 1602, 1577, 1546, 1434, 1363, 1350, 1252, 1222, 1120, 1072, cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.82 (s, 1H, H4), 5.33 (bs, 2H, NH<sub>2</sub>), 4.39 (q, <i>J</i> = 7.5 Hz, 2H, CO<sub>2</sub>C<i>H</i><sub><i>2</i></sub>CH<sub>3</sub>), 3.05 (m, 2H, H9), 2.91 [s, 3H, CH<sub>3</sub>C(2)], 2.58 (m, 2H, H6), 1.92 (m, 4H, H7, H8), 1.41 (t, <i>J</i> = 7.5 Hz, 3H, CO<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub><i>3</i></sub>); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75.4 MHz) δ 166.7 (CO), 163.9 (C9a), 162.0 (C2), 154.6 (C10a), 149.5 (C5), 135.0 (C4), 121.8 (C3), 111.5 (C5a), 109.0 (C4a), 61.8 (O<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 34.2 (C9), 26.4 [<i>C</i>H<sub>3</sub>C(2)], 23.9 (C6), 22.8 (C7, C8), 14.7 (<i>C</i>H<sub>3</sub>CH<sub>2</sub>O). MS (API-ES+) <i>m</i>/<i>z</i>: 286.2 [(M + 1)<sup>+</sup>, 100], 593.5 [(2 × M + Na)<sup>+</sup>, 5], 308.3 [(M + Na)<sup>+</sup>, 4], 272.2 (10), 258.2 (12). Anal. (C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Ethyl 5-Amino-2-methyl-7,8,9,10-tetrahydro-6<i>H</i>-cyclohepta[<i>b</i>][1,8]naphthyridine-3-carboxylate (<b>15</b>)</h3><div class="NLM_p last">This compound was obtained following the general method for the Friedländer reaction. To a stirred suspension of AlCl<sub>3</sub> (100 mg, 0.75 mmol) in dry 1,2-dichloroethane (6 mL) were added ethyl 6-amino-5-cyano-2-methyl-3-pyridinecarboxylate <b>8</b> (110 mg, 0.54 mmol) and cycloheptanone (84 mg, 0.75 mmol). Upon the TLC analysis, 36 mg of AlCl<sub>3</sub> (0.27 mmol) and 30 mg of cycloheptanone (0.27 mmol) were added after 10 and 24 h of reflux. The reaction was complete at 33 h of total time, yielding compound <b>15</b> (130 mg, 80%) as a yellow solid: mp 252−255 °C; IR (KBr) ν 3381, 3327, 3153, 2923, 2850, 1714, 1670, 1603, 1576, 1543, 1344, 1288, 1254, 1223, 1111, 1082, 1049, 812, 781 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz) δ 8.75 (s, 1H, H4), 5.03 (bs, 2H, NH<sub>2</sub>), 4.44 (q, <i>J</i> = 7.0 Hz, 2H, CO<sub>2</sub>C<i>H</i><sub><i>2</i></sub>CH<sub>3</sub>), 3.19 (m, 2H, H10), 2.96 [s, 3H, CH<sub>3</sub>C(2)], 2.75 (m, 2H, H6), 2.00−1.60 (m, 6H, H7, H8, H9), 1.44 (t, <i>J</i> = 7.0 Hz, 3H, CO<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub><i>3</i></sub>); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 75.4 MHz) δ 169.1 (CO), 166.1 (C10a), 158.8 (C2), 154.6 (C11a), 149.1 (C5), 135.9 (C4), 120.5 (C3), 114.9 (C5a), 109.3 (C4a), 60.8 (O<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 39.2 (C10), 31.5 (C9), 27.3 (C8), 26.2 (C6), 25.1, 25.0 [<i>C</i>H<sub>3</sub>C(2), C7], 14.1 (OCH<sub>2</sub><i>C</i>H<sub>3</sub>). MS (API-ES+) <i>m</i>/<i>z</i>: 300.2 [(M + 1)<sup>+</sup>, 100], 205.1 (17), 157.1 (13). Anal. (C<sub>17</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Ethyl 5-Amino-2-methyl-6,7,8,9,10,11-hexahydrocycloocta[<i>b</i>][1,8]naphthyridine-3-carboxylate (<b>16</b>)</h3><div class="NLM_p last">This compound was obtained following the general method for the Friedländer reaction. To a stirred suspension of AlCl<sub>3</sub> (73 mg, 0.55 mmol) in dry 1,2-dichloroethane (4 mL) were added ethyl 6-amino-5-cyano-2-methyl-3-pyridinecarboxylate <b>8</b> (80 mg, 0.39 mmol) and cyclooctanone (69 mg, 0.55 mmol). Upon the TLC analysis, 26 mg of AlCl<sub>3</sub> (0.19 mmol) and 25 mg of cyclooctanone (0.19 mmol) were added after 15 and 21 h of reflux. The reaction was complete at 39 h of total time, yielding compound <b>16</b> (110 mg, 90%) as a white solid: mp 241−243 °C; IR (KBr) ν 3345, 2920, 2846, 1716, 1618, 1599, 1570, 1541, 1431, 1356, 1350, 1290, 1259, 1242, 1167, 1107, 1090, 818, 779 cm<sup>−1</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz) δ 8.75 (s, 1H, H4), 5.02 (bs, 2H, NH<sub>2</sub>), 4.43 (q, <i>J</i> = 7.0 Hz, 2H, CO<sub>2</sub>C<i>H</i><sub><i>2</i></sub>CH<sub>3</sub>), 3.14 (m, 2H, H11), 2.97 [s, 3H, CH<sub>3</sub>C(2)], 2.87 (m, 2H, H6), 1.88 (m, 2H, H10), 1.72 (m, 2H, H7), 1.43 (t, <i>J</i> = 7.0 Hz, 3H, CO<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub><i>3</i></sub>), 1.38 (m, 4H, H8, H9); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75.4 MHz) δ 166.6 (C11a), 166.1 (CO), 159.3 (C2), 154.6 (C12a), 149.9 (C5), 136.0 (C4), 120.5 (C3), 112.5 (C5a), 108.8 (C4a), 60.8 (O<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 35.7 (C11), 30.7 (C10), 27.8 (C7), 26.0, 25.8 (C8, C9), 25.1 [<i>C</i>H<sub>3</sub>C(2)], 23.7 (C6), 14.1 (OCH<sub>2</sub><i>C</i>H<sub>3</sub>). MS (API-ES+) <i>m</i>/<i>z</i>: 314.2 [(M + 1)<sup>+</sup>, 100], 205.1 (12). Anal. (C<sub>18</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Molecular Modeling</h3><div class="NLM_p">Molecular modeling studies were carried out with QUANTA/CHARMm sofware running on a Silicon Graphics workstation. The OA structure was retrieved from Protein Data Bank and used as template. Tautomers <b>14a</b>, <b>14b</b>, <b>14c</b>, and <b>14d</b> were assembled within QUANTA using standard bond lengths and bond angles. With the CHARMm force field<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> and partial atomic charges, the molecular geometries of OA and tautomers <b>14a</b>, <b>14b</b>, <b>14c</b>, and <b>14d</b> were each separately energy-minimized using the adopted-based Newton−Raphson algorithm. Structures were considered fully optimized when the energy changes between iterations were less than 0.01 kcal/mol.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Tautomers <b>14a</b>, <b>14b</b>, <b>14c</b>, and <b>14d</b> were manually aligned on OA, and the superimposition was based on a similar substructure embedded in OA. Then a rigid body fit of tautomers to targeted atoms on OA was done with Quanta. The set of atoms used for the superpositioning is described in <a class="ref internalNav" href="#sec2" aria-label="Results and Discussion">Results and Discussion</a>.</div><div class="NLM_p">The blind docking experiment was carried out on the complex <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IE4">2IE4</a> obtained from the Protein Data Bank (PDB). For docking study, initial protein was prepared by removing all water compounds, heteroatoms, and the ligand (okadaic acid) and CHARMm force field was applied using the receptor−ligand interactions tool in Discovery Studio, version 2.1, software package. The docking of <b>14d</b> into PP2Awas performed with the program AUTODOCK VINA.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> AUTODOCKTOOLS (ADT) (version 1.5.4) was used to add hydrogens and partial charges for protein and ligand using Gasteiger charges. Flexible torsions in the ligand were assigned with the AUTOTORS module, and the acyclic dihedral angles were allowed to rotate freely.</div><div class="NLM_p last">Because VINA uses rectangular boxes for the binding site, the box center was defined and the docking box was displayed using ADT. The docking procedure was applied to whole protein target, without imposing the binding site (“blind docking”). The grid field was a 120 Å cube with grid points separated 1 Å, at the middle of the protein (<i>x</i> = 60936; <i>y</i> = −25558; <i>z</i> = −17702). Default parameters were used except num_modes, which was set to 30. The lowest docking-energy conformations were included in the largest cluster found (which contains 40% of total conformations). Otherwise, the lowest docking-energy conformation was considered as the most stable orientation. Finally, the docking results generated were directly loaded into Discovery Studio, version 2.1.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Biology. Data Analysis</h3><div class="NLM_p last">Data are represented as the mean ± standard error of the mean. Comparisons between experimental and control groups were performed by one-way ANOVA followed by Newman−Keuls post hoc test. Differences were considered to be statistically significant when <i>p</i> < 0.05. All statistical procedures were carried out using GraphPad Prism software version 5.0 for an IBM compatible computer.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Culture of SH-SY5Y Cells</h3><div class="NLM_p last">SH-SY5Y cells were maintained in a 1:1 mixture of F-12 nutrient mixture (Ham12) (Sigma-Aldrich, Madrid, Spain) and Eagle’s minimum essential medium (EMEM) supplemented with 15 nonessential amino acids, 1 mM sodium pyruvate, 10% heat-inactivated fetal bovine serum (FBS), 100 units/mL penicillin, and 100 μg/mL streptomycin (reagents from Invitrogen, Madrid, Spain). Cultures were seeded into flasks containing supplemented medium and maintained at 37 °C in a humidified atmosphere of 5% CO<sub>2</sub> and 95% air. For assays, SH-SY5Y cells were subcultured in 48-well plates at a seeding density of 1 × 10<sup>5</sup> cells per well. Cells were treated with the drugs before confluence in EMEM with 1% FBS. All the cells used in this study were used at a low passage number (<13).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Incubation of drugs</h3><div class="NLM_p last">Concentrated solutions of drugs were prepared in DMSO. For the DMSO group (control), 0.1% DMSO was incubated, having the same DMSO concentration of the tested drugs group. Compounds at 1 μM were administered 24 h before adding the cytotoxic stimuli (rotenone/oligomycin A, okadaic acid, or Aβ). Then cells were co-incubated for another 24 h with the drug in the presence of stimuli. All toxic stimuli were incubated in serum-free EMEM.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Inhibition Experiments of AChE and BuChE</h3><div class="NLM_p last">To assess the inhibitory activity of the compounds toward AChE or BuChE, we followed the spectrophotometric method of Ellman,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> using purified AChE from <i>Electrophorus electricus</i> (type V-S), human erythrocytes (buffered aqueous solution) or BuChE from equine serum (lyophilized powder) (Sigma-Aldrich, Madrid, Spain). The reaction took place in a final volume of 3 mL of a phosphate-buffered solution (0.1 M) at pH 8, containing 0.035 U of AChE or 0.05 U of BuChE and 0.35 mM of 5,5′-dithiobis-2-nitrobenzoic acid (DTNB, Sigma-Aldrich, Madrid, Spain). Inhibition curves were made by preincubating this mixture with at least nine concentrations of each compound for 10 min. A sample with no compound was always present to determine the 100% of enzyme activity. After this preincubation period, acetylthiocholine iodide (0.35 mM) or butyrylthiocholine iodide (0.5 mM) (Sigma-Aldrich, Madrid, Spain) was added, allowing 15 min more of incubation, where the DTNB produces the yellow anion 5-thio-2-nitrobenzoic acid along with the enzymatic degradation of acetylthiocholine iodide or butyrylthiocholine iodide. Changes in absorbance were detected at 405 nm in a spectrophotometric plate reader (FluoStar OPTIMA, BMG Labtech). Compounds inhibiting AChE or BuChE activity would reduce the color generation; thus, IC<sub>50</sub> values were calculated as the concentration of compound that produces 50% AChE activity inhibition. Data are expressed as the mean ± SEM of at least three different experiments in quadruplicate.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Kinetic Analysis of the AChE Inhibition</h3><div class="NLM_p last">To obtain estimates of the competitive inhibition constant <i>K</i><sub>i</sub>, reciprocal plots of 1/<i>V</i> versus 1/[S] were constructed at different concentrations of the substrate acetylthiocholine (0.1−1 mM) by using Ellman’s method.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Experiments were performed in a transparent 48-well plate containing in each well 350 μL of the DTNB solution and 1 μL of DMSO (control) or inhibitor solution to give desired final concentration. Reaction was initiated by adding 45 μL of AChE (0.18 U/mL) at 30 °C. Progress curves were monitored at 412 nm over 2 min in a Fluostar Optima (BMG-Technologies, Germany) fluorescence plate reader. Progress curves were characterized by a linear steady-state turnover of the substrate, and values of a linear regression were fitted according to Lineweaver−Burk replots using Origin software. The plots were assessed by a weighted least-squares analysis. Determination of the Michaelis constant for the substrate ATCh was done at seven different concentrations (0.1−1 mM) to give <i>K</i><sub>M</sub> = 0.64 ± 0.09 mM and <i>V</i><sub>max</sub> = 1.7 ± 0.2 min<sup>−1</sup>. Slopes of the reciprocal plots were then plotted against the concentration of <b>14</b> (range 0−0.5 μM) as described,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> to evaluate <i>K</i><sub>i</sub> data. Data analysis was performed with Origin Pro 7.5 software (Origin Lab Corp.).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Measurement of Cytosolic Ca<sup>2+</sup> Concentrations, [Ca<sup>2+</sup>]<sub>c</sub></h3><div class="NLM_p last">SH-SY5Y neuroblastoma cells were grown at confluence in 96-well black dishes. Cells were loaded with 4 μM Fluo-4/AM for 1 h at 37 °C in EMEM. Then cells were washed twice with Krebs Hepes solution and kept at room temperature for 15 min before the beginning of the experiment. Compounds were incubated 10 min before K<sup>+</sup> (70 mM) was applied to evoke the increment of [Ca<sup>2+</sup>]<sub>c</sub>. At the end of the experiment, Triton X-100 (5%) and 1 mM MnCl<sub>2</sub> were applied to record maximal and basal fluorescence, respectively. Fluorescence was measured in a fluorescence microplate reader (FLUOstar Optima, BMG, Germany). Wavelengths of excitation and emission were 485 and 520 nm, respectively.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Measurement of LDH Activity</h3><div class="NLM_p last">LDH activity was spectrophotometrically measured using a cytotoxicity cell death kit (Roche-Boehringer, Mannheim, Germany) according to the manufacturer’s indications. Total LDH activity was defined as the sum of intracellular and extracellular LDH activity. Released LDH was defined as the percentage of extracellular compared to total LDH activity. At the end of the toxic stimulus exposition (24 h), samples were collected to estimate extracellular LDH as indication of cell death.<a onclick="showRef(event, 'ref53 ref65'); return false;" href="javascript:void(0);" class="ref ref53 ref65">(53, 65)</a> Intracellular LDH activity was measured in the cells after incubation with 10% Triton X-100. LDH activity was measured at 490 and 620 nm, using a microplate reader (Labsystems iEMS reader MF; Labsystems, Helsinki, Finland). Total LDH (intracellular plus extracellular) was normalized to 100%. Then the amount of LDH released to the extracellular medium was expressed as a percentage of this total. Data were normalized by subtracting basal LDH (cells not subjected to any treatment) from the different treatment groups in each individual experiment, and the result for the Rot/Olig group was normalized to 100% (percentage cell death).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Quantification of Viability by MTT in SH-SY5Y Cells</h3><div class="NLM_p last">Cell viability, virtually the mitochondrial activity of living cells, was measured by quantitative colorimetric assay with MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide, Sigma-Aldrich, Madrid, Spain), as described previously.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> SH-SY5Y cells were seeded into 48-well culture plates and allowed to attach. MTT was added to all wells (5 mg/mL) and allowed to incubate in the dark at 37 °C for 2 h followed by cell lysis and spectrophotometric measurement at 540 nm. The tetrazolium ring of MTT can be cleaved by active reductases in order to produce a precipitated formazan derivative. The formazan produced was dissolved by adding 200 μL of DMSO, resulting in a colored compound whose optical density was measured in an ELISA reader at 540 nm. All MTT assays were performed in triplicate.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> In Vitro Malachite Green Phosphatase Assay</h3><div class="NLM_p last">Cortex were homogenized and lysed in 20 mM imidazole−HCl, 2 mM EDTA, 2 mM EGTA, pH 7.0, with 10 μg/mL leupeptin, 1 mM PMSF, and protease inhibitor cocktail. An amount of 500 μg of whole lysates was used to immunoprecipitate PP2A with an antibody against the subunit C of PP2A and protein A/agarose following the protocol of PP2A immunoprecipitation phosphatase assay kit (Millipore). Subsequently, the beads were washed three times with the above lysis buffer and twice with the phosphatase assay buffer (50 mM Tris-HCl, pH 7.0, 0.1 mM CaCl<sub>2</sub>). The phosphatase activity of immunoprecipitated PP2A was assayed using Lys-Arg-pThr-Ile-Arg-Arg as the enzymatic substrate provided, following the manufacturer’s instructions. Absorbance was measured at 620 nm using a microplate reader (Labsystems iEMS reader MF). Assays were performed in triplicate.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Viability in Hippocampal Slices Preparations</h3><div class="NLM_p last">We followed the protocol described by Egea and co-workers<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> with slight modifications. Rats were quickly decapitated under sodium pentobarbital anesthesia (60 mg/kg, ip). Forebrains were rapidly removed from the skull and placed into ice-cold Krebs bicarbonate dissection buffer (pH 7.4) containing the following: NaCl 120 mM, KCl 2 mM, CaCl<sub>2</sub> 0.5 mM, NaHCO<sub>3</sub> 26 mM, MgSO<sub>4</sub> 10 mM, KH<sub>2</sub>PO<sub>4</sub> 1.18 mM, glucose 11 mM, and sucrose 200 mM. The hippocampi were quickly dissected, and slices (350 μm thick) were rapidly prepared using a McIlwain tissue chopper, separated in Krebs buffer at 4 °C, and allowed to recover for 45 min in Krebs bicarbonate buffer at 37 °C. For OGD experiments, after an initial preincubation period of 30 min, hippocampal slices corresponding to the control group were incubated for 15 min in a Krebs solution with the following composition: NaCl 120 mM, KCl 2 mM, CaCl<sub>2</sub> 2 mM, NaHCO<sub>3</sub> 26 mM, MgSO<sub>4</sub> 1.19 mM, KH<sub>2</sub>PO<sub>4</sub> 1.18 mM, and glucose 11 mM. This solution was equilibrated with 95% O<sub>2</sub> and 5% CO<sub>2</sub>. OGD was induced by incubating the slices in a glucose-free Krebs solution, equilibrated with a 95% N<sub>2</sub> and 5% CO<sub>2</sub> gas mixture. Glucose was replaced by 2-deoxyglucose. After this OGD period, the slices were returned to an oxygenated normal Krebs solution containing glucose (reoxygenation period). Experiments were performed at 37 °C. A control and OGD group was included in all experiments. The OGD−reoxygenation protocol was 15 min OGD followed by 120 min reoxygenation. Hippocampal slice viability was determined through the ability of the cells to reduce MTT.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Hippocampal slices were collected immediately after the reoxygenation period and were incubated with MTT (0.5 mg/mL) in Krebs bicarbonate solution for 30 min at 37 °C. Formazan production was measured as described above.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60"><a href="/doi/suppl/10.1021/jm901902w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis results for compounds <b>9</b>−<b>16</b>, results and experimental details of the propidium displacement assay, full data of Ca<sup>2+</sup> channel blocking activity of <b>9</b>−<b>16</b>, tables of results for all neuroprotection experiments, protocol of animal usage, and references. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901902w/suppl_file/jm901902w_si_001.pdf">jm901902w_si_001.pdf (70.91 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm901902w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristóbal de los Ríos</span> - <span class="hlFld-Affiliation affiliation">Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratorio de Radicales Libres y Química Computacional, Instituto de Química Orgánica General, Consejo Superior de Investigaciones Científicas, C/Juan de la Cierva 3, 28006 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento de Química Orgánica, Facultad de Farmacia, Universidad de Alcalá de Henares, Ctra. Barcelona, Km. 33.5, 28817, Alcalá de Henares, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6605140f15120904070a4802030a0915140f09152613070b480315460f1709055457260f1709014805150f05480315"><span class="__cf_email__" data-cfemail="fb988992888f94999a97d59f9e97948889929488bb8e9a96d59e88">[email protected]</span> <span class="__cf_email__" data-cfemail="c4adb5aba7f6f584adb5aba3eaa7b7ada7eaa1b7">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Marco-Contelles</span> - <span class="hlFld-Affiliation affiliation">Laboratorio de Radicales Libres y Química Computacional, Instituto de Química Orgánica General, Consejo Superior de Investigaciones Científicas, C/Juan de la Cierva 3, 28006 Madrid, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9ffcedf6ecebf0fdfef3b1fbfaf3f0ecedf6f0ecdfeafef2b1faecbff6eef0fcadaedff6eef0f8b1fcecf6fcb1faec"><span class="__cf_email__" data-cfemail="5635243f25223934373a7832333a3925243f39251623373b783325">[email protected]</span> <span class="__cf_email__" data-cfemail="a2cbd3cdc19093e2cbd3cdc58cc1d1cbc18cc7d1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Javier Egea</span> - <span class="hlFld-Affiliation affiliation">Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rafael León</span> - <span class="hlFld-Affiliation affiliation">Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abdelouahid Samadi</span> - <span class="hlFld-Affiliation affiliation">Laboratorio de Radicales Libres y Química Computacional, Instituto de Química Orgánica General, Consejo Superior de Investigaciones Científicas, C/Juan de la Cierva 3, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabel Iriepa</span> - <span class="hlFld-Affiliation affiliation">Departamento de Química Orgánica, Facultad de Farmacia, Universidad de Alcalá de Henares, Ctra. Barcelona, Km. 33.5, 28817, Alcalá de Henares, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ignacio Moraleda</span> - <span class="hlFld-Affiliation affiliation">Departamento de Química Orgánica, Facultad de Farmacia, Universidad de Alcalá de Henares, Ctra. Barcelona, Km. 33.5, 28817, Alcalá de Henares, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Enrique Gálvez</span> - <span class="hlFld-Affiliation affiliation">Departamento de Química Orgánica, Facultad de Farmacia, Universidad de Alcalá de Henares, Ctra. Barcelona, Km. 33.5, 28817, Alcalá de Henares, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio G. García</span> - <span class="hlFld-Affiliation affiliation">Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Servicio de Farmacología Clínica, Hospital Universitario de la Princesa, C/Diego de León 62, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuela G. López</span> - <span class="hlFld-Affiliation affiliation">Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mercedes Villarroya</span> - <span class="hlFld-Affiliation affiliation">Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alejandro Romero</span> - <span class="hlFld-Affiliation affiliation">Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">C.d.l.R. thanks Ministerio de Ciencia e Innovación for a “Juan de la Cierva” contract. A.S. thanks CSIC for an I3P postdoctoral contract. The present work was supported by the Comunidad Autónoma de Madrid CAM (Grant S/SAL-0275-2006) and Instituto de Salud Carlos III (MICINN, Spain) [RETIC “RENEVAS” (Grants RD06/0026/0009, RD06/0026/1002). M.G.L. (Grant SAF2009-12150) and J.M.-C. (Grants SAF2006-08764-C02-01, SAF2009-07271) thank Spanish Ministry of Science and Innovation for financial support. This work was supported in part by grants to A.G.G.: (1) Fundación C.I.E.N., Instituto de Salud Carlos III, MICINN; (2) Grant NDE 07/09, Agencia Laín Entralgo, Comunidad de Madrid; (3) Grant SAF2006-03589, MICINN, Spain.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 74 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span> </span><span class="NLM_article-title">A century of Alzheimer’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+century+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520century%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4377</span><span class="NLM_x">–</span> <span class="NLM_lpage">4387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.2174%2F138161206778792985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=17105433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4377-4387&author=A.+Castroauthor=A.+Martinez&title=Targeting+beta-amyloid+pathogenesis+through+acetylcholinesterase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span></div><div class="casAuthors">Castro, Ana; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4377-4387</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Although the hallmarks of neurodegeneration in Alzheimer's brains are well known, one of the current difficulties is related to the lack of solid evidence about the ultimate factors that give rise to the pathogenesis of this disease, creating a great challenge for the definition of efficient treatments for Alzheimer's disease (AD).  Current therapeutic option for AD patients is the use of acetylcholinesterase (AChE) inhibitors, which gives only a symptomatic relief.  However, recent studies show a long-lasting effect in a certain percentage of patients.  In fact, there is accumulating evidence that an AChE has secondary non-cholinergic functions including the processing and deposition of β-amyloid (Aβ).  AChE could play a role in the Aβ metab. and during an early step in the development of the senile plaque, as revealed by the finding that AChE accelerates Aβ deposition.  Considering the non-classical AChE functions, their relationships with AD hallmarks, and the putative role of peripheral anionic site in all these functions, the dual binding site AChE inhibitors may acquire importance for AD treatment.  On the other hand, the interference of AChE inhibitors with Aβ processing is not a general rule for this class of compds. with the involvement of other features such as chem. structure and/or genetic regulation.  This review highlights the collection of several compds. with an outstanding profile against AChE-induced amyloid aggregation and potent AChE inhibitory activity, indicating the possibility of targeting Aβ through the inhibition of AChE and reveals the emergence of a new generation of AChE inhibitors aiming to be excellent candidate drugs for the future cure of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrisn7G_dIHxrVg90H21EOLACvtfcHk0lhc77bcijo9TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI&md5=fd41eca56c6433d9ee6a3989908ff2c5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F138161206778792985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778792985%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DTargeting%2520beta-amyloid%2520pathogenesis%2520through%2520acetylcholinesterase%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4377%26epage%3D4387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gong, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span> </span><span class="NLM_article-title">Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2321</span><span class="NLM_x">–</span> <span class="NLM_lpage">2328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.2174%2F092986708785909111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=18855662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2321-2328&author=C.+X.+Gongauthor=K.+Iqbal&title=Hyperphosphorylation+of+microtubule-associated+protein+tau%3A+a+promising+therapeutic+target+for+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease</span></div><div class="casAuthors">Gong, C.-X.; Iqbal, K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2321-2328</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease (AD) is the most common cause of dementia in adults.  The current therapy for AD has only moderate efficacy in controlling symptoms, and it does not cure the disease.  Recent studies have suggested that abnormal hyperphosphorylation of tau in the brain plays a vital role in the mol. pathogenesis of AD and in neurodegeneration.  This article reviews the current advances in understanding of tau protein, regulation of tau phosphorylation, and the role of its abnormal hyperphosphorylation in neurofibrillary degeneration.  Furthermore, several therapeutic strategies for treating AD on the basis of the important role of tau hyperphosphorylation in the pathogenesis of the disease are described.  These strategies include (1) inhibition of glycogen synthase kinase-3β (GSK-3β), cyclin-dependent kinase 5 (cdk5), and other tau kinases; (2) restoration of PP2A activity; and (3) targeting tau O-GlcNAcylation.  Development of drugs on the basis of these strategies is likely to lead to disease-modifying therapies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYsNnpBYEpr7Vg90H21EOLACvtfcHk0lhc77bcijo9TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsb7F&md5=8b860e765e134fa7eeb471026d40d90b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F092986708785909111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785909111%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DHyperphosphorylation%2520of%2520microtubule-associated%2520protein%2520tau%253A%2520a%2520promising%2520therapeutic%2520target%2520for%2520Alzheimer%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2321%26epage%3D2328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Pratico, D.</span><span> </span><span class="NLM_article-title">Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1147</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1147&publication_year=2008&pages=70-78&author=D.+Pratico&title=Evidence+of+oxidative+stress+in+Alzheimer%E2%80%99s+disease+brain+and+antioxidant+therapy%3A+lights+and+shadows"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPratico%26aufirst%3DD.%26atitle%3DEvidence%2520of%2520oxidative%2520stress%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%2520and%2520antioxidant%2520therapy%253A%2520lights%2520and%2520shadows%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2008%26volume%3D1147%26spage%3D70%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Treatment of Alzheimer’s disease: current and future therapeutic approaches</span> <span class="citation_source-journal">Rev. Neurol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=16400259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FhslSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=60-69&author=J.+L.+Cummings&title=Treatment+of+Alzheimer%E2%80%99s+disease%3A+current+and+future+therapeutic+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Alzheimer's disease: current and future therapeutic approaches</span></div><div class="casAuthors">Cummings Jeffrey L</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in neurological diseases</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">60-9</span>
        ISSN:<span class="NLM_cas:issn">1545-2913</span>.
    </div><div class="casAbstract">The pathophysiology of Alzheimer's disease (AD) includes the deposition of amyloid beta protein (Abeta) and the ensuing initiation of a variety of secondary processes, including tau hyperphosphorylation, excitotoxicity, oxidation, and inflammation.  Nerve cell loss in structures responsible for manufacturing neurotransmitters results in a variety of neurochemical deficits.  Current therapeutic approaches to the treatment of AD include cholinesterase inhibitors for mild to moderate disease, memantine for moderate to severe disease, and vitamin E or selegiline.  Reduction of Abeta generation or aggregation, enhancement of Abeta removal, interruption of tau hyperphosphorylation, and the use of more efficacious antioxidant or anti-inflammatory agents represent promising therapeutic strategies currently being investigated.  Improved methodologies for clinical trial design and analysis and the development of biological markers may hasten the identification of effective treatments for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7-rxo5VUM0rHHuJhbyicZfW6udTcc2ebrPxqoLc1Errntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FhslSisA%253D%253D&md5=b88c53187ff8cadf0a0e58f0f1015d1a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DTreatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520current%2520and%2520future%2520therapeutic%2520approaches%26jtitle%3DRev.%2520Neurol.%2520Dis.%26date%3D2004%26volume%3D1%26spage%3D60%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Rafii, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span> </span><span class="NLM_article-title">Recent developments in Alzheimer’s disease therapeutics</span> <span class="citation_source-journal">BMC Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1186%2F1741-7015-7-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=19228370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADC%252BD1M7nsVKksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=7&author=M.+S.+Rafiiauthor=P.+S.+Aisen&title=Recent+developments+in+Alzheimer%E2%80%99s+disease+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in Alzheimer's disease therapeutics</span></div><div class="casAuthors">Rafii Michael S; Aisen Paul S</div><div class="citationInfo"><span class="NLM_cas:title">BMC medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease is a devastating neurological disorder that affects more than 37 million people worldwide.  The economic burden of Alzheimer's disease is massive; in the United States alone, the estimated direct and indirect annual cost of patient care is at least $100 billion.  Current FDA-approved drugs for Alzheimer's disease do not prevent or reverse the disease, and provide only modest symptomatic benefits.  Driven by the clear unmet medical need and a growing understanding of the molecular pathophysiology of Alzheimer's disease, the number of agents in development has increased dramatically in recent years.  Truly *'disease-modifying' therapies that target the underlying mechanisms of Alzheimer's disease have now reached late stages of human clinical trials.  Primary targets include beta-amyloid, whose presence and accumulation in the brain is thought to contribute to the development of Alzheimer's disease, and tau protein which, when hyperphosphorylated, results in the self-assembly of tangles of paired helical filaments also believed to be involved in the pathogenesis of Alzheimer's disease.  In this review, we briefly discuss the current status of Alzheimer's disease therapies under study, as well the scientific context in which they have been developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQBqsOYVNCvy6Ufuk_1xoTfW6udTcc2ebrPxqoLc1Errntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7nsVKksA%253D%253D&md5=fddd28d862a1be10ae4a10cc2769c3a4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-7-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-7-7%26sid%3Dliteratum%253Aachs%26aulast%3DRafii%26aufirst%3DM.%2BS.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26atitle%3DRecent%2520developments%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DBMC%2520Med.%26date%3D2009%26volume%3D7%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">van Marum, R. J.</span><span> </span><span class="NLM_article-title">Current and future therapy in Alzheimer’s disease</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1472-8206.2008.00578.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=18485144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=265-274&author=R.+J.+van+Marum&title=Current+and+future+therapy+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Current and future therapy in Alzheimer's disease</span></div><div class="casAuthors">van Marum, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-274</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Dementia is increasingly being recognized as one of the most important medical problems in the elderly.  As most pharmacol. research within the field of dementia is focused on Alzheimer's dementia (AD), this review will focus on pharmacol. interventions in AD.  Most disease-modifying therapies are based on the amyloid hypothesis.  In this hypothesis, the pathol. accumulation of Aβ in the brain leads to oxidative stress, neuronal destruction and finally the clin. syndrome of AD.  Following this hypothesis, secondary prevention of AD can be made by: decreasing the prodn. of Aβ, stimulation of clearance of Aβ formed or prevention of aggregation of Aβ into amyloid plaques.  First a short overview on current approved therapies for AD is given.  The main part of the review will focus on potential disease-modifying therapies for AD that are currently being studied in phase I to phase III trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYSu96SxTqLVg90H21EOLACvtfcHk0lhKWwBJfzUS_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D&md5=0813e575e9440a3e1ffc0e0ee79c5e7a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.2008.00578.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.2008.00578.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMarum%26aufirst%3DR.%2BJ.%26atitle%3DCurrent%2520and%2520future%2520therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D22%26spage%3D265%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Fillit, H. M.; Doody, R. S.; Binaso, K.; Crooks, G. M.; Ferris, S. H.; Farlow, M. R.; Leifer, B.; Mills, C.; Minkoff, N.; Orland, B.; Reichman, W. E.; Salloway, S.</span><span> </span><span class="NLM_article-title">Recommendations for best practices in the treatment of Alzheimer's disease in managed care</span>.  <span class="citation_source-journal">Am. J. Geriatr. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. A</span>),  <span class="NLM_fpage">S9</span>− <span class="NLM_lpage">S24</span>; quiz S25−S28.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=S9-S24&issue=Suppl.+A&author=H.+M.+Fillit&author=R.+S.+Doody&author=K.+Binaso&author=G.+M.+Crooks&author=S.+H.+Ferris&author=M.+R.+Farlow&author=B.+Leifer&author=C.+Mills&author=N.+Minkoff&author=B.+Orland&author=W.+E.+Reichman&author=S.+Salloway&title=Recommendations+for+best+practices+in+the+treatment+of+Alzheimer%27s+disease+in+managed+care"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFillit%26aufirst%3DH.%2BM.%26atitle%3DRecommendations%2520for%2520best%2520practices%2520in%2520the%2520treatment%2520of%2520Alzheimer%2527s%2520disease%2520in%2520managed%2520care%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Pharmacother.%26date%3D2006%26volume%3D4%26issue%3DSuppl.%2520A%26spage%3DS9%26epage%3DS24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzucchelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porrello, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govoni, S.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors: novel activities of old molecules</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2Fj.phrs.2003.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=15304241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVCqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=441-451&author=M.+Racchiauthor=M.+Mazzucchelliauthor=E.+Porrelloauthor=C.+Lanniauthor=S.+Govoni&title=Acetylcholinesterase+inhibitors%3A+novel+activities+of+old+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors: novel activities of old molecules</span></div><div class="casAuthors">Racchi, Marco; Mazzucchelli, Michela; Porrello, Emanuela; Lanni, Cristina; Govoni, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-451</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The therapeutic approach for improving the cognitive function in patients with Alzheimer's disease (AD) is mainly based on the potentiation of central cholinergic activity and is achieved clin. by the use of acetylcholinesterase (AChE) inhibitors such as tacrine, donepezil, rivastigmine, galantamine and other drugs currently in clin. trials.  These are, by their pharmacol., only symptomatic drugs yet recently these mols. have shown some potential also in the modulation of amyloid precursor protein (APP) processing.  We explore in this review the exptl. evidence that suggests a role for AChEIs in APP processing and point to multiple complex mechanisms involving either a cholinergic agonist effect, coupled to multiple signal transduction pathways, or post-transcriptional effects that modulate the expression of cellular APP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVpOo04QwYy7Vg90H21EOLACvtfcHk0lhbFpQ0EBzodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVCqsr8%253D&md5=7f81d066fa285380f75c36d18ec46313</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2003.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2003.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DMazzucchelli%26aufirst%3DM.%26aulast%3DPorrello%26aufirst%3DE.%26aulast%3DLanni%26aufirst%3DC.%26aulast%3DGovoni%26aufirst%3DS.%26atitle%3DAcetylcholinesterase%2520inhibitors%253A%2520novel%2520activities%2520of%2520old%2520molecules%26jtitle%3DPharmacol.%2520Res.%26date%3D2004%26volume%3D50%26spage%3D441%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Talesa, V. N.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase in Alzheimer’s disease</span> <span class="citation_source-journal">Mech. Ageing Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2001&pages=1961-1969&author=V.+N.+Talesa&title=Acetylcholinesterase+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalesa%26aufirst%3DV.%2BN.%26atitle%3DAcetylcholinesterase%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMech.%2520Ageing%2520Dev.%26date%3D2001%26volume%3D122%26spage%3D1961%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">O’Neill, M. F.</span><span> </span><span class="NLM_article-title">Difficult times for Alzheimer’s treatments</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1333-1335&author=M.+F.+O%E2%80%99Neill&title=Difficult+times+for+Alzheimer%E2%80%99s+treatments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BF.%26atitle%3DDifficult%2520times%2520for%2520Alzheimer%25E2%2580%2599s%2520treatments%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D1333%26epage%3D1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bullock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touchon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapatz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, R.</span><span> </span><span class="NLM_article-title">Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer’s disease over a 2-year period</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1185%2F030079905X56565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=16083542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGltrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=1317-1327&author=R.+Bullockauthor=J.+Touchonauthor=H.+Bergmanauthor=G.+Gambinaauthor=Y.+Heauthor=G.+Rapatzauthor=J.+Nagelauthor=R.+Lane&title=Rivastigmine+and+donepezil+treatment+in+moderate+to+moderately-severe+Alzheimer%E2%80%99s+disease+over+a+2-year+period"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period</span></div><div class="casAuthors">Bullock, Roger; Touchon, Jacques; Bergman, Howard; Gambina, Giuseppe; He, Yunsheng; Rapatz, Gunter; Nagel, Jennifer; Lane, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1317-1327</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">Randomized controlled trials that directly compare cholinesterase inhibitors for the treatment of Alzheimer's disease have been characterized by significant methodol. limitations.  As a consequence, they have failed to establish whether there are differences between agents in this class.  A double-blind, randomized, controlled, multicenter trial was designed to evaluate the efficacy and tolerability of cholinesterase inhibitor treatment in patients with moderate to moderately-severe Alzheimer's disease over a 2-yr period.  Patients were randomly assigned to rivastigmine 3-12 mg/day or donepezil 5-10 mg/day.  Efficacy measures comprised assessments of cognition, activities of daily living, global functioning and behavioral symptoms.  Safety and tolerability assessments included adverse events and measurement of vital signs.  In total, 994 patients received cholinesterase inhibitor treatment (rivastigmine, n = 495; donepezil, n = 499), and 57.9% of patients completed the study.  The most frequent reason for premature discontinuation in both treatment groups was adverse events, primarily gastrointestinal.  Adverse events were more frequent in the rivastigmine group during the titrn. phase, but similar in the maintenance phase.  Serious adverse events were reported by 31.7% of rivastigmine- and 32.5% of donepezil-treated patients, resp.  Rivastigmine and donepezil had similar effects on measures of cognition and behavior, but rivastigmine showed a statistically significant advantage on measures of activities of daily living and global functioning in the ITT-LOCF population.  However, this was not maintained in the non-ITT-LOCF populations.  In secondary subgroup analyses, AD patients who had genotypes that encoded for full expression of the butyrylcholinesterase enzyme (BuChE wt/wt; n = 226/340), who were < 75 years of age (n = 362/994) or who had symptoms suggestive of concomitant Lewy body disease (n = 49/994) showed significantly greater benefits from rivastigmine treatment.  Cholinesterase inhibitor treatment may offer continued therapeutic benefit for up to 2 years in patients with moderate AD.  Although both drugs performed similarly on cognition and behavior, rivastigmine may provide greater benefit in activities of daily living and global functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxRLhcjewR27Vg90H21EOLACvtfcHk0lhbFpQ0EBzodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGltrrM&md5=27e399adae3f407b7ea4e9b092f6634c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1185%2F030079905X56565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079905X56565%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DR.%26aulast%3DTouchon%26aufirst%3DJ.%26aulast%3DBergman%26aufirst%3DH.%26aulast%3DGambina%26aufirst%3DG.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DRapatz%26aufirst%3DG.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DLane%26aufirst%3DR.%26atitle%3DRivastigmine%2520and%2520donepezil%2520treatment%2520in%2520moderate%2520to%2520moderately-severe%2520Alzheimer%25E2%2580%2599s%2520disease%2520over%2520a%25202-year%2520period%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2005%26volume%3D21%26spage%3D1317%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span> </span><span class="NLM_article-title">Novel anti-Alzheimer’s dimer bis(7)-cognitin: cellular and molecular mechanisms of neuroprotection through multiple targets</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=187-201&author=W.+Liauthor=M.+Makauthor=H.+Jiangauthor=Q.+Wangauthor=Y.+Pangauthor=K.+Chenauthor=Y.+Han&title=Novel+anti-Alzheimer%E2%80%99s+dimer+bis%287%29-cognitin%3A+cellular+and+molecular+mechanisms+of+neuroprotection+through+multiple+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMak%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DY.%26atitle%3DNovel%2520anti-Alzheimer%25E2%2580%2599s%2520dimer%2520bis%25287%2529-cognitin%253A%2520cellular%2520and%2520molecular%2520mechanisms%2520of%2520neuroprotection%2520through%2520multiple%2520targets%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D187%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Lorrio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobrado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arias, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span> </span><span class="NLM_article-title">Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1124%2Fjpet.107.122747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=17526807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=591-599&author=S.+Lorrioauthor=M.+Sobradoauthor=E.+Ariasauthor=J.+M.+Rodaauthor=A.+G.+Garciaauthor=M.+G.+Lopez&title=Galantamine+postischemia+provides+neuroprotection+and+memory+recovery+against+transient+global+cerebral+ischemia+in+gerbils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils</span></div><div class="casAuthors">Lorrio, Silvia; Sobrado, Monica; Arias, Esperanza; Roda, Jose M.; Garcia, Antonio G.; Lopez, Manuela G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">591-599</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Galantamine, currently used in Alzheimer's patients, has shown neuroprotection in hippocampal slices subjected to oxygen-glucose deprivation.  Here, we present an in vivo study to evaluate the potential neuroprotective effects of galantamine in a transient global cerebral ischemia model in gerbils.  Three treatment protocols were used.  In the pretreatment protocol, gerbils were treated before ischemia and for 3 consecutive days thereafter.  Eight groups of animals were included: sham operation plus placebo, 10 mg/kg mecamylamine and 10 mg/kg galantamine, resp.; and ischemia plus placebo, 10 mg/kg mecamylamine, 1 mg/kg galantamine, and 10 mg/kg galantamine and 10 mg/kg mecamylamine plus galantamine, resp.  Postischemia protocols included three groups of animals: sham operation, ischemia plus placebo, and ischemia plus 10 mg/kg galantamine; substances were administered 3 or 6 h after ischemia and for 2 consecutive days thereafter.  Pyramidal neurons surviving in the cornus ammonis 1 region of the hippocampus were evaluated 72 h after reperfusion, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) histochem., caspase-3 and superoxide dismutase (SOD)-2 immunohistochemistries, and Western blottings were performed, and object placement tests were carried out.  Galantamine significantly increased the no. of living pyramidal neurons after ischemia-reperfusion injury.  Galantamine significantly reduced TUNEL, active caspase-3, and SOD-2 immunoreactivity.  The nicotinic antagonist mecamylamine blocked the protective effects of galantamine.  The neuroprotective effects of galantamine were preserved even when first administered at 3 h postischemia.  These results correlated with the performance in the object placement test.  This study shows that galantamine provides in vivo neuroprotection and memory recovery against global cerebral ischemia, even when administration begins 3 h postischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMjXG-BDErbVg90H21EOLACvtfcHk0lhOR04dJe90jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSjtLk%253D&md5=d9bff0788463da058533e1af0c3efe46</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.122747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.122747%26sid%3Dliteratum%253Aachs%26aulast%3DLorrio%26aufirst%3DS.%26aulast%3DSobrado%26aufirst%3DM.%26aulast%3DArias%26aufirst%3DE.%26aulast%3DRoda%26aufirst%3DJ.%2BM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26atitle%3DGalantamine%2520postischemia%2520provides%2520neuroprotection%2520and%2520memory%2520recovery%2520against%2520transient%2520global%2520cerebral%2520ischemia%2520in%2520gerbils%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D591%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Arias, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ales, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabilan, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano-Abad, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span> </span><span class="NLM_article-title">Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2004&pages=103-114&author=E.+Ariasauthor=E.+Alesauthor=N.+H.+Gabilanauthor=M.+F.+Cano-Abadauthor=M.+Villarroyaauthor=A.+G.+Garciaauthor=M.+G.+Lopez&title=Galantamine+prevents+apoptosis+induced+by+beta-amyloid+and+thapsigargin%3A+involvement+of+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArias%26aufirst%3DE.%26aulast%3DAles%26aufirst%3DE.%26aulast%3DGabilan%26aufirst%3DN.%2BH.%26aulast%3DCano-Abad%26aufirst%3DM.%2BF.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26atitle%3DGalantamine%2520prevents%2520apoptosis%2520induced%2520by%2520beta-amyloid%2520and%2520thapsigargin%253A%2520involvement%2520of%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D46%26spage%3D103%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Melo, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostinho, P.</span><span> </span><span class="NLM_article-title">Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1460-9568.2009.06612.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=19222556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ltlSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=455-464&author=J.+B.+Meloauthor=C.+Sousaauthor=P.+Garcaoauthor=C.+R.+Oliveiraauthor=P.+Agostinho&title=Galantamine+protects+against+oxidative+stress+induced+by+amyloid-beta+peptide+in+cortical+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons</span></div><div class="casAuthors">Melo Joana B; Sousa Carla; Garcao Pedro; Oliveira Catarina R; Agostinho Paula</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Galantamine is currently used in the treatment of patients with mild-to-moderate Alzheimer's disease (AD).  Although its action is mostly directed at the regulation of cholinergic transmission, galantamine can also afford neuroprotection against amyloid-beta peptide (Abeta), which is involved in AD pathogenesis.  In this study, we used cultured rat cortical neurons treated with two forms of Abeta(1-40), fresh and previously aged (enriched in fibrils).  First, we confirmed that galantamine prevented neurodegeneration induced by both peptide forms in a concentration-dependent manner.  Moreover, we observed that when neurons were co-incubated with fresh Abeta(1-40) plus galantamine, the amount of amyloid aggregates was reduced.  As oxidative conditions influence Abeta aggregation, we investigated whether galantamine prevents oxidative stress induced by this peptide.  The data show that either fresh or aged Abeta(1-40) significantly increased the amount of reactive oxygen species and lipoperoxidation, these effects being prevented by galantamine.  In Abeta(1-40)-treated neurons, the depletion of reduced glutathione (GSH) seems to be related to the decrease in glutathione peroxidase and glutathione reductase activities(.) These alterations in the GSH antioxidant system were prevented by galantamine.  Overall, these results constitute the first evidence that galantamine can prevent the neuronal oxidative damage induced by Abeta, providing an in vitro basis for the beneficial actions of galantamine in the AD neurodegenerative process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJ45F6z1jQI8ULxIEhxUjPfW6udTcc2eaa9hCImYfeY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ltlSmsA%253D%253D&md5=2c73855b5b7334bcf926d97afa39ae93</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2009.06612.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2009.06612.x%26sid%3Dliteratum%253Aachs%26aulast%3DMelo%26aufirst%3DJ.%2BB.%26aulast%3DSousa%26aufirst%3DC.%26aulast%3DGarcao%26aufirst%3DP.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26aulast%3DAgostinho%26aufirst%3DP.%26atitle%3DGalantamine%2520protects%2520against%2520oxidative%2520stress%2520induced%2520by%2520amyloid-beta%2520peptide%2520in%2520cortical%2520neurons%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D455%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Noh, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1471-4159.2008.05837.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=19077054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFelsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2009&pages=1116-1125&author=M.+Y.+Nohauthor=S.+H.+Kohauthor=Y.+Kimauthor=H.+Y.+Kimauthor=G.+W.+Choauthor=S.+H.+Kim&title=Neuroprotective+effects+of+donepezil+through+inhibition+of+GSK-3+activity+in+amyloid-beta-induced+neuronal+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-β-induced neuronal cell death</span></div><div class="casAuthors">Noh, Min-Young; Koh, Seong-Ho; Kim, Youngchul; Kim, Hyun Young; Cho, Goang Won; Kim, Seung Hyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1116-1125</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Acetylcholinesterase inhibitors (AChE-inhibitors) are used for the treatment of Alzheimer's disease.  Recently, the AChE-inhibitor donepezil was found to have neuroprotective effects.  However, the protective mechanisms of donepezil have not yet been clearly identified.  We investigated the neuroprotective effects of donepezil and other AChE-inhibitors against amyloid-β1-42 (Aβ42)-induced neurotoxicity in rat cortical neurons.  To evaluate the neuroprotective effects of AChE-inhibitors, primary cultured cortical neurons were pre-treated with several concns. of AChE-inhibitors for 24 h and then treated with 20 μM Aβ42 for 6 h.  In addn. to donepezil, other AChE-inhibitors (galantamine and huperzine A) also showed increased neuronal cell viability against Aβ42 toxicity in a concn.-dependent manner.  However, we demonstrated that donepezil has a more potent effect in inhibiting glycogen synthase kinase-3 (GSK-3) activity compared with other AChE-inhibitors.  The neuroprotective effects of donepezil were blocked by LY294002 (10 μM), a phosphoinositide 3 kinase inhibitor, but only partially by mecamylamine (10 μM), a blocker of nicotinic acetylcholine receptors.  Addnl., donepezil's neuroprotective mechanism was related to the enhanced phosphorylation of Akt and GSK-3β and reduced phosphorylation of tau and glycogen synthase.  These results suggest that donepezil prevents Aβ42-induced neurotoxicity through the activation of phosphoinositide 3 kinase/Akt and inhibition of GSK-3, as well as through the activation of nicotinic acetylcholine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAlKKJMgtliLVg90H21EOLACvtfcHk0lhmVA0UPzGHYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFelsrs%253D&md5=574ac70d2b0d533599b4c11a11332d55</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05837.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05837.x%26sid%3Dliteratum%253Aachs%26aulast%3DNoh%26aufirst%3DM.%2BY.%26aulast%3DKoh%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DCho%26aufirst%3DG.%2BW.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DNeuroprotective%2520effects%2520of%2520donepezil%2520through%2520inhibition%2520of%2520GSK-3%2520activity%2520in%2520amyloid-beta-induced%2520neuronal%2520cell%2520death%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D108%26spage%3D1116%26epage%3D1125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanueva, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=881-891&author=N.+C.+Inestrosaauthor=A.+Alvarezauthor=C.+A.+Perezauthor=R.+D.+Morenoauthor=M.+Vicenteauthor=C.+Linkerauthor=O.+I.+Casanuevaauthor=C.+Sotoauthor=J.+Garrido&title=Acetylcholinesterase+accelerates+assembly+of+amyloid-beta-peptides+into+Alzheimer%E2%80%99s+fibrils%3A+possible+role+of+the+peripheral+site+of+the+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%2BA.%26aulast%3DMoreno%26aufirst%3DR.%2BD.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DLinker%26aufirst%3DC.%26aulast%3DCasanueva%26aufirst%3DO.%2BI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520accelerates%2520assembly%2520of%2520amyloid-beta-peptides%2520into%2520Alzheimer%25E2%2580%2599s%2520fibrils%253A%2520possible%2520role%2520of%2520the%2520peripheral%2520site%2520of%2520the%2520enzyme%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D881%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2FS0006-2952%2802%2901514-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=12527333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=407-416&author=M.+Bartoliniauthor=C.+Bertucciauthor=V.+Cavriniauthor=V.+Andrisano&title=beta-Amyloid+aggregation+induced+by+human+acetylcholinesterase%3A+inhibition+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span></div><div class="casAuthors">Bartolini, Manuela; Bertucci, Carlo; Cavrini, Vanni; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The aggregation of β-amyloid (1-40) (Aβ) induced by human recombinant acetylcholinesterase (HuAChE) was studied by means of CD (CD) and by thioflavin T fluorescence spectroscopy.  Aβ was incubated alone and with HuAChE.  The kinetic of fibrils formation was followed for 48 h.  The increasing β-conformation content induced by HuAChE, preliminary to the formation of Aβ fibrils, was detd. by CD.  This phenomenon was found to be related to the thioflavin T emission of fluorescence at 490 nm.  Incubation expts. were performed in the presence of known AChE inhibitors (physostigmine, edrophonium, decamethonium, propidium) and drugs used for Alzheimer's disease (AD) (tacrine, donepezil), to test their capability of preventing the HuAChE-induced Aβ aggregation.  The non-competitive or mixed mode of AChE inhibition was confirmed to be an essential feature.  At 100 μM propidium, decamethonium, donepezil and physostigmine were found to inhibit the HuAChE-induced Aβ aggregation by 82, 25, 22 and 30%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2eDGIBesVCbVg90H21EOLACvtfcHk0lgSd36U3QwniQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D&md5=51d1021e8be93014f0b15a61db241392</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901514-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901514-9%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3Dbeta-Amyloid%2520aggregation%2520induced%2520by%2520human%2520acetylcholinesterase%253A%2520inhibition%2520studies%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D65%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Espinoza-Fonseca, L. M.</span><span> </span><span class="NLM_article-title">The benefits of the multi-target approach in drug design and discovery</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">896</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2Fj.bmc.2005.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=16203151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=896-897&author=L.+M.+Espinoza-Fonseca&title=The+benefits+of+the+multi-target+approach+in+drug+design+and+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The benefits of the multi-target approach in drug design and discovery</span></div><div class="casAuthors">Espinoza-Fonseca, L. Michel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">896-897</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Promiscuous binding has been considered to be a problem in the design and development of new drugs against a given disease.  However, promiscuity in mol. recognition is not all bad news, and scientists are currently taking advantage of the emerging promiscuous binding' or multi-target approach' in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocGqPWnEVzk7Vg90H21EOLACvtfcHk0lgSd36U3QwniQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOjuw%253D%253D&md5=3daf3304b9bc2c60575b5e3003e89897</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DEspinoza-Fonseca%26aufirst%3DL.%2BM.%26atitle%3DThe%2520benefits%2520of%2520the%2520multi-target%2520approach%2520in%2520drug%2520design%2520and%2520discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D896%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0ljCp-4hJ8bLcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpellini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estelrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lizondo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3588</span><span class="NLM_x">–</span> <span class="NLM_lpage">3598</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8001313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3588-3598&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=T.+Gomezauthor=D.+Munoz-Torreroauthor=M.+Scarpelliniauthor=E.+Viaynaauthor=A.+Badiaauthor=M.+V.+Closauthor=A.+Caminsauthor=M.+Pallasauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=J.+Estelrichauthor=M.+Lizondoauthor=A.+Bidon-Chanalauthor=F.+J.+Luque&title=Novel+donepezil-based+inhibitors+of+acetyl-+and+butyrylcholinesterase+and+acetylcholinesterase-induced+beta-amyloid+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm8001313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001313%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DGomez%26aufirst%3DT.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26aulast%3DScarpellini%26aufirst%3DM.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPallas%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DEstelrich%26aufirst%3DJ.%26aulast%3DLizondo%26aufirst%3DM.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNovel%2520donepezil-based%2520inhibitors%2520of%2520acetyl-%2520and%2520butyrylcholinesterase%2520and%2520acetylcholinesterase-induced%2520beta-amyloid%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3588%26epage%3D3598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colizzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2Fj.bmcl.2007.09.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=17998161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1WgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=423-426&author=L.+Piazziauthor=A.+Cavalliauthor=F.+Colizziauthor=F.+Bellutiauthor=M.+Bartoliniauthor=F.+Manciniauthor=M.+Recanatiniauthor=V.+Andrisanoauthor=A.+Rampa&title=Multi-target-directed+coumarin+derivatives%3A+hAChE+and+BACE1+inhibitors+as+potential+anti-Alzheimer+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds</span></div><div class="casAuthors">Piazzi, Lorna; Cavalli, Andrea; Colizzi, Francesco; Belluti, Federica; Bartolini, Manuela; Mancini, Francesca; Recanatini, Maurizio; Andrisano, Vincenza; Rampa, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">423-426</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The complex etiol. of Alzheimer's disease (AD) prompts scientists to develop multifunctional compds. to combat causes and symptoms of such neurodegeneration.  A series of compds., e.g., I, has been designed, synthesized, and tested by introducing halophenylalkylamidic functions on the scaffold of AP2238 (II), which is a dual binding site acetylcholinesterase inhibitor.  The inhibitory activity was successfully extended to the beta-site amyloid precursor protein cleavage enzyme, leading to the discovery of a potent inhibitor of this enzyme and affording multifunctional compds. for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQZP5TwhQKrVg90H21EOLACvtfcHk0lh5YYkI6vAc8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1WgtA%253D%253D&md5=f97fcfe0199fced046a876d98ed481bc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.100%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DColizzi%26aufirst%3DF.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DMulti-target-directed%2520coumarin%2520derivatives%253A%2520hAChE%2520and%2520BACE1%2520inhibitors%2520as%2520potential%2520anti-Alzheimer%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D423%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dafni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Pyrano[3,2-<i>c</i>]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5365</span><span class="NLM_x">–</span> <span class="NLM_lpage">5379</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900859q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5365-5379&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=D.+Munoz-Torreroauthor=L.+Ramirezauthor=E.+Gomezauthor=N.+Isambertauthor=R.+Lavillaauthor=A.+Badiaauthor=M.+V.+Closauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodriguez-Francoauthor=O.+Huertasauthor=T.+Dafniauthor=F.+J.+Luque&title=Pyrano%5B3%2C2-c%5Dquinoline-6-chlorotacrine+hybrids+as+a+novel+family+of+acetylcholinesterase-+and+beta-amyloid-directed+anti-Alzheimer+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm900859q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900859q%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26aulast%3DRamirez%26aufirst%3DL.%26aulast%3DGomez%26aufirst%3DE.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DDafni%26aufirst%3DT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DPyrano%255B3%252C2-c%255Dquinoline-6-chlorotacrine%2520hybrids%2520as%2520a%2520novel%2520family%2520of%2520acetylcholinesterase-%2520and%2520beta-amyloid-directed%2520anti-Alzheimer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5365%26epage%3D5379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Weinstock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschbaum-Slager, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarovici, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bejar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoham, S.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">939</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=939&publication_year=2001&pages=148-161&author=M.+Weinstockauthor=N.+Kirschbaum-Slagerauthor=P.+Lazaroviciauthor=C.+Bejarauthor=M.+B.+Youdimauthor=S.+Shoham&title=Neuroprotective+effects+of+novel+cholinesterase+inhibitors+derived+from+rasagiline+as+potential+anti-Alzheimer+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstock%26aufirst%3DM.%26aulast%3DKirschbaum-Slager%26aufirst%3DN.%26aulast%3DLazarovici%26aufirst%3DP.%26aulast%3DBejar%26aufirst%3DC.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DShoham%26aufirst%3DS.%26atitle%3DNeuroprotective%2520effects%2520of%2520novel%2520cholinesterase%2520inhibitors%2520derived%2520from%2520rasagiline%2520as%2520potential%2520anti-Alzheimer%2520drugs%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2001%26volume%3D939%26spage%3D148%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinchon, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Novel tacrine derivatives that block neuronal calcium channels</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2088</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2077-2088&author=C.+de+los+Riosauthor=J.+L.+Marcoauthor=M.+D.+Carreirasauthor=P.+M.+Chinchonauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Novel+tacrine+derivatives+that+block+neuronal+calcium+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3DCarreiras%26aufirst%3DM.%2BD.%26aulast%3DChinchon%26aufirst%3DP.%2BM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNovel%2520tacrine%2520derivatives%2520that%2520block%2520neuronal%2520calcium%2520channels%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2077%26epage%3D2088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banos, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivas, N. M.</span><span> </span><span class="NLM_article-title">Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=727-732&author=J.+L.+Marcoauthor=C.+de+los+Riosauthor=M.+C.+Carreirasauthor=J.+E.+Banosauthor=A.+Badiaauthor=N.+M.+Vivas&title=Synthesis+and+acetylcholinesterase%2Fbutyrylcholinesterase+inhibition+activity+of+new+tacrine-like+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DCarreiras%26aufirst%3DM.%2BC.%26aulast%3DBanos%26aufirst%3DJ.%2BE.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26atitle%3DSynthesis%2520and%2520acetylcholinesterase%252Fbutyrylcholinesterase%2520inhibition%2520activity%2520of%2520new%2520tacrine-like%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D727%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglietta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terencio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Novel multipotent tacrine−dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7607</span><span class="NLM_x">–</span> <span class="NLM_lpage">7610</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061047j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7607-7610&author=J.+Marco-Contellesauthor=R.+Leonauthor=C.+de+Los+Riosauthor=A.+Gugliettaauthor=J.+Terencioauthor=M.+G.+Lopezauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Novel+multipotent+tacrine%E2%88%92dihydropyridine+hybrids+with+improved+acetylcholinesterase+inhibitory+and+neuroprotective+activities+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm061047j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061047j%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3Dde%2BLos%2BRios%26aufirst%3DC.%26aulast%3DGuglietta%26aufirst%3DA.%26aulast%3DTerencio%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNovel%2520multipotent%2520tacrine%25E2%2588%2592dihydropyridine%2520hybrids%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520neuroprotective%2520activities%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7607%26epage%3D7610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras Mdo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Tacripyrines, the first tacrine−dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2724</span><span class="NLM_x">–</span> <span class="NLM_lpage">2732</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801292b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2724-2732&author=J.+Marco-Contellesauthor=R.+Leonauthor=C.+de+los+Riosauthor=A.+Samadiauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=O.+Huertasauthor=X.+Barrilauthor=F.+J.+Luqueauthor=M.+I.+Rodriguez-Francoauthor=B.+Lopezauthor=M.+G.+Lopezauthor=A.+G.+Garciaauthor=C.+Carreiras+Mdoauthor=M.+Villarroya&title=Tacripyrines%2C+the+first+tacrine%E2%88%92dihydropyridine+hybrids%2C+as+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm801292b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801292b%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DLopez%26aufirst%3DB.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DCarreiras%2BMdo%26aufirst%3DC.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DTacripyrines%252C%2520the%2520first%2520tacrine%25E2%2588%2592dihydropyridine%2520hybrids%252C%2520as%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2724%26epage%3D2732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Summers, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majovski, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachiki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, A.</span><span> </span><span class="NLM_article-title">Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">1241</span><span class="NLM_x">–</span> <span class="NLM_lpage">1245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1056%2FNEJM198611133152001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=2430180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADyaL2s%252FjvFahsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=1986&pages=1241-1245&author=W.+K.+Summersauthor=L.+V.+Majovskiauthor=G.+M.+Marshauthor=K.+Tachikiauthor=A.+Kling&title=Oral+tetrahydroaminoacridine+in+long-term+treatment+of+senile+dementia%2C+Alzheimer+type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type</span></div><div class="casAuthors">Summers W K; Majovski L V; Marsh G M; Tachiki K; Kling A</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1241-5</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">We treated 17 patients who had moderate to severe Alzheimer's disease with oral tetrahydroaminoacridine (THA), a centrally active anticholinesterase, in a three-phase study.  In the nonblinded first phase of the study, significant improvement occurred in subjects who received the drug, as compared with their pretreatment status, on the global assessment (P = 0.001), the Orientation Test (P = 0.001), and the more sophisticated Names Learning Test (P = 0.001).  During the second phase, the subjects served as their own controls in a double-blind, placebo-controlled, cross-over study in which the order of administration of the drug and placebo was randomly assigned.  Among the 14 subjects completing Phase II, THA treatment produced significantly better results than placebo on the global assessment (P = 0.003), the Orientation Test (P = 0.004), the Alzheimer's Deficit Scale (P = 0.003), and the Names Learning Test (P = 0.001).  Twelve subjects have entered Phase III, which involves long-term administration of oral THA.  The average duration of treatment in these subjects at present is 12.6 months; symptomatic improvements have occurred, and no serious side effects attributable to THA have been observed.  These encouraging initial results suggest that THA may be at least temporarily useful in the long-term palliative treatment of patients with Alzheimer's disease.  We stress that further observations will be required before a clear assessment of the role of this agent can be made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXMwVWLd0gLpp6t8nS6Nc3fW6udTcc2ea3I6uGWIHVLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s%252FjvFahsA%253D%253D&md5=cdb2761ff58c436d8e12d9a9ab219ccd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1056%2FNEJM198611133152001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198611133152001%26sid%3Dliteratum%253Aachs%26aulast%3DSummers%26aufirst%3DW.%2BK.%26aulast%3DMajovski%26aufirst%3DL.%2BV.%26aulast%3DMarsh%26aufirst%3DG.%2BM.%26aulast%3DTachiki%26aufirst%3DK.%26aulast%3DKling%26aufirst%3DA.%26atitle%3DOral%2520tetrahydroaminoacridine%2520in%2520long-term%2520treatment%2520of%2520senile%2520dementia%252C%2520Alzheimer%2520type%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1986%26volume%3D315%26spage%3D1241%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Mori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varadi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakamori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, A.</span><span> </span><span class="NLM_article-title">Molecular pharmacology of voltage-dependent calcium channels</span> <span class="citation_source-journal">Jpn. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1254%2Fjjp.72.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=8912911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaK28XmsVCrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1996&pages=83-109&author=Y.+Moriauthor=G.+Mikalaauthor=G.+Varadiauthor=T.+Kobayashiauthor=S.+Kochauthor=M.+Wakamoriauthor=A.+Schwartz&title=Molecular+pharmacology+of+voltage-dependent+calcium+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology of voltage-dependent calcium channels</span></div><div class="casAuthors">Mori, Yasuo; Mikala, Gabor; Varadi, Gyula; Kobayashi, Tsutomu; Koch, Sheryl; Wakamori, Minoru; Schwartz, Arnold</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-109</span>CODEN:
                <span class="NLM_cas:coden">JJPAAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-5198</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A review, with 262 refs., describing recent progress in understanding the interactions between Ca2+ channels and their blockers, i.e., Ca2+ antagonists, from a mol. and structural point of view.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmtvN84D43hrVg90H21EOLACvtfcHk0lgYhD1pkCgb5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsVCrsbc%253D&md5=09045dbbe2aa4799b15a21e0ec5883c8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1254%2Fjjp.72.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjjp.72.83%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DY.%26aulast%3DMikala%26aufirst%3DG.%26aulast%3DVaradi%26aufirst%3DG.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DKoch%26aufirst%3DS.%26aulast%3DWakamori%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DA.%26atitle%3DMolecular%2520pharmacology%2520of%2520voltage-dependent%2520calcium%2520channels%26jtitle%3DJpn.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D72%26spage%3D83%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, Y.</span><span> </span><span class="NLM_article-title">Ca<sup>2+</sup> channel antagonists and neuroprotection from cerebral ischemia</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2FS0014-2999%2898%2900774-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=9877076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaK1cXotFWjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=1998&pages=1-15&author=T.+Kobayashiauthor=Y.+Mori&title=Ca2%2B+channel+antagonists+and+neuroprotection+from+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ channel antagonists and neuroprotection from cerebral ischemia</span></div><div class="casAuthors">Kobayashi, Tsutomu; Mori, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 114 refs. Stroke is the 3rd leading cause of death and the main disabling neurol. disease.  The finding in exptl. studies that neuronal death does not occur immediately after ischemic injury has encouraged the development of neuroprotective agents.  Various Ca2+ channel antagonists, i.e., L-type-selective or nonselective derivs. of classical Ca2+ channel antagonists, have been examd. for their ability to produce neuroprotection through improvement of cerebral blood circulation or inhibition of Ca2+ overload induced by excessive glutamate release.  Although some of the antagonists gave efficient neuroprotection in animal models, systemic hypotension limited the utility of these drugs, and none of the compds. had beneficial effects in treatments for acute ischemic stroke in clin. trials.  Drugs other than Ca2+ channel antagonists which have been developed on the basis of the glutamate-Ca2+ overload hypothesis also lack clin. benefit.  Recently, some mechanisms have been proposed to interpret neuronal death in relation to hyperexcitability or apoptosis after ischemic insult.  In these hypotheses, activation of the Ca2+ channel types selectively expressed in neuronal tissues is proposed as a crit. step of the pathways toward neurodegeneration.  Thus, it is increasingly recognized that developing highly selective compds. for interacting with neuronal Ca2+ channels is not only important for treatment of stroke but also for elucidation of mechanisms that underlie neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoET9ON4I4zw7Vg90H21EOLACvtfcHk0lgYhD1pkCgb5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotFWjtLw%253D&md5=7c76108499474a770d09bc7ae48f7993</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2898%2900774-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252898%252900774-2%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DY.%26atitle%3DCa2%252B%2520channel%2520antagonists%2520and%2520neuroprotection%2520from%2520cerebral%2520ischemia%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D363%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lukic-Panin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span> </span><span class="NLM_article-title">Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1176</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2Fj.brainres.2007.07.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=17904110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2ht7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1176&publication_year=2007&pages=143-150&author=V.+Lukic-Paninauthor=T.+Kamiyaauthor=H.+Zhangauthor=T.+Hayashiauthor=A.+Tsuchiyaauthor=Y.+Seharaauthor=K.+Deguchiauthor=T.+Yamashitaauthor=K.+Abe&title=Prevention+of+neuronal+damage+by+calcium+channel+blockers+with+antioxidative+effects+after+transient+focal+ischemia+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats</span></div><div class="casAuthors">Lukic-Panin, Violeta; Kamiya, Tatsushi; Zhang, HanZhe; Hayashi, Takeshi; Tsuchiya, Atsushi; Sehara, Yoshihide; Deguchi, Kentaro; Yamashita, Toru; Abe, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-150</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Background:: Cerebral ischemia is a major leading cause of death and at the first place cause of disability all over the world.  There are a lot of drugs that are in exptl. stage for treatment of stroke.  Among them are calcium channel blockers (CCBs) that have, in animal models, different effectiveness in healing of ischemic damage in brain.  Mechanism of CCBs' action in cerebral ischemia is still unclear, but antioxidative property is supposed to be implicated.  In the present study, we investigated antioxidative and neuroprotective properties of two CCBs, azelnidipine and amlodipine.  Methods:: Male Wistar Kyoto rats were subjected to 90 min of transient middle cerebral artery occlusion (MCAO) by a nylon thread.  Animals were divided into 3 groups, vehicle, azelnidipine and amlodipine group.  In the azelnidipine and amlodipine groups, rats were treated with azelnidipine (1 mg/kg) and amlodipine (1 mg/kg) by gastric gavage for 2 wk before MCAO.  Vehicle group was treated by soln. of Me cellulose for 2 wk.  Rats were killed 24 h after MCAO.  Physiol. parameters (mean arterial pressure, heart rate, body wt.), infarct vol., brain edema index, cerebral blood flow (CBF), oxidative stress markers which are HEL, 4-HNE, AGE and 8-OHdG, and evidence of apoptosis by TUNEL, were investigated.  Results:: There were no significant differences among groups in mean arterial pressure, heart rate and body wt.  Treatment with azelnidipine and amlodipine reduced infarct vol. and brain edema.  Azelnidipine treated group showed more marked redn. of infarct vol. and cerebral edema than amlodipine group.  There was no attenuation of CBF in CCBs groups.  The no. of HEL, 4-HNE, AGE and 8-OHdG pos. cells were significantly decreased in the CCBs treated groups.  These mols. were again fewer in the azelnidipine group than in the amlodipine group.  In TUNEL staining, the nos. of pos. cells was smaller in the CCBs treated groups, esp. in the azelnidipine group.  Conclusions:: Pretreatment of azelnidipine and amlodipine had a neuroprotective effect in ischemic brain.  Antioxidative property is one of the important profiles of CCBs that is implicated in brain protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo13EnmF33kpbVg90H21EOLACvtfcHk0lh4bg2h3bNnSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2ht7fK&md5=68e558261bf27445603b3f8b8a029e45</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.07.038%26sid%3Dliteratum%253Aachs%26aulast%3DLukic-Panin%26aufirst%3DV.%26aulast%3DKamiya%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DTsuchiya%26aufirst%3DA.%26aulast%3DSehara%26aufirst%3DY.%26aulast%3DDeguchi%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DK.%26atitle%3DPrevention%2520of%2520neuronal%2520damage%2520by%2520calcium%2520channel%2520blockers%2520with%2520antioxidative%2520effects%2520after%2520transient%2520focal%2520ischemia%2520in%2520rats%26jtitle%3DBrain%2520Res.%26date%3D2007%26volume%3D1176%26spage%3D143%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleuterio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morreale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca<sup>2+</sup> channels and nicotinic receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2199-2218&author=J.+L.+Marcoauthor=C.+de+los+Riosauthor=A.+G.+Garciaauthor=M.+Villarroyaauthor=M.+C.+Carreirasauthor=C.+Martinsauthor=A.+Eleuterioauthor=A.+Morrealeauthor=M.+Orozcoauthor=F.+J.+Luque&title=Synthesis%2C+biological+evaluation+and+molecular+modelling+of+diversely+functionalized+heterocyclic+derivatives+as+inhibitors+of+acetylcholinesterase%2Fbutyrylcholinesterase+and+modulators+of+Ca2%2B+channels+and+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DCarreiras%26aufirst%3DM.%2BC.%26aulast%3DMartins%26aufirst%3DC.%26aulast%3DEleuterio%26aufirst%3DA.%26aulast%3DMorreale%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520molecular%2520modelling%2520of%2520diversely%2520functionalized%2520heterocyclic%2520derivatives%2520as%2520inhibitors%2520of%2520acetylcholinesterase%252Fbutyrylcholinesterase%2520and%2520modulators%2520of%2520Ca2%252B%2520channels%2520and%2520nicotinic%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2199%26epage%3D2218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Orozco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arias, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span> </span><span class="NLM_article-title">ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with “calcium promotor” and neuroprotective properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1124%2Fjpet.104.068189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=15111641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1eqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=987-994&author=C.+Orozcoauthor=C.+de+Los+Riosauthor=E.+Ariasauthor=R.+Leonauthor=A.+G.+Garciaauthor=J.+L.+Marcoauthor=M.+Villarroyaauthor=M.+G.+Lopez&title=ITH4012+%28ethyl+5-amino-6%2C7%2C8%2C9-tetrahydro-2-methyl-4-phenylbenzol%5B1%2C8%5Dnaphthyridine-3-carboxylate%29%2C+a+novel+acetylcholinesterase+inhibitor+with+%E2%80%9Ccalcium+promotor%E2%80%9D+and+neuroprotective+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with "calcium promotor" and neuroprotective properties</span></div><div class="casAuthors">Orozco, Camilo; de los Rios, Cristobal; Arias, Esperanza; Leon, Rafael; Garcia, Antonio G.; Marco, Jose L.; Villarroya, Mercedes; Lopez, Manuela G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">987-994</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">ITH4012 is a novel tacrine deriv. that can reduce cell death induced by various compds. with different mechanisms of action, such as thapsigargin (reticular stress), H2O2 (free radicals), and veratridine (calcium overload), in bovine chromaffin cell.  Cell viability, quantified as lactic dehydrogenase release, was significantly reduced by ITH4012 at concns. ranging from 0.01 to 3 μM.  In the human neuroblastoma cell line SH-SY5Y, ITH4012 also reduced amyloid β25-35-induced apoptosis, detd. by flow cytometry.  ITH4012 caused a slight elevation in the cytosolic concn. of Ca2+ in fura 2-loaded bovine chromaffin cells, which could be related to the induction of protein synthesis relevant for cell survival.  Blockade of protein synthesis by cycloheximide or blockade of Bcl-2's active site with HA14-1 (Et 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate) reversed the cytoprotective action of ITH4012.  Furthermore, exposure of bovine chromaffin cells for 24 or 48 h to neuroprotective concns. of this compd. enhanced, nearly 3-fold, the expression of the antiapoptotic protein Bcl-2.  In conclusion, ITH4012 is a tacrine deriv. that maintains acetylcholinesterase-inhibiting activity (IC50 = 0.8 μM) but has the addnl. property of acting as a calcium promotor, a property leading to neuroprotection through the induction of antiapoptotic proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSWEJ4AXfFlbVg90H21EOLACvtfcHk0lh4bg2h3bNnSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1eqtLo%253D&md5=68e7e0669459ddf4721c550ef301535a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.068189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.068189%26sid%3Dliteratum%253Aachs%26aulast%3DOrozco%26aufirst%3DC.%26aulast%3Dde%2BLos%2BRios%26aufirst%3DC.%26aulast%3DArias%26aufirst%3DE.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26atitle%3DITH4012%2520%2528ethyl%25205-amino-6%252C7%252C8%252C9-tetrahydro-2-methyl-4-phenylbenzol%255B1%252C8%255Dnaphthyridine-3-carboxylate%2529%252C%2520a%2520novel%2520acetylcholinesterase%2520inhibitor%2520with%2520%25E2%2580%259Ccalcium%2520promotor%25E2%2580%259D%2520and%2520neuroprotective%2520properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26spage%3D987%26epage%3D994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Abushanab, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aly, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakefield, B. J.</span><span> </span><span class="NLM_article-title">Synthesis of substituted nicotinamides from enamines derived from <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1055%2Fs-1995-4039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=923-925&author=F.+A.+Abushanabauthor=F.+M.+Alyauthor=B.+J.+Wakefield&title=Synthesis+of+substituted+nicotinamides+from+enamines+derived+from+N%2CN-dimethylformamide+dimethyl+acetal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1055%2Fs-1995-4039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1995-4039%26sid%3Dliteratum%253Aachs%26aulast%3DAbushanab%26aufirst%3DF.%2BA.%26aulast%3DAly%26aufirst%3DF.%2BM.%26aulast%3DWakefield%26aufirst%3DB.%2BJ.%26atitle%3DSynthesis%2520of%2520substituted%2520nicotinamides%2520from%2520enamines%2520derived%2520from%2520N%252CN-dimethylformamide%2520dimethyl%2520acetal%26jtitle%3DSynthesis%26date%3D1995%26spage%3D923%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Crey-Desbiolles, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotera, M.</span><span> </span><span class="NLM_article-title">Synthesis of 3-deaza-3-nitro-2′-deoxyadenosine</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1935-1941&author=C.+Crey-Desbiollesauthor=M.+Kotera&title=Synthesis+of+3-deaza-3-nitro-2%E2%80%B2-deoxyadenosine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrey-Desbiolles%26aufirst%3DC.%26aulast%3DKotera%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25203-deaza-3-nitro-2%25E2%2580%25B2-deoxyadenosine%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1935%26epage%3D1941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Sunthankar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidya, S. D.</span><span> </span><span class="NLM_article-title">Some reactions of 5-carbethoxy-3-cyano-6-methyl-2-pyridone</span> <span class="citation_source-journal">Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaE2sXls1OrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1977&pages=187-188&author=S.+V.+Sunthankarauthor=S.+D.+Vaidya&title=Some+reactions+of+5-carbethoxy-3-cyano-6-methyl-2-pyridone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Some reactions of 5-carbethoxy-3-cyano-6-methyl-2-pyridone</span></div><div class="casAuthors">Sunthankar, S. V.; Vaidya, S. D.</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">15B</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-8</span>CODEN:
                <span class="NLM_cas:coden">IJSBDB</span>;
        ISSN:<span class="NLM_cas:issn">0376-4699</span>.
    </div><div class="casAbstract">5-Carbethoxy-3-cyano-6-methyl-2-pyridone, obtained by the reaction of Et ethoxymethyleneacetoacetate with cyanoacetamide, is converted to 5-carbethoxy-2-chloro-3-cyano-6-methylpyridine (I) with POCl3-PCl5.  I reacts readily with aniline and NaOEt to give 2-anilino-5-carbethoxy-3-cyano-6-methyl- and 5-carbethoxy-3-cyano-2-ethoxy-6-methylpyridines, resp.  I also reacts with hydrazine hydrate and PhNHNH2 to give pyrazolopyridines II and III, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1xuaBRX9Q1LVg90H21EOLACvtfcHk0ljKZluNAdEtWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXls1OrsbY%253D&md5=879f28fcf1d910b274a9b3c12476c71c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSunthankar%26aufirst%3DS.%2BV.%26aulast%3DVaidya%26aufirst%3DS.%2BD.%26atitle%3DSome%2520reactions%2520of%25205-carbethoxy-3-cyano-6-methyl-2-pyridone%26jtitle%3DIndian%2520J.%2520Chem.%252C%2520Sect.%2520B%253A%2520Org.%2520Chem.%2520Incl.%2520Med.%2520Chem.%26date%3D1977%26volume%3D15%26spage%3D187%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Minetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinti, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carminati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castorina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cesare, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Serio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghirardi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoccini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span> </span><span class="NLM_article-title">2-<i>n</i>-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9<i>H</i>-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">–</span> <span class="NLM_lpage">6896</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058018d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6887-6896&author=P.+Minettiauthor=M.+O.+Tintiauthor=P.+Carminatiauthor=M.+Castorinaauthor=M.+A.+Di+Cesareauthor=S.+Di+Serioauthor=G.+Galloauthor=O.+Ghirardiauthor=F.+Giorgiauthor=L.+Giorgiauthor=G.+Piersantiauthor=F.+Bartocciniauthor=G.+Tarzia&title=2-n-Butyl-9-methyl-8-%5B1%2C2%2C3%5Dtriazol-2-yl-9H-purin-6-ylamine+and+analogues+as+A2A+adenosine+receptor+antagonists.+Design%2C+synthesis%2C+and+pharmacological+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm058018d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058018d%26sid%3Dliteratum%253Aachs%26aulast%3DMinetti%26aufirst%3DP.%26aulast%3DTinti%26aufirst%3DM.%2BO.%26aulast%3DCarminati%26aufirst%3DP.%26aulast%3DCastorina%26aufirst%3DM.%26aulast%3DDi%2BCesare%26aufirst%3DM.%2BA.%26aulast%3DDi%2BSerio%26aufirst%3DS.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGhirardi%26aufirst%3DO.%26aulast%3DGiorgi%26aufirst%3DF.%26aulast%3DGiorgi%26aufirst%3DL.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DBartoccini%26aufirst%3DF.%26aulast%3DTarzia%26aufirst%3DG.%26atitle%3D2-n-Butyl-9-methyl-8-%255B1%252C2%252C3%255Dtriazol-2-yl-9H-purin-6-ylamine%2520and%2520analogues%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists.%2520Design%252C%2520synthesis%252C%2520and%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6887%26epage%3D6896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Cheng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. J.</span><span> </span><span class="NLM_article-title">The Friedlander synthesis of quinolines</span> <span class="citation_source-journal">Org. React.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaL38XlvVais74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1982&pages=37-201&author=C.+C.+Chengauthor=S.+J.+Yan&title=The+Friedlander+synthesis+of+quinolines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The Friedlander synthesis of quinolines</span></div><div class="casAuthors">Cheng, Chia Chung; Yan, Shou Jen</div><div class="citationInfo"><span class="NLM_cas:title">Organic Reactions (New York)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-201</span>CODEN:
                <span class="NLM_cas:coden">ORREAW</span>;
        ISSN:<span class="NLM_cas:issn">0078-6179</span>.
    </div><div class="casAbstract">A review with 176 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL7kAe6I0n-7Vg90H21EOLACvtfcHk0ljKZluNAdEtWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlvVais74%253D&md5=8f57bdc36e8a0db0df6d2212a27e0df2</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DC.%2BC.%26aulast%3DYan%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520Friedlander%2520synthesis%2520of%2520quinolines%26jtitle%3DOrg.%2520React.%26date%3D1982%26volume%3D28%26spage%3D37%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feather-Stone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Feather-Stone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0lhYSLXj9pR8aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeather-Stone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Bourne, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bougis, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchot, P.</span><span> </span><span class="NLM_article-title">Conformational flexibility of the acetylcholinesterase tetramer suggested by X-ray crystallography</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">30370</span><span class="NLM_x">–</span> <span class="NLM_lpage">30376</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=30370-30376&author=Y.+Bourneauthor=J.+Grassiauthor=P.+E.+Bougisauthor=P.+Marchot&title=Conformational+flexibility+of+the+acetylcholinesterase+tetramer+suggested+by+X-ray+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DY.%26aulast%3DGrassi%26aufirst%3DJ.%26aulast%3DBougis%26aufirst%3DP.%2BE.%26aulast%3DMarchot%26aufirst%3DP.%26atitle%3DConformational%2520flexibility%2520of%2520the%2520acetylcholinesterase%2520tetramer%2520suggested%2520by%2520X-ray%2520crystallography%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D30370%26epage%3D30376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Ott, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lustig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbusch, J. P.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase from human erythrocytes membranes: dimers as functional units</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1982&pages=187-189&author=P.+Ottauthor=A.+Lustigauthor=U.+Brodbeckauthor=J.+P.+Rosenbusch&title=Acetylcholinesterase+from+human+erythrocytes+membranes%3A+dimers+as+functional+units"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DP.%26aulast%3DLustig%26aufirst%3DA.%26aulast%3DBrodbeck%26aufirst%3DU.%26aulast%3DRosenbusch%26aufirst%3DJ.%2BP.%26atitle%3DAcetylcholinesterase%2520from%2520human%2520erythrocytes%2520membranes%253A%2520dimers%2520as%2520functional%2520units%26jtitle%3DFEBS%2520Lett.%26date%3D1982%26volume%3D138%26spage%3D187%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heider, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, U.</span><span> </span><span class="NLM_article-title">Different glycosylation in acetylcholinesterases from mammalian brain and erythrocytes</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1471-4159.1992.tb11333.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=1548461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaK38XhvFSit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1992&pages=1230-1238&author=J.+Liaoauthor=H.+Heiderauthor=M.+C.+Sunauthor=U.+Brodbeck&title=Different+glycosylation+in+acetylcholinesterases+from+mammalian+brain+and+erythrocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Different glycosylation in acetylcholinesterases from mammalian brain and erythrocytes</span></div><div class="casAuthors">Liao, Jian; Heider, Harald; Sun, Man Chi; Brodbeck, Urs</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1230-8</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Acetylcholinesterases (EC 3.1.1.7, AChE) have varying amts. of carbohydrates attached to the core protein.  Sequence anal. of the known primary structures gives evidence for several asparagine-linked carbohydrates.  From the differences in mol. wt. detd. by SDS-PAGE before and after deglycosylation with N-glycosidase F (EC 3.2.2.18), it was seen that dimeric AChE from red cell membranes was more heavily glycosylated than the tetrameric brain enzyme.  Furthermore, dimeric and tetrameric forms of bovine AChE were more heavily glycosylated than the corresponding human enzymes.  Monoclonal antibodies 2E6, 1H11, and 2G8 raised against detergent-sol. AChE from elec. organs of Torpedo nacline timilei as well as Elec-39 raised against AChE from Electrophorus electricus cross-reacted with AChE from bovine and human brain but not with AChE from erythrocytes.  Treatment of the enzyme with N-glycosidase F abolished binding of monoclonal antibodies, suggesting that the epitope, or part of it, consists of N-linked carbohydrates.  Anal. of N-acetylglucosamine sugars revealed the presence of N-acetylglucosamine in all forms of cholinesterases investigated, giving evidence for N-linked glycosylation.  On the other hand, N-acetylgalactosamine was not found in AChE from human and bovine brain or in butyrylcholinesterase (EC 3.1.1.8) from human serum, indicating that these forms of cholinesterase did not contain O-linked carbohydrates.  Despite the notion that within 1 species, the different forms of AChE arise from 1 gene by different splicing, the present results showed that dimeric erythrocyte and tetrameric brain AChE must undergo different postsynthetic modifications leading to differences in their glycosylation patterns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5UlwcyS7xVbVg90H21EOLACvtfcHk0lhYSLXj9pR8aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhvFSit7s%253D&md5=11af6f373d3ec13bd0296469e66e0fdb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1992.tb11333.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1992.tb11333.x%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DHeider%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DM.%2BC.%26aulast%3DBrodbeck%26aufirst%3DU.%26atitle%3DDifferent%2520glycosylation%2520in%2520acetylcholinesterases%2520from%2520mammalian%2520brain%2520and%2520erythrocytes%26jtitle%3DJ.%2520Neurochem.%26date%3D1992%26volume%3D58%26spage%3D1230%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Acheson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, D. M.</span><span> </span><span class="NLM_article-title">Anatomy of acetylcholinesterase catalysis: reaction dynamics analogy for human erythrocyte and electric eel enzymes</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">1040</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1040&publication_year=1990&pages=199-205&author=S.+A.+Achesonauthor=D.+M.+Quinn&title=Anatomy+of+acetylcholinesterase+catalysis%3A+reaction+dynamics+analogy+for+human+erythrocyte+and+electric+eel+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAcheson%26aufirst%3DS.%2BA.%26aulast%3DQuinn%26aufirst%3DD.%2BM.%26atitle%3DAnatomy%2520of%2520acetylcholinesterase%2520catalysis%253A%2520reaction%2520dynamics%2520analogy%2520for%2520human%2520erythrocyte%2520and%2520electric%2520eel%2520enzymes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1990%26volume%3D1040%26spage%3D199%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Atack, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncrant, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapoport, S. I.</span><span> </span><span class="NLM_article-title">Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">249</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=2709330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaL1MXkslSgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=1989&pages=194-202&author=J.+R.+Atackauthor=Q.+S.+Yuauthor=T.+T.+Soncrantauthor=A.+Brossiauthor=S.+I.+Rapoport&title=Comparative+inhibitory+effects+of+various+physostigmine+analogs+against+acetyl-+and+butyrylcholinesterases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases</span></div><div class="casAuthors">Atack, John R.; Yu, Qian Sheng; Soncrant, Timothy T.; Brossi, Arnold; Rapoport, Stanley I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">249</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Carbamoyl- and N1-substituted analogs of physostigmine (I) were synthesized and their in vitro potencies (IC50 values) vs. human erythrocyte and brain (cerebral cortex and caudate nucleus) acetylcholinesterase (AChE) and elec. eel AChE and against human brain and plasma butyrylcholinesterase (BChE) were compared to the potencies of physostigmine and other traditional anticholinesterases.  In general, increasingly hydrophobic, simple nonbranching carbamoyl groups (as in octyl-, butyl- and benzylcarbamoyleseroline) did not generally alter potency vs. AChE whereas increasingly hydrophobic N1-substitutions [i.e., N1-allyl-, -phenethyl and -benzylphysostigmines] decreased potency vs. AChE.  In contrast, increasing the hydrophobicity of both the carbamoyl and N1 groups increased the potency of the compd. against BChE.  Furthermore, quaternization at the N1 position (physostigmine methosulfate) increased potency vs. AChE but reduced potency vs. BChE.  Bulky, branched carbamoyl groups (e.g., N-benzyl-N-benzylallophanyleseroline) were all poor anticholinesterases.  N-Phenylcarbamoyleseroline was as potent as benzylcarbamoyleseroline against AChE yet was 50-100-fold less potent than the benzyl analog vs. BChE.  Therefore, the Ph substitution appears to increase greatly the selectivity of the compd. for AChE.  Although it is not possible to det. whether physostigmine analogs that are potent in vitro might be of interest in vivo, these results do show that the structure of physostigmine can be changed significantly while retaining biol. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWLiNmZ2ZAH7Vg90H21EOLACvtfcHk0lhYSLXj9pR8aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkslSgs70%253D&md5=27e81ef90357c2bae1b6b6573f02176e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26aulast%3DYu%26aufirst%3DQ.%2BS.%26aulast%3DSoncrant%26aufirst%3DT.%2BT.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DRapoport%26aufirst%3DS.%2BI.%26atitle%3DComparative%2520inhibitory%2520effects%2520of%2520various%2520physostigmine%2520analogs%2520against%2520acetyl-%2520and%2520butyrylcholinesterases%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1989%26volume%3D249%26spage%3D194%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Andersen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aaraas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaare, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonnum, F.</span><span> </span><span class="NLM_article-title">Inhibition of acetylcholinesterase from different species by organophosphorus compounds, carbamates and methylsulphonyfluoride</span> <span class="citation_source-journal">Gen. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2F0306-3623%2877%2990009-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=564313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaE1cXktVWgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1977&pages=331-334&author=R.+A.+Andersenauthor=I.+Aaraasauthor=G.+Gaareauthor=F.+Fonnum&title=Inhibition+of+acetylcholinesterase+from+different+species+by+organophosphorus+compounds%2C+carbamates+and+methylsulphonyfluoride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acetylcholinesterase from different species by organophosphorus compounds, carbamates and methylsulfonylfluoride</span></div><div class="casAuthors">Andersen, R. A.; Aaraas, I.; Gaare, G.; Fonnum, F.</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">331-4</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    </div><div class="casAbstract">Acetylcholinesterase  [9000-81-1] from frog brain was more resistant to inhibition by organophosphorus compds. or carbamate than were the enzymes from chicken brain or rat brain, but only a slight species difference occurred in the inhibition of acetylcholinesterase by methylsulfonylfluoride  [558-25-8].  The insensitivity of the frog enzyme to many of these inhibitors apparently involved a diminished affinity for the acetylcholinesterase, and did not involve species differences in phosphorylation rates or enzyme conformation.  Steric hindrance at the active site of the mol. was the most probable explanation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTk4IcUZAw5rVg90H21EOLACvtfcHk0ljnaUEL9I1L9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXktVWgtLk%253D&md5=ad92eb1098af8aba58361614d5333580</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2877%2990009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252877%252990009-X%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DR.%2BA.%26aulast%3DAaraas%26aufirst%3DI.%26aulast%3DGaare%26aufirst%3DG.%26aulast%3DFonnum%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520acetylcholinesterase%2520from%2520different%2520species%2520by%2520organophosphorus%2520compounds%252C%2520carbamates%2520and%2520methylsulphonyfluoride%26jtitle%3DGen.%2520Pharmacol.%26date%3D1977%26volume%3D8%26spage%3D331%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Chan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirachi, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhargava, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevor, A. J.</span><span> </span><span class="NLM_article-title">Purifcation and properties of multiple forms of brain acetylcholinesterase (EC 3.1.1.7)</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2747</span><span class="NLM_x">–</span> <span class="NLM_lpage">2758</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1471-4159.1972.tb03812.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=4652627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaE3sXpsVWksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1972&pages=2747-2758&author=S.+L.+Chanauthor=D.+Y.+Shirachiauthor=H.+N.+Bhargavaauthor=E.+Gardnerauthor=A.+J.+Trevor&title=Purifcation+and+properties+of+multiple+forms+of+brain+acetylcholinesterase+%28EC+3.1.1.7%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and properties of multiple forms of brain acetylcholinesterase (EC 3.1.1.7)</span></div><div class="casAuthors">Chan, S. L.; Shirachi, D. Y.; Bhargava, H. N.; Gardner, E.; Trevor, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2747-58</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Approx. 70% of the total AChE(acetylcholinesterase) of bovine brain tissue was solubilized by repeated homogenization and centrifugation in 0.32M sucrose containing EDTA.  After (NH4)2SO4 fractionation, application of the enzyme preparation to an agarose affinity gel column effected a 700-fold purification.  Subsequent mol. filtration separated 3 active forms of AChE with mol. wts. of 13,000, 270,000, and 290,000 with an av. sp. activity of 575 mmoles of acetylthiocholine hydrolyzed/mg of protein/hr.  The complete procedure represented an approx. 23,000-fold purification of the enzyme from that in the original tissue homogenate.  The 3 forms of AChE exhibited certain differences in properties, including apparent Km values, pH optima, and sensitivity to inhibitory agents.  Ancillary studies on less purified enzyme preparations by use of polyacrylamide gel electrophoresis and isoelectric focusing techniques also suggested that brain AChE exists in multiple forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogXdNLPoa7WLVg90H21EOLACvtfcHk0ljnaUEL9I1L9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXpsVWksw%253D%253D&md5=5dbfce8e1acc1be347bde24580947186</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1972.tb03812.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1972.tb03812.x%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DS.%2BL.%26aulast%3DShirachi%26aufirst%3DD.%2BY.%26aulast%3DBhargava%26aufirst%3DH.%2BN.%26aulast%3DGardner%26aufirst%3DE.%26aulast%3DTrevor%26aufirst%3DA.%2BJ.%26atitle%3DPurifcation%2520and%2520properties%2520of%2520multiple%2520forms%2520of%2520brain%2520acetylcholinesterase%2520%2528EC%25203.1.1.7%2529%26jtitle%3DJ.%2520Neurochem.%26date%3D1972%26volume%3D19%26spage%3D2747%26epage%3D2758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors for potential use in Alzheimer’s disease: molecular modeling, synthesis and kinetic evaluation of 11<i>H</i>-indeno-[1,2-<i>b</i>]-quinolin-10-ylamine derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=497-506&author=A.+Rampaauthor=A.+Bisiauthor=F.+Bellutiauthor=S.+Gobbiauthor=P.+Valentiauthor=V.+Andrisanoauthor=V.+Cavriniauthor=A.+Cavalliauthor=M.+Recanatini&title=Acetylcholinesterase+inhibitors+for+potential+use+in+Alzheimer%E2%80%99s+disease%3A+molecular+modeling%2C+synthesis+and+kinetic+evaluation+of+11H-indeno-%5B1%2C2-b%5D-quinolin-10-ylamine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520for%2520potential%2520use%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520molecular%2520modeling%252C%2520synthesis%2520and%2520kinetic%2520evaluation%2520of%252011H-indeno-%255B1%252C2-b%255D-quinolin-10-ylamine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2000%26volume%3D8%26spage%3D497%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallender, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szegletes, T.</span><span> </span><span class="NLM_article-title">A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">119−120</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2FS0009-2797%2899%2900017-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=10421442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaK1MXkvVKit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119%E2%88%92120&publication_year=1999&pages=85-97&author=T.+L.+Rosenberryauthor=W.+D.+Mallenderauthor=P.+J.+Thomasauthor=T.+Szegletes&title=A+steric+blockade+model+for+inhibition+of+acetylcholinesterase+by+peripheral+site+ligands+and+substrate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate</span></div><div class="casAuthors">Rosenberry, Terrone L.; Mallender, William D.; Thomas, Patrick J.; Szegletes, Tivadar</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">119-120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-97</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The active site gorge of acetylcholinesterase (AChE) contains two sites of ligand binding, an acylation site near the base of the gorge and a peripheral site at its mouth.  We recently introduced a steric blockade model which demonstrated that small peripheral site ligands like propidium can inhibit substrate hydrolysis simply by decreasing the substrate assocn. and dissocn. rate consts. without altering the equil. const. for substrate binding to the acylation site.  We now employ our nonequil. kinetic anal. to extend this model to include blockade of the dissocn. of substrate hydrolysis products by bound peripheral site ligand.  We also report here that acetylthiocholine can bind to the AChE peripheral site with an equil. dissocn. const. KS of about 1 mM.  This value was detd. from the effect of the acetylthiocholine concn. on the rate at which fasciculin assocs. with the peripheral site.  When substrate binding to the peripheral site is incorporated into our steric blockade model, hydrolysis rates at low substrate concn. appear to be accelerated while substrate inhibition of hydrolysis occurs at high substrate concn.  The model predicts that hydrolysis rates for substrates which equilibrate with the acylation site prior to the acylation step should not be inhibited by bound peripheral site ligand.  Organophosphates equilibrate with AChE prior to phosphorylating the active site serine residue, and as predicted propidium had little effect on the phosphorylation rate consts. for the fluorogenic organophosphate ethylmethyl-phosphonylcoumarin (EMPC).  The 2nd-order phosphorylation rate const. kOP/KOP was decreased 3-fold by a high concn. of propidium and the 1st-order rate const. kOP increased somewhat.  In contrast to propidium, when the neurotoxin fasciculin bound to the AChE peripheral site both a steric blockade and a conformational change in the acylation site appeared to occur.  With satg. fasciculin, kOP/KOP decreased by a factor of more than 750 and kOP decreased 300-fold.  These data suggest that new peripheral site ligands may be designed to have selective effects on AChE phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvzXlkBuOvcLVg90H21EOLACvtfcHk0ljnaUEL9I1L9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvVKit7Y%253D&md5=8731b3e4e833a42870412dbcffa71c25</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2899%2900017-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252899%252900017-4%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DMallender%26aufirst%3DW.%2BD.%26aulast%3DThomas%26aufirst%3DP.%2BJ.%26aulast%3DSzegletes%26aufirst%3DT.%26atitle%3DA%2520steric%2520blockade%2520model%2520for%2520inhibition%2520of%2520acetylcholinesterase%2520by%2520peripheral%2520site%2520ligands%2520and%2520substrate%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D1999%26volume%3D119%25E2%2588%2592120%26spage%3D85%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Berridge, M. J.</span><span> </span><span class="NLM_article-title">Calcium hypothesis of Alzheimer's disease</span>.  <span class="citation_source-journal">Pfluegers Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">459</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span>− <span class="NLM_lpage">449</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1007%2Fs00424-009-0736-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=19795132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Wqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2010&pages=441-449&author=M.+J.+Berridge&title=Calcium+hypothesis+of+Alzheimer%27s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Berridge, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-449</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by an increase in amyloid metab.  The ca hypothesis of AD explores how activation of the amyloidogenic pathway may function to remodel the neuronal Ca2+ signaling pathways responsible for cognition.  Hydrolysis of the β-amyloid precursor protein (APP) yields two products that can influence Ca2+ signaling.  Firstly, the amyloids released to the outside form oligomers that enhance the entry of Ca2+ that is pumped into the endoplasmic reticulum (ER).  An increase in the luminal level of Ca2+ within the ER enhances the sensitivity of the ryanodine receptors (RYRs) to increase the amt. of Ca2+ being released from the internal stores.  Secondly, the APP intracellular domain may alter the expression of key signaling components such as the RYR.  It is proposed that this remodeling of Ca2+ signaling will result in the learning and memory deficits that occur early during the onset of AD.  In particular, the Ca2+ signaling remodeling may erase newly acquired memories by enhancing the mechanism of long-term depression that depends on activation of the Ca2+-dependent protein phosphatase calcineurin.  The alteration in Ca2+ signaling will also contribute to the neurodegeneration that characterizes the later stages of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbH6HJhWPHCbVg90H21EOLACvtfcHk0ljrS9zAP7lgEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Wqsw%253D%253D&md5=fa22a8338ae0819c41fad684e4bb5839</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs00424-009-0736-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-009-0736-1%26sid%3Dliteratum%253Aachs%26aulast%3DBerridge%26aufirst%3DM.%2BJ.%26atitle%3DCalcium%2520hypothesis%2520of%2520Alzheimer%2527s%2520disease%26jtitle%3DPfluegers%2520Arch.%26date%3D2010%26volume%3D459%26spage%3D441%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuadrado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span> </span><span class="NLM_article-title">Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1852</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1471-4159.2007.04665.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=17540012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVyksLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=1842-1852&author=J.+Egeaauthor=A.+O.+Rosaauthor=A.+Cuadradoauthor=A.+G.+Garciaauthor=M.+G.+Lopez&title=Nicotinic+receptor+activation+by+epibatidine+induces+heme+oxygenase-1+and+protects+chromaffin+cells+against+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress</span></div><div class="casAuthors">Egea, Javier; Rosa, Angelo O.; Cuadrado, Antonio; Garcia, Antonio G.; Lopez, Manuela G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1842-1852</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Activation of neuronal nicotinic acetylcholine receptors (nAChR) provides neuroprotection against different toxic stimuli that often lead to overprodn. of reactive oxygen species (ROS) and cell death.  ROS prodn. has been related with disease progression in several neurodegenerative pathologies such as Alzheimer's or Parkinson's diseases.  In this context, we investigated here if the exposure of bovine chromaffin cells to the potent nAChR agonist epibatidine protected against rotenone (30 μmol/L) plus oligomycin (10 μmol/L) (rot/oligo) toxicity, an in vitro model of mitochondrial ROS prodn.  Epibatidine induced a concn.- and time-dependent protection, which was maximal at 3 μmol/L after 24 h.  Pre-incubation with dantrolene (100 μmol/L) (a blocker of the ryanodine receptor channel), chelerythrine (1 μmol/L) (a protein kinase C inhibitor), or PD98059 (50 μmol/L) (a MEK inhibitor), aborted epibatidine-elicited cytoprotection.  Mitochondrial depolarization, ROS, and caspase 3 active produced by rot/oligo were also prevented by epibatidine.  Epibatidine doubled the amt. of heme oxygenase-1 (HO-1), a crit. cell defense enzyme against oxidative stress.  Furthermore, the HO-1 inhibitor Sn(IV) protoporphyrin IX dichloride reversed the epibatidine protecting effects and HO-1 inducer Co (III) protoporphyrin IX dichloride exhibited neuroprotective effects by itself.  The results of this study point to HO-1 as the cytoprotective target of nAChR activation through the following pathway: endoplasmic reticulum Ca2+-induced Ca2+-release activates the protein kinase C/extracellular regulated kinase/HO-1 axis to mitigate mitochondrial depolarization and ROS prodn.  This study provides a mechanistic insight on how nAChR activation translates into an antioxidant and antiapoptotic signal through up-regulation of HO-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3XG5b3a4IOLVg90H21EOLACvtfcHk0ljrS9zAP7lgEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVyksLbF&md5=689683073dac18206961fec581367cd9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.04665.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.04665.x%26sid%3Dliteratum%253Aachs%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRosa%26aufirst%3DA.%2BO.%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26atitle%3DNicotinic%2520receptor%2520activation%2520by%2520epibatidine%2520induces%2520heme%2520oxygenase-1%2520and%2520protects%2520chromaffin%2520cells%2520against%2520oxidative%2520stress%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D102%26spage%3D1842%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Koh, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D. W.</span><span> </span><span class="NLM_article-title">Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2F0165-0270%2887%2990041-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=2884353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaL2sXktF2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1987&pages=83-90&author=J.+Y.+Kohauthor=D.+W.+Choi&title=Quantitative+determination+of+glutamate+mediated+cortical+neuronal+injury+in+cell+culture+by+lactate+dehydrogenase+efflux+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay</span></div><div class="casAuthors">Koh, Jae Young; Choi, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-90</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">Measurement of lactate dehydrogenase (LDH) activity released to the extracellular bathing media was a simple yet quant. method for assessing glutamate-mediated central neuronal cell injury in cortical cell culture.  Extracellular LDH is both chem. and biol. stable; the magnitude of LDH efflux in the cultures correlates in a linear fashion with the no. of neurons damaged by glutamate exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc5CWdojkmkLVg90H21EOLACvtfcHk0ljrS9zAP7lgEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktF2is74%253D&md5=8f9806e0deff8d482c25c1fb50c6992a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2887%2990041-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252887%252990041-0%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DJ.%2BY.%26aulast%3DChoi%26aufirst%3DD.%2BW.%26atitle%3DQuantitative%2520determination%2520of%2520glutamate%2520mediated%2520cortical%2520neuronal%2520injury%2520in%2520cell%2520culture%2520by%2520lactate%2520dehydrogenase%2520efflux%2520assay%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1987%26volume%3D20%26spage%3D83%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Dodd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copolov, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berk, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-Acetylcysteine for antioxidant therapy: pharmacology and clinical utility</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1955</span><span class="NLM_x">–</span> <span class="NLM_lpage">1962</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1517%2F14728220802517901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=18990082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlCjt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1955-1962&author=S.+Doddauthor=O.+Deanauthor=D.+L.+Copolovauthor=G.+S.+Malhiauthor=M.+Berk&title=N-Acetylcysteine+for+antioxidant+therapy%3A+pharmacology+and+clinical+utility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility</span></div><div class="casAuthors">Dodd, Seetal; Dean, Olivia; Copolov, David L.; Malhi, Gin S.; Berk, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1955-1962</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Glutathione is an endogenous antioxidant and has a ubiquitous role in many of the body's defences.  Treatment with N-acetylcysteine (NAC) has been shown to increase levels of glutathione.  NAC has been proposed as a treatment for several illnesses.  Objectives: The efficacy and tolerability of NAC was examd. across a range of conditions to evaluate the evidence supporting the use of NAC for each indication.  Methods: A literature search was conducted using PubMed.  Information was also collected from other online sources including the websites of the Therapeutic Goods Administration of Australia and the FDA.  Results: Reports ranged from case studies to clin. trials.  There is strong evidence to support the use of NAC for the treatment of paracetamol overdose and emerging evidence suggesting it has utility in psychiatric disorders, particularly schizophrenia and bipolar disorder.  NAC is safe and well tolerated when administered orally but has documented risks with i.v. administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDamUPmW8CgLVg90H21EOLACvtfcHk0lhHREICJJa0og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlCjt7vO&md5=cf8679acd667b7cd1a7d22a0cefd73f7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1517%2F14728220802517901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220802517901%26sid%3Dliteratum%253Aachs%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DDean%26aufirst%3DO.%26aulast%3DCopolov%26aufirst%3DD.%2BL.%26aulast%3DMalhi%26aufirst%3DG.%2BS.%26aulast%3DBerk%26aufirst%3DM.%26atitle%3DN-Acetylcysteine%2520for%2520antioxidant%2520therapy%253A%2520pharmacology%2520and%2520clinical%2520utility%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2008%26volume%3D8%26spage%3D1955%26epage%3D1962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Arendt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruckner, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartner, U.</span><span> </span><span class="NLM_article-title">The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer’s disease</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1998&pages=1337-1340&author=T.+Arendtauthor=M.+Holzerauthor=M.+K.+Brucknerauthor=C.+Jankeauthor=U.+Gartner&title=The+use+of+okadaic+acid+in+vivo+and+the+induction+of+molecular+changes+typical+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DBruckner%26aufirst%3DM.%2BK.%26aulast%3DJanke%26aufirst%3DC.%26aulast%3DGartner%26aufirst%3DU.%26atitle%3DThe%2520use%2520of%2520okadaic%2520acid%2520in%2520vivo%2520and%2520the%2520induction%2520of%2520molecular%2520changes%2520typical%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuroscience%26date%3D1998%26volume%3D85%26spage%3D1337%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Z.</span><span> </span><span class="NLM_article-title">Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2003&pages=1175-1182&author=L.+Sunauthor=S.+Y.+Liuauthor=X.+W.+Zhouauthor=X.+C.+Wangauthor=R.+Liuauthor=Q.+Wangauthor=J.+Z.+Wang&title=Inhibition+of+protein+phosphatase+2A-+and+protein+phosphatase+1-induced+tau+hyperphosphorylation+and+impairment+of+spatial+memory+retention+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%2BY.%26aulast%3DZhou%26aufirst%3DX.%2BW.%26aulast%3DWang%26aufirst%3DX.%2BC.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26atitle%3DInhibition%2520of%2520protein%2520phosphatase%25202A-%2520and%2520protein%2520phosphatase%25201-induced%2520tau%2520hyperphosphorylation%2520and%2520impairment%2520of%2520spatial%2520memory%2520retention%2520in%2520rats%26jtitle%3DNeuroscience%26date%3D2003%26volume%3D118%26spage%3D1175%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Denizot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, R.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2F0022-1759%2886%2990368-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=3486233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1986&pages=271-277&author=F.+Denizotauthor=R.+Lang&title=Rapid+colorimetric+assay+for+cell+growth+and+survival.+Modifications+to+the+tetrazolium+dye+procedure+giving+improved+sensitivity+and+reliability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span></div><div class="casAuthors">Denizot F; Lang R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-7</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A convenient way to estimate the number of viable cells growing in microtitre tray wells is to use a colorimetric assay and an automatic microplate scanning spectrophotometer.  One such assay, developed by Mosmann, depends on the reduction by living cells of tetrazolium salt, MTT, to form a blue formazan product.  However the original technique has several technical limitations, namely a less than optimal sensitivity, a variable background due to protein precipitation on adding an organic solvent to dissolve the blue formazan product, and a low solubility of the product.  These problems have been overcome by the following modifications: avoidance of serum in the incubation medium, thus overcoming precipitation problems in the organic solvent; avoidance of phenol red in the incubation medium, thus avoiding the use of acid in the final solvent which altered the spectral properties of the formazan; elimination of the medium containing MTT after the reaction and subsequent use of pure propanol or ethanol to rapidly solubilize the formazan; use of a higher concentration of MTT; use of half-area microtitre trays to increase the spectrophotometer readings from a given amount of formazan; use of a more judicious reference wavelength in a dual wavelength spectrophotometer.  With these modifications the reliability and sensitivity of the test have been increased to the point where it can in many cases replace the [3H]thymidine uptake assay to measure cell proliferation or survival in growth factor or cytotoxicity assays.  Examples of its use in IL-2 assays are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpURYu5ihmxO98rul4nhSdfW6udTcc2eb4B4bOLU34Gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D&md5=9e5506f28a0b29b20046b7e21bb5527e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2886%2990368-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252886%252990368-6%26sid%3Dliteratum%253Aachs%26aulast%3DDenizot%26aufirst%3DF.%26aulast%3DLang%26aufirst%3DR.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cell%2520growth%2520and%2520survival.%2520Modifications%2520to%2520the%2520tetrazolium%2520dye%2520procedure%2520giving%2520improved%2520sensitivity%2520and%2520reliability%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1986%26volume%3D89%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Arias, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallego-Sandin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span> </span><span class="NLM_article-title">Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">1346</span><span class="NLM_x">–</span> <span class="NLM_lpage">1353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1124%2Fjpet.105.090365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=16144975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlalurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=1346-1353&author=E.+Ariasauthor=S.+Gallego-Sandinauthor=M.+Villarroyaauthor=A.+G.+Garciaauthor=M.+G.+Lopez&title=Unequal+neuroprotection+afforded+by+the+acetylcholinesterase+inhibitors+galantamine%2C+donepezil%2C+and+rivastigmine+in+SH-SY5Y+neuroblastoma+cells%3A+role+of+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: Role of nicotinic receptors</span></div><div class="casAuthors">Arias, Esperanza; Gallego-Sandin, Sonia; Villarroya, Mercedes; Garcia, Antonio G.; Lopez, Manuela G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1346-1353</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Donepezil, rivastigmine, and galantamine are three drugs with acetylcholinesterase (AChE)-inhibiting activity that are currently being used to treat patients suffering from Alzheimer's disease.  We have studied the neuroprotective effects of these drugs, in comparison with nicotine, on cell death caused by β-amyloid (Aβ) and okadaic acid, two models that are relevant to Alzheimer's pathol., in the human neuroblastoma cell line SH-SY5Y.  Galantamine and donepezil showed a U-shaped neuroprotective curve against okadaic acid toxicity; max. protection was achieved at 0.3 μM galantamine and at 1 μM donepezil; at higher concns., protection was diminished.  Rivastigmine showed a concn.-dependent effect; max. protection was achieved at 3 μM.  When apoptosis was induced by Aβ25-35, galantamine, donepezil, and rivastigmine showed max. protection at the same concns.: 0.3, 1, and 3 μM, resp.  Nicotine also afforded protection against Aβ- and okadaic acid-induced toxicity.  The neuroprotective effects of galantamine, donepezil, and nicotine were reversed by the α7 nicotinic antagonist methyllycaconitine but not by the α4β2 nicotinic antagonist dihydro-β-erythroidine.  The phosphoinositide 3-kinase (PI3K)-Akt blocker 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY294002) reversed the protective effects of galantamine, donepezil, and nicotine but not that of rivastigmine.  In contrast, the bcl-2 antagonist ethyl[2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)]-4H-chromene-3- carboxylate (HA 14-1) reversed the protective effects of the three AChE inhibitors and that of nicotine.  Our results show that galantamine, donepezil, and rivastigmine afford neuroprotection through a mechanism that is likely unrelated to AChE inhibition.  Such neuroprotection seemed to be linked to α7 nicotinic receptors and the PI3K-Akt pathway in the case of galantamine and donepezil but not for rivastigmine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomaPp9wSWEeLVg90H21EOLACvtfcHk0lhHREICJJa0og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlalurbL&md5=a51e42bf1bef8009f760299c7e389cbd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.090365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.090365%26sid%3Dliteratum%253Aachs%26aulast%3DArias%26aufirst%3DE.%26aulast%3DGallego-Sandin%26aufirst%3DS.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26atitle%3DUnequal%2520neuroprotection%2520afforded%2520by%2520the%2520acetylcholinesterase%2520inhibitors%2520galantamine%252C%2520donepezil%252C%2520and%2520rivastigmine%2520in%2520SH-SY5Y%2520neuroblastoma%2520cells%253A%2520role%2520of%2520nicotinic%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D1346%26epage%3D1353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Sheppeck, J. E.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauss, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlin, A. R.</span><span> </span><span class="NLM_article-title">Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1750</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=1739-1750&author=J.+E.+Sheppeckauthor=C.+M.+Gaussauthor=A.+R.+Chamberlin&title=Inhibition+of+the+Ser-Thr+phosphatases+PP1+and+PP2A+by+naturally+occurring+toxins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DChamberlin%26aufirst%3DA.%2BR.%26atitle%3DInhibition%2520of%2520the%2520Ser-Thr%2520phosphatases%2520PP1%2520and%2520PP2A%2520by%2520naturally%2520occurring%2520toxins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1997%26volume%3D5%26spage%3D1739%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Harder, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark-Lewis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirik, F. R.</span><span> </span><span class="NLM_article-title">Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=1994&pages=395-401&issue=Part+2&author=K.+W.+Harderauthor=P.+Owenauthor=L.+K.+Wongauthor=R.+Aebersoldauthor=I.+Clark-Lewisauthor=F.+R.+Jirik&title=Characterization+and+kinetic+analysis+of+the+intracellular+domain+of+human+protein+tyrosine+phosphatase+beta+%28HPTP+beta%29+using+synthetic+phosphopeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DK.%2BW.%26aulast%3DOwen%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DL.%2BK.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DClark-Lewis%26aufirst%3DI.%26aulast%3DJirik%26aufirst%3DF.%2BR.%26atitle%3DCharacterization%2520and%2520kinetic%2520analysis%2520of%2520the%2520intracellular%2520domain%2520of%2520human%2520protein%2520tyrosine%2520phosphatase%2520beta%2520%2528HPTP%2520beta%2529%2520using%2520synthetic%2520phosphopeptides%26jtitle%3DBiochem.%2520J.%26date%3D1994%26volume%3D298%26issue%3DPart%25202%26spage%3D395%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Begum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragolia, L.</span><span> </span><span class="NLM_article-title">cAMP counter-regulates insulin-mediated protein phosphatase-2A inactivation in rat skeletal muscle cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">31166</span><span class="NLM_x">–</span> <span class="NLM_lpage">31171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=31166-31171&author=N.+Begumauthor=L.+Ragolia&title=cAMP+counter-regulates+insulin-mediated+protein+phosphatase-2A+inactivation+in+rat+skeletal+muscle+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBegum%26aufirst%3DN.%26aulast%3DRagolia%26aufirst%3DL.%26atitle%3DcAMP%2520counter-regulates%2520insulin-mediated%2520protein%2520phosphatase-2A%2520inactivation%2520in%2520rat%2520skeletal%2520muscle%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D31166%26epage%3D31171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Jarrett, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.,  Jr.</span><span> </span><span class="NLM_article-title">The C-terminus of the beta protein is critical in amyloidogenesis</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">695</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=695&publication_year=1993&pages=144-148&author=J.+T.+Jarrettauthor=E.+P.+Bergerauthor=P.+T.+Lansbury&title=The+C-terminus+of+the+beta+protein+is+critical+in+amyloidogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJarrett%26aufirst%3DJ.%2BT.%26aulast%3DBerger%26aufirst%3DE.%2BP.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DThe%2520C-terminus%2520of%2520the%2520beta%2520protein%2520is%2520critical%2520in%2520amyloidogenesis%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1993%26volume%3D695%26spage%3D144%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Pappolla, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bick, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson-Bick, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efthimiopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robakis, N. K.</span><span> </span><span class="NLM_article-title">Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1523%2FJNEUROSCI.17-05-01683.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=9030627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaK2sXhtlOms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=1683-1690&author=M.+A.+Pappollaauthor=M.+Sosauthor=R.+A.+Omarauthor=R.+J.+Bickauthor=D.+L.+Hickson-Bickauthor=R.+J.+Reiterauthor=S.+Efthimiopoulosauthor=N.+K.+Robakis&title=Melatonin+prevents+death+of+neuroblastoma+cells+exposed+to+the+Alzheimer+amyloid+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide</span></div><div class="casAuthors">Pappolla, Miguel A.; Sos, Melisa; Omar, Rawhi A.; Bick, Roger J.; Hickson-Bick, Diane L. M.; Reiter, Russel J.; Efthimiopoulos, Spiros; Robakis, Nickolaos K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1683-1690</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Studies from several labs. have generated evidence suggesting that oxidative stress is involved in the pathogenesis of Alzheimer's disease (AD).  The finding that the amyloid β protein (Aβ) has neurotoxic properties and that such effects are, in part, mediated by free radicals has provided insights into mechanisms of cell death in AD and an avenue to explore new therapeutic approaches.  In this study melatonin, a pineal hormone with recently established antioxidant properties, is remarkably effective in preventing death of cultured neuroblastoma cells as well as oxidative damage and intracellular Ca2+ increases induced by a cytotoxic fragment of Aβ.  The effects of melatonin were extremely reproducible and corroborated by multiple quant. methods, including cell viability studies by confocal laser microscopy, electron microscopy, and measurements of intracellular calcium levels.  The importance of this finding is that, in contrast to conventional antioxidants, melatonin has a proposed physiol. role in the aging process.  Secretion levels of this hormone are decreased in aging and more severely reduced in AD.  The reported phenomenon may be of therapeutic relevance in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq8o3cVyfX4rVg90H21EOLACvtfcHk0liL1kQRk9VCEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtlOms7s%253D&md5=f9f078c4a30661c0ef9645118efa5a9f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.17-05-01683.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.17-05-01683.1997%26sid%3Dliteratum%253Aachs%26aulast%3DPappolla%26aufirst%3DM.%2BA.%26aulast%3DSos%26aufirst%3DM.%26aulast%3DOmar%26aufirst%3DR.%2BA.%26aulast%3DBick%26aufirst%3DR.%2BJ.%26aulast%3DHickson-Bick%26aufirst%3DD.%2BL.%26aulast%3DReiter%26aufirst%3DR.%2BJ.%26aulast%3DEfthimiopoulos%26aufirst%3DS.%26aulast%3DRobakis%26aufirst%3DN.%2BK.%26atitle%3DMelatonin%2520prevents%2520death%2520of%2520neuroblastoma%2520cells%2520exposed%2520to%2520the%2520Alzheimer%2520amyloid%2520peptide%26jtitle%3DJ.%2520Neurosci.%26date%3D1997%26volume%3D17%26spage%3D1683%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Masilamoni, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesudason, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhandayuthapani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashok, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jebaraj, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayakumar, R.</span><span> </span><span class="NLM_article-title">The neuroprotective role of melatonin against amyloid beta peptide injected mice</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1080%2F10715760802277388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=18654881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFWktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2008&pages=661-673&author=J.+G.+Masilamoniauthor=E.+P.+Jesudasonauthor=S.+Dhandayuthapaniauthor=B.+S.+Ashokauthor=S.+Vigneshauthor=W.+C.+Jebarajauthor=S.+F.+Paulauthor=R.+Jayakumar&title=The+neuroprotective+role+of+melatonin+against+amyloid+beta+peptide+injected+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The neuroprotective role of melatonin against amyloid β peptide injected mice</span></div><div class="casAuthors">Masilamoni, J. Gunasingh; Jesudason, E. Philip; Dhandayuthapani, S.; Ashok, Ben S.; Vignesh, S.; Jebaraj, W. Charles E.; Paul, Solomon F. D.; Jayakumar, Rajadas</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-673</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Widespread cerebral deposition of a 40-42 amino acid peptide called amyloid β peptide (Aβ) in the form of amyloid fibrils is one of the most prominent neuropathol. features of Alzheimer's disease (AD).  The clin. study provides evidence that accumulation of protofibrils due to the Arctic mutation (E22G) causes early AD onset.  Melatonin showed beneficial effects in an AD mouse model.  Mice were divided into four different groups (n=8 per group): (i) control group, (ii) scrambled Aβ-injected group, (iii) Aβ protofibril-injected group and (iv) melatonin-treated group.  A single dose of (5 μg) Aβ protofibril was administered to the Aβ protofibril-injected and melatonin-treated groups via intracerebroventricular injections.  The results demonstrate that melatonin treatment significantly reduces Aβ protofibril-induced reactive oxygen species (ROS) prodn., intracellular calcium levels and acetylcholinesterase activity in the neocortex and hippocampus regions.  Based on these findings it is suggested that melatonin therapy might be a useful treatment for AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX8RU_qDKPH7Vg90H21EOLACvtfcHk0ljdmXDQElbLVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFWktLs%253D&md5=24553739fb84a1c65a1d75ac6fd01eac</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1080%2F10715760802277388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760802277388%26sid%3Dliteratum%253Aachs%26aulast%3DMasilamoni%26aufirst%3DJ.%2BG.%26aulast%3DJesudason%26aufirst%3DE.%2BP.%26aulast%3DDhandayuthapani%26aufirst%3DS.%26aulast%3DAshok%26aufirst%3DB.%2BS.%26aulast%3DVignesh%26aufirst%3DS.%26aulast%3DJebaraj%26aufirst%3DW.%2BC.%26aulast%3DPaul%26aufirst%3DS.%2BF.%26aulast%3DJayakumar%26aufirst%3DR.%26atitle%3DThe%2520neuroprotective%2520role%2520of%2520melatonin%2520against%2520amyloid%2520beta%2520peptide%2520injected%2520mice%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2008%26volume%3D42%26spage%3D661%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Sobrado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span> </span><span class="NLM_article-title">Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen−glucose deprivation</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2004&pages=132-136&author=M.+Sobradoauthor=J.+M.+Rodaauthor=M.+G.+Lopezauthor=J.+Egeaauthor=A.+G.+Garcia&title=Galantamine+and+memantine+produce+different+degrees+of+neuroprotection+in+rat+hippocampal+slices+subjected+to+oxygen%E2%88%92glucose+deprivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSobrado%26aufirst%3DM.%26aulast%3DRoda%26aufirst%3DJ.%2BM.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26atitle%3DGalantamine%2520and%2520memantine%2520produce%2520different%2520degrees%2520of%2520neuroprotection%2520in%2520rat%2520hippocampal%2520slices%2520subjected%2520to%2520oxygen%25E2%2588%2592glucose%2520deprivation%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D365%26spage%3D132%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrilova, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachurin, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seely, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, D.</span><span> </span><span class="NLM_article-title">Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer’s disease: a randomised, double-blind, placebo-controlled study</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=207-215&author=R.+S.+Doodyauthor=S.+I.+Gavrilovaauthor=M.+Sanoauthor=R.+G.+Thomasauthor=P.+S.+Aisenauthor=S.+O.+Bachurinauthor=L.+Seelyauthor=D.+Hung&title=Effect+of+dimebon+on+cognition%2C+activities+of+daily+living%2C+behaviour%2C+and+global+function+in+patients+with+mild-to-moderate+Alzheimer%E2%80%99s+disease%3A+a+randomised%2C+double-blind%2C+placebo-controlled+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DGavrilova%26aufirst%3DS.%2BI.%26aulast%3DSano%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DBachurin%26aufirst%3DS.%2BO.%26aulast%3DSeely%26aufirst%3DL.%26aulast%3DHung%26aufirst%3DD.%26atitle%3DEffect%2520of%2520dimebon%2520on%2520cognition%252C%2520activities%2520of%2520daily%2520living%252C%2520behaviour%252C%2520and%2520global%2520function%2520in%2520patients%2520with%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520study%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26spage%3D207%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Bachurin, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsova, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireeva, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxenkrug, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sablin, S. O.</span><span> </span><span class="NLM_article-title">Mitochondria as a target for neurotoxins and neuroprotective agents</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">993</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><div class="note"><p class="first last">; discussion 345−339</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=993&publication_year=2003&pages=334-344&author=S.+O.+Bachurinauthor=E.+P.+Shevtsovaauthor=E.+G.+Kireevaauthor=G.+F.+Oxenkrugauthor=S.+O.+Sablin&title=Mitochondria+as+a+target+for+neurotoxins+and+neuroprotective+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBachurin%26aufirst%3DS.%2BO.%26aulast%3DShevtsova%26aufirst%3DE.%2BP.%26aulast%3DKireeva%26aufirst%3DE.%2BG.%26aulast%3DOxenkrug%26aufirst%3DG.%2BF.%26aulast%3DSablin%26aufirst%3DS.%2BO.%26atitle%3DMitochondria%2520as%2520a%2520target%2520for%2520neurotoxins%2520and%2520neuroprotective%2520agents%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D993%26spage%3D334%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Lermontova, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkozubov, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsova, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serkova, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireeva, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachurin, S. O.</span><span> </span><span class="NLM_article-title">Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channels</span> <span class="citation_source-journal">Bull. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1023%2FA%3A1017972709652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=11865327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFOhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=1079-1083&author=N.+N.+Lermontovaauthor=A.+E.+Redkozubovauthor=E.+F.+Shevtsovaauthor=T.+P.+Serkovaauthor=E.+G.+Kireevaauthor=S.+O.+Bachurin&title=Dimebon+and+tacrine+inhibit+neurotoxic+action+of+beta-amyloid+in+culture+and+block+L-type+Ca%282%2B%29+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Dimebon and tacrine inhibit neurotoxic action of β-amyloid in culture and block L-type Ca2+ channels</span></div><div class="casAuthors">Lermontova, N. N.; Redkozubov, A. E.; Shevtsova, E. F.; Serkova, T. P.; Kireeva, E. G.; Bachurin, S. O.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of Experimental Biology and Medicine (Translation of Byulleten Eksperimental'noi Biologii i Meditsiny)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1079-1083</span>CODEN:
                <span class="NLM_cas:coden">BEXBAN</span>;
        ISSN:<span class="NLM_cas:issn">0007-4888</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">Dimebon, a Russian-made drug, inhibited toxic effects of β-amyloid on cultured neurons.  Excessive accumulation of β-amyloid in the brain is characteristic of Alzheimer dementias.  Anti-Alzheimer prepns. tacrine and dimebon improve survival of cerebellar granule cells during long-term incubation with Aβ25-35, the neurotoxic fragment of β-amyloid.  Both prepns. can block potential-dependent Ca2+ entry into neurons by about 20%, which is explained by their selective action on L-type Ca2+ channels.  It was assumed that the neuroprotective effect of dimebon and tacrine against Aβ25-35 partially depends on inhibition of potential-dependent Ca2+ entry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGST_I29hTtbVg90H21EOLACvtfcHk0ljdmXDQElbLVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFOhtbk%253D&md5=da716770f509333da85cab7e45988edf</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1023%2FA%3A1017972709652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1017972709652%26sid%3Dliteratum%253Aachs%26aulast%3DLermontova%26aufirst%3DN.%2BN.%26aulast%3DRedkozubov%26aufirst%3DA.%2BE.%26aulast%3DShevtsova%26aufirst%3DE.%2BF.%26aulast%3DSerkova%26aufirst%3DT.%2BP.%26aulast%3DKireeva%26aufirst%3DE.%2BG.%26aulast%3DBachurin%26aufirst%3DS.%2BO.%26atitle%3DDimebon%2520and%2520tacrine%2520inhibit%2520neurotoxic%2520action%2520of%2520beta-amyloid%2520in%2520culture%2520and%2520block%2520L-type%2520Ca%25282%252B%2529%2520channels%26jtitle%3DBull.%2520Exp.%2520Biol.%2520Med.%26date%3D2001%26volume%3D132%26spage%3D1079%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Brooks, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruccoleri, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olafson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">States, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karplus, M.</span><span> </span><span class="NLM_article-title">Charmm, a program for macromolecular energy, minimization, and dynamics calculations</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1983&pages=187-217&author=B.+R.+Brooksauthor=R.+E.+Bruccoleriauthor=B.+D.+Olafsonauthor=D.+J.+Statesauthor=S.+Swaminathanauthor=M.+Karplus&title=Charmm%2C+a+program+for+macromolecular+energy%2C+minimization%2C+and+dynamics+calculations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26aulast%3DBruccoleri%26aufirst%3DR.%2BE.%26aulast%3DOlafson%26aufirst%3DB.%2BD.%26aulast%3DStates%26aufirst%3DD.%2BJ.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DKarplus%26aufirst%3DM.%26atitle%3DCharmm%252C%2520a%2520program%2520for%2520macromolecular%2520energy%252C%2520minimization%252C%2520and%2520dynamics%2520calculations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1983%26volume%3D4%26spage%3D187%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Morreale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maseras, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvez, E.</span><span> </span><span class="NLM_article-title">Ligand−receptor interaction at the neural nicotinic acetylcholine binding site: a theoretical model</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2FS1093-3263%2802%2900127-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1yks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=111-118&author=A.+Morrealeauthor=F.+Maserasauthor=I.+Iriepaauthor=E.+Galvez&title=Ligand%E2%88%92receptor+interaction+at+the+neural+nicotinic+acetylcholine+binding+site%3A+a+theoretical+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-receptor interaction at the neural nicotinic acetylcholine binding site: a theoretical model</span></div><div class="casAuthors">Morreale, A.; Maseras, F.; Iriepa, I.; Galvez, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-118</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Recent mutagenesis expts. have identified some of the functional amino acids that are essential in the interaction of nicotinic agents with the binding site of the neural nicotinic acetylcholine receptor (nAChR).  Although this receptor is one of the best studied and characterized the lack of detailed exptl. information regarding its quaternary structure has turned it into a challenge for computational chem.  The authors have previously reported a computational protocol based on mol. mechanics and mol. dynamics (MD) where SER82, ASP83, TRP86, ASP89, TYR93, TYR190, TYR198 and ARG209 were placed around selected agonists and antagonists aided by stereoelectronic criteria.  Explicit water mols. were used with the double goal of simulating aq. environment and keeping the system from falling apart.  The protocol was stable enough to allow the ligands to evolve to their thermodynamically most probable structure while maintaining the key interactions.  In this communication the authors use the av. model for the agonists (one av. structure for each agonist) to calc. quantum mech. the interactions of the binding site with one neurotransmitter acetylcholine (ACh) (1), as well as with two of the most potent agonists described so far [nicotine (2) and epibatidine (3)] and the modeled binding site.  A wide variety of methods as well as basis sets were used to rationalize the best way to treat the problem.  In this limited set of compds., a good correlation between total interaction energies and biol. affinity is obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroGwEJdEu4NbVg90H21EOLACvtfcHk0lj6v79B97bxhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1yks7s%253D&md5=1f670a0505e526eabe9264d81a41152b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2FS1093-3263%2802%2900127-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1093-3263%252802%252900127-4%26sid%3Dliteratum%253Aachs%26aulast%3DMorreale%26aufirst%3DA.%26aulast%3DMaseras%26aufirst%3DF.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DGalvez%26aufirst%3DE.%26atitle%3DLigand%25E2%2588%2592receptor%2520interaction%2520at%2520the%2520neural%2520nicotinic%2520acetylcholine%2520binding%2520site%253A%2520a%2520theoretical%2520model%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2002%26volume%3D21%26spage%3D111%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lj6v79B97bxhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Segel, I. H.</span> <span class="citation_source-book">Enzyme Kinetics</span>; <span class="NLM_publisher-name">John Wiley</span>: <span class="NLM_publisher-loc">Toronto, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">1975</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1975&author=I.+H.+Segel&title=Enzyme+Kinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSegel%26aufirst%3DI.%2BH.%26btitle%3DEnzyme%2520Kinetics%26pub%3DJohn%2520Wiley%26date%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobrado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span> </span><span class="NLM_article-title">Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2007&pages=866-872&author=J.+Egeaauthor=A.+O.+Rosaauthor=M.+Sobradoauthor=L.+Gandiaauthor=M.+G.+Lopezauthor=A.+G.+Garcia&title=Neuroprotection+afforded+by+nicotine+against+oxygen+and+glucose+deprivation+in+hippocampal+slices+is+lost+in+alpha7+nicotinic+receptor+knockout+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRosa%26aufirst%3DA.%2BO.%26aulast%3DSobrado%26aufirst%3DM.%26aulast%3DGandia%26aufirst%3DL.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26atitle%3DNeuroprotection%2520afforded%2520by%2520nicotine%2520against%2520oxygen%2520and%2520glucose%2520deprivation%2520in%2520hippocampal%2520slices%2520is%2520lost%2520in%2520alpha7%2520nicotinic%2520receptor%2520knockout%2520mice%26jtitle%3DNeuroscience%26date%3D2007%26volume%3D145%26spage%3D866%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Mosmann, T.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2F0022-1759%2883%2990303-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=6606682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1983&pages=55-63&author=T.+Mosmann&title=Rapid+colorimetric+assay+for+cellular+growth+and+survival%3A+application+to+proliferation+and+cytotoxicity+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span></div><div class="casAuthors">Mosmann T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A tetrazolium salt has been used to develop a quantitative colorimetric assay for mammalian cell survival and proliferation.  The assay detects living, but not dead cells and the signal generated is dependent on the degree of activation of the cells.  This method can therefore be used to measure cytotoxicity, proliferation or activation.  The results can be read on a multiwell scanning spectrophotometer (ELISA reader) and show a high degree of precision.  No washing steps are used in the assay.  The main advantages of the colorimetric assay are its rapidity and precision, and the lack of any radioisotope.  We have used the assay to measure proliferative lymphokines, mitogen stimulations and complement-mediated lysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBbRLMWf0dI3thwrmtH4OBfW6udTcc2eZEtPazzI-Ljrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D&md5=c1116f4ca7a7d2b79fab2a0bd2c2d439</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2883%2990303-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252883%252990303-4%26sid%3Dliteratum%253Aachs%26aulast%3DMosmann%26aufirst%3DT.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cellular%2520growth%2520and%2520survival%253A%2520application%2520to%2520proliferation%2520and%2520cytotoxicity%2520assays%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1983%26volume%3D65%26spage%3D55%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 53 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Shubhranshu Shekhar Choudhury, Subhrakant Jena, Dipak Kumar Sahoo, Shamasoddin Shekh, Rajiv K. Kar, Ambuj Dhakad, Konkallu Hanumae Gowd, <span class="NLM_string-name hlFld-ContribAuthor">Himansu S. Biswal</span>. </span><span class="cited-content_cbyCitation_article-title">Gram-Scale Synthesis of 1,8-Naphthyridines in Water: The Friedlander Reaction Revisited. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (29)
                                     , 19304-19313. <a href="https://doi.org/10.1021/acsomega.1c02798" title="DOI URL">https://doi.org/10.1021/acsomega.1c02798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.1c02798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.1c02798%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DGram-Scale%252BSynthesis%252Bof%252B1%25252C8-Naphthyridines%252Bin%252BWater%25253A%252BThe%252BFriedlander%252BReaction%252BRevisited%26aulast%3DChoudhury%26aufirst%3DShubhranshu%2BShekhar%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D28052021%26date%3D29062021%26date%3D12072021%26volume%3D6%26issue%3D29%26spage%3D19304%26epage%3D19313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinhua Zhao, Fucheng Yin, Limei Ji, Cheng Wang, Cunjian Shi, Xingchen Liu, Huali Yang, Xiaobing Wang, <span class="NLM_string-name hlFld-ContribAuthor">Lingyi Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Tau-Targeted Drug Delivery System Using a Multifunctional Nanoscale Metal–Organic Framework for Alzheimer’s Disease Therapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2020,</strong> <em>12 </em>
                                    (40)
                                     , 44447-44458. <a href="https://doi.org/10.1021/acsami.0c11064" title="DOI URL">https://doi.org/10.1021/acsami.0c11064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.0c11064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.0c11064%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DDevelopment%252Bof%252Ba%252BTau-Targeted%252BDrug%252BDelivery%252BSystem%252BUsing%252Ba%252BMultifunctional%252BNanoscale%252BMetal%2525E2%252580%252593Organic%252BFramework%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%26aulast%3DZhao%26aufirst%3DJinhua%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23062020%26date%3D08092020%26date%3D16092020%26date%3D08092020%26volume%3D12%26issue%3D40%26spage%3D44447%26epage%3D44458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Junting Zhou, Xueyang Jiang, Siyu He, Hongli Jiang, Feng Feng, Wenyuan Liu, Wei Qu, <span class="NLM_string-name hlFld-ContribAuthor">Haopeng Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 8881-8914. <a href="https://doi.org/10.1021/acs.jmedchem.9b00017" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BMultitarget-Directed%252BLigands%25253A%252BStrategies%252Band%252BEmerging%252BParadigms%26aulast%3DZhou%26aufirst%3DJunting%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04012019%26date%3D28052019%26date%3D13052019%26volume%3D62%26issue%3D20%26spage%3D8881%26epage%3D8914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, Loreto Martinez-Gonzalez, Carlos Roca, Nuria E. Campillo, Josefa Zaldivar-Diez, Concepción Perez, Giampaolo Zuccheri, Andrea Miti, Alessandra Feoli, Sabrina Castellano, Sabrina Petralla, Barbara Monti, Martina Rossi, Fabio Moda, Giuseppe Legname, Ana Martinez, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7640-7656. <a href="https://doi.org/10.1021/acs.jmedchem.8b00610" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00610%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTau-Centric%252BMultitarget%252BApproach%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BDevelopment%252Bof%252BFirst-in-Class%252BDual%252BGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%252Band%252BTau-Aggregation%252BInhibitors%26aulast%3DGandini%26aufirst%3DAnnachiara%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17042018%26date%3D24082018%26date%3D04082018%26volume%3D61%26issue%3D17%26spage%3D7640%26epage%3D7656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rocío  Lajarín-Cuesta</span>, <span class="hlFld-ContribAuthor ">Carmen  Nanclares</span>, <span class="hlFld-ContribAuthor ">Juan-Alberto  Arranz-Tagarro</span>, <span class="hlFld-ContribAuthor ">Laura  González-Lafuente</span>, <span class="hlFld-ContribAuthor ">Raquel L.  Arribas</span>, <span class="hlFld-ContribAuthor ">Monique  Araujo de Brito</span>, <span class="hlFld-ContribAuthor ">Luis  Gandía</span>, and <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>  . </span><span class="cited-content_cbyCitation_article-title">Gramine Derivatives Targeting Ca2+ Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6265-6280. <a href="https://doi.org/10.1021/acs.jmedchem.6b00478" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00478%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGramine%252BDerivatives%252BTargeting%252BCa2%25252B%252BChannels%252Band%252BSer%25252FThr%252BPhosphatases%25253A%252BA%252BNew%252BDual%252BStrategy%252Bfor%252Bthe%252BTreatment%252Bof%252BNeurodegenerative%252BDiseases%26aulast%3DLajar%25C3%25ADn-Cuesta%26aufirst%3DRoc%25C3%25ADo%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D31032016%26date%3D24062016%26date%3D14072016%26date%3D09062016%26volume%3D59%26issue%3D13%26spage%3D6265%26epage%3D6280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Fu</span>, <span class="hlFld-ContribAuthor ">Xian  Feng</span>, <span class="hlFld-ContribAuthor ">Jian-Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Zhan  Xun</span>, <span class="hlFld-ContribAuthor ">Jun-Die  Hu</span>, <span class="hlFld-ContribAuthor ">Juan-Juan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan-Wei  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhi-Bin  Huang</span>, and <span class="hlFld-ContribAuthor ">Da-Qing  Shi</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis and Evaluation of Antitumor Activities of Novel Functionalized 1,8-Naphthyridine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2015,</strong> <em>17 </em>
                                    (1)
                                     , 24-31. <a href="https://doi.org/10.1021/co500120b" title="DOI URL">https://doi.org/10.1021/co500120b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/co500120b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fco500120b%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DEfficient%252BSynthesis%252Band%252BEvaluation%252Bof%252BAntitumor%252BActivities%252Bof%252BNovel%252BFunctionalized%252B1%25252C8-Naphthyridine%252BDerivatives%26aulast%3DFu%26aufirst%3DLei%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D06082014%26date%3D22102014%26date%3D02122014%26date%3D12012015%26date%3D20112014%26volume%3D17%26issue%3D1%26spage%3D24%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Gema C.  González-Muñoz</span>, <span class="hlFld-ContribAuthor ">M<sup>a</sup> Dolores  Martı́n de Saavedra</span>, <span class="hlFld-ContribAuthor ">Laura  del Barrio</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Santiago  Conde</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span>, and <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>  . </span><span class="cited-content_cbyCitation_article-title">ITH12410/SC058: A New Neuroprotective Compound with Potential in the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2014,</strong> <em>5 </em>
                                    (9)
                                     , 770-775. <a href="https://doi.org/10.1021/cn500131t" title="DOI URL">https://doi.org/10.1021/cn500131t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn500131t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn500131t%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DITH12410%25252FSC058%25253A%252BA%252BNew%252BNeuroprotective%252BCompound%252Bwith%252BPotential%252Bin%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DRomero%26aufirst%3DAlejandro%26date%3D2014%26date%3D2014%26date%3D10072014%26date%3D15072014%26date%3D17092014%26date%3D10072014%26volume%3D5%26issue%3D9%26spage%3D770%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Lorrio</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Laura  González-Lafuente</span>, <span class="hlFld-ContribAuthor ">Rocío  Lajarín-Cuesta</span>, <span class="hlFld-ContribAuthor ">Francisco J.  Martínez-Sanz</span>, <span class="hlFld-ContribAuthor ">Martín  Estrada</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Jose  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, and <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>  . </span><span class="cited-content_cbyCitation_article-title">PP2A Ligand ITH12246 Protects against Memory Impairment and Focal Cerebral Ischemia in Mice. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (9)
                                     , 1267-1277. <a href="https://doi.org/10.1021/cn400050p" title="DOI URL">https://doi.org/10.1021/cn400050p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn400050p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn400050p%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DPP2A%252BLigand%252BITH12246%252BProtects%252Bagainst%252BMemory%252BImpairment%252Band%252BFocal%252BCerebral%252BIschemia%252Bin%252BMice%26aulast%3DLorrio%26aufirst%3DSilvia%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D19022013%26date%3D28052013%26date%3D13062013%26date%3D18092013%26date%3D28052013%26volume%3D4%26issue%3D9%26spage%3D1267%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  González-Lafuente</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Rafael  León</span>, <span class="hlFld-ContribAuthor ">Francisco J.  Martínez-Sanz</span>, <span class="hlFld-ContribAuthor ">Leticia  Monjas</span>, <span class="hlFld-ContribAuthor ">Concepción  Perez</span>, <span class="hlFld-ContribAuthor ">Cristina  Merino</span>, <span class="hlFld-ContribAuthor ">Antonio M.  García-De Diego</span>, <span class="hlFld-ContribAuthor ">María I.  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Antonio G.  García</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, and <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>  . </span><span class="cited-content_cbyCitation_article-title">Benzothiazepine CGP37157 and Its Isosteric 2′-Methyl Analogue Provide Neuroprotection and Block Cell Calcium Entry. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2012,</strong> <em>3 </em>
                                    (7)
                                     , 519-529. <a href="https://doi.org/10.1021/cn300009e" title="DOI URL">https://doi.org/10.1021/cn300009e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn300009e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn300009e%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DBenzothiazepine%252BCGP37157%252Band%252BIts%252BIsosteric%252B2%2525E2%252580%2525B2-Methyl%252BAnalogue%252BProvide%252BNeuroprotection%252Band%252BBlock%252BCell%252BCalcium%252BEntry%26aulast%3DGonz%25C3%25A1lez-Lafuente%26aufirst%3DLaura%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D19012012%26date%3D26032012%26date%3D15042012%26date%3D18072012%26date%3D26032012%26volume%3D3%26issue%3D7%26spage%3D519%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinxiu  Chu</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Cui</span>, <span class="hlFld-ContribAuthor ">Shuai  Liu</span>, <span class="hlFld-ContribAuthor ">Nina  An</span>, <span class="hlFld-ContribAuthor ">Jian  Han</span>, <span class="hlFld-ContribAuthor ">Xiaohang  Che</span>, <span class="hlFld-ContribAuthor ">Chunfu  Wu</span>, <span class="hlFld-ContribAuthor ">Jingyu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Pseudoginsenoside-F11 ameliorates okadiac acid-induced learning and memory impairment in rats via modulating protein phosphatase 2A. </span><span class="cited-content_cbyCitation_journal-name">Mechanisms of Ageing and Development</span><span> <strong>2021,</strong> <em>197 </em>, 111496. <a href="https://doi.org/10.1016/j.mad.2021.111496" title="DOI URL">https://doi.org/10.1016/j.mad.2021.111496</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mad.2021.111496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mad.2021.111496%26sid%3Dliteratum%253Aachs%26jtitle%3DMechanisms%2520of%2520Ageing%2520and%2520Development%26atitle%3DPseudoginsenoside-F11%252Bameliorates%252Bokadiac%252Bacid-induced%252Blearning%252Band%252Bmemory%252Bimpairment%252Bin%252Brats%252Bvia%252Bmodulating%252Bprotein%252Bphosphatase%252B2A%26aulast%3DChu%26aufirst%3DJinxiu%26date%3D2021%26volume%3D197%26spage%3D111496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisha  Wang</span>, <span class="hlFld-ContribAuthor ">Bharti</span>, <span class="hlFld-ContribAuthor ">Rajnish  Kumar</span>, <span class="hlFld-ContribAuthor ">Pavel F.  Pavlov</span>, <span class="hlFld-ContribAuthor ">Bengt  Winblad</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112915. <a href="https://doi.org/10.1016/j.ejmech.2020.112915" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112915</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112915%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252Bmolecule%252Btherapeutics%252Bfor%252Btauopathy%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252BWalking%252Bon%252Bthe%252Bpath%252Bof%252Bmost%252Bresistance%26aulast%3DWang%26aufirst%3DLisha%26date%3D2021%26volume%3D209%26spage%3D112915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Otávio Augusto  Chaves</span>, <span class="hlFld-ContribAuthor ">Tainara P.  Calheiro</span>, <span class="hlFld-ContribAuthor ">José Carlos  Netto-Ferreira</span>, <span class="hlFld-ContribAuthor ">Márcia C.C.  de Oliveira</span>, <span class="hlFld-ContribAuthor ">Steffany Z.  Franceschini</span>, <span class="hlFld-ContribAuthor ">Cristiane Martins Cardoso  de Salles</span>, <span class="hlFld-ContribAuthor ">Nilo  Zanatta</span>, <span class="hlFld-ContribAuthor ">Clarissa P.  Frizzo</span>, <span class="hlFld-ContribAuthor ">Bernardo A.  Iglesias</span>, <span class="hlFld-ContribAuthor ">Helio G.  Bonacorso</span>. </span><span class="cited-content_cbyCitation_article-title">Biological assays of BF2-naphthyridine compounds: Tyrosinase and acetylcholinesterase activity, CT-DNA and HSA binding property evaluations. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2020,</strong> <em>160 </em>, 1114-1129. <a href="https://doi.org/10.1016/j.ijbiomac.2020.05.162" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2020.05.162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2020.05.162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2020.05.162%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DBiological%252Bassays%252Bof%252BBF2-naphthyridine%252Bcompounds%25253A%252BTyrosinase%252Band%252Bacetylcholinesterase%252Bactivity%25252C%252BCT-DNA%252Band%252BHSA%252Bbinding%252Bproperty%252Bevaluations%26aulast%3DChaves%26aufirst%3DOt%25C3%25A1vio%2BAugusto%26date%3D2020%26volume%3D160%26spage%3D1114%26epage%3D1129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Wei</span>, <span class="hlFld-ContribAuthor ">Hui-liang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia-zhao  Xie</span>, <span class="hlFld-ContribAuthor ">Dong-li  Meng</span>, <span class="hlFld-ContribAuthor ">Xiao-chuan  Wang</span>, <span class="hlFld-ContribAuthor ">Dan  Ke</span>, <span class="hlFld-ContribAuthor ">Ji  Zeng</span>, <span class="hlFld-ContribAuthor ">Rong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Medical Science</span><span> <strong>2020,</strong> <em>40 </em>
                                    (1)
                                     , 1-8. <a href="https://doi.org/10.1007/s11596-020-2140-1" title="DOI URL">https://doi.org/10.1007/s11596-020-2140-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11596-020-2140-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11596-020-2140-1%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medical%2520Science%26atitle%3DProtein%252BPhosphatase%252B2A%252Bas%252Ba%252BDrug%252BTarget%252Bin%252Bthe%252BTreatment%252Bof%252BCancer%252Band%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWei%26aufirst%3DHui%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D1%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aso Hameed  Hasan</span>, <span class="hlFld-ContribAuthor ">Syazwani Itri  Amran</span>, <span class="hlFld-ContribAuthor ">Faiq Hama  Saeed Hussain</span>, <span class="hlFld-ContribAuthor ">Baram Ahmed  Jaff</span>, <span class="hlFld-ContribAuthor ">Joazaizulfazli  Jamalis</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Docking and Recent Advances in the Design and Development of Cholinesterase Inhibitor Scaffolds: Coumarin Hybrids. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (48)
                                     , 14140-14156. <a href="https://doi.org/10.1002/slct.201903607" title="DOI URL">https://doi.org/10.1002/slct.201903607</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201903607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201903607%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DMolecular%252BDocking%252Band%252BRecent%252BAdvances%252Bin%252Bthe%252BDesign%252Band%252BDevelopment%252Bof%252BCholinesterase%252BInhibitor%252BScaffolds%25253A%252BCoumarin%252BHybrids%26aulast%3DHasan%26aufirst%3DAso%2BHameed%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D48%26spage%3D14140%26epage%3D14156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Lu</span>, <span class="hlFld-ContribAuthor ">LiangDi  Sun</span>, <span class="hlFld-ContribAuthor ">YaXin  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>. </span><span class="cited-content_cbyCitation_article-title">New barrigenol-type triterpenoids with anti-Alzheimer’s disease activity from Koelreuteria paniculata Laxm.. </span><span class="cited-content_cbyCitation_journal-name">Journal of Functional Foods</span><span> <strong>2019,</strong> <em>61 </em>, 103459. <a href="https://doi.org/10.1016/j.jff.2019.103459" title="DOI URL">https://doi.org/10.1016/j.jff.2019.103459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jff.2019.103459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jff.2019.103459%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Functional%2520Foods%26atitle%3DNew%252Bbarrigenol-type%252Btriterpenoids%252Bwith%252Banti-Alzheimer%2525E2%252580%252599s%252Bdisease%252Bactivity%252Bfrom%252BKoelreuteria%252Bpaniculata%252BLaxm.%26aulast%3DLu%26aufirst%3DXiao%26date%3D2019%26volume%3D61%26spage%3D103459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Ramos</span>, <span class="hlFld-ContribAuthor ">Alejandra  Palomino-Antolín</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Ignacio  Moraleda</span>, <span class="hlFld-ContribAuthor ">Daniel  Diez-Iriepa</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Carol V.  Cortina</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (8)
                                     , 1503. <a href="https://doi.org/10.3390/molecules24081503" title="DOI URL">https://doi.org/10.3390/molecules24081503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24081503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24081503%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DQuinoxalineTacrine%252BQT78%25252C%252Ba%252BCholinesterase%252BInhibitor%252Bas%252Ba%252BPotential%252BLigand%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%26aulast%3DRamos%26aufirst%3DEva%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D8%26spage%3D1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 381-389. <a href="https://doi.org/10.1016/j.ejmech.2019.02.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTacrines%252Bfor%252BAlzheimer%252527s%252Bdisease%252Btherapy.%252BIII.%252BThe%252BPyridoTacrines%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DCrist%25C3%25B3bal%26date%3D2019%26volume%3D166%26spage%3D381%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franziska  Pohl</span>, <span class="hlFld-ContribAuthor ">Paul  Kong Thoo Lin</span>. </span><span class="cited-content_cbyCitation_article-title">The Potential Use of Plant Natural Products and Plant Extracts with Antioxidant Properties for the Prevention/Treatment of Neurodegenerative Diseases: In Vitro, In Vivo and Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (12)
                                     , 3283. <a href="https://doi.org/10.3390/molecules23123283" title="DOI URL">https://doi.org/10.3390/molecules23123283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23123283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23123283%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BPotential%252BUse%252Bof%252BPlant%252BNatural%252BProducts%252Band%252BPlant%252BExtracts%252Bwith%252BAntioxidant%252BProperties%252Bfor%252Bthe%252BPrevention%25252FTreatment%252Bof%252BNeurodegenerative%252BDiseases%25253A%252BIn%252BVitro%25252C%252BIn%252BVivo%252Band%252BClinical%252BTrials%26aulast%3DPohl%26aufirst%3DFranziska%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D12%26spage%3D3283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chamseddine  Derabli</span>, <span class="hlFld-ContribAuthor ">Imen  Boualia</span>, <span class="hlFld-ContribAuthor ">Ahmed B.  Abdelwahab</span>, <span class="hlFld-ContribAuthor ">Raouf  Boulcina</span>, <span class="hlFld-ContribAuthor ">Chawki  Bensouici</span>, <span class="hlFld-ContribAuthor ">Gilbert  Kirsch</span>, <span class="hlFld-ContribAuthor ">Abdelmadjid  Debache</span>. </span><span class="cited-content_cbyCitation_article-title">A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (14)
                                     , 2481-2484. <a href="https://doi.org/10.1016/j.bmcl.2018.05.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bcascade%252Bsynthesis%25252C%252Bin%252Bvitro%252Bcholinesterases%252Binhibitory%252Bactivity%252Band%252Bdocking%252Bstudies%252Bof%252Bnovel%252BTacrine-pyranopyrazole%252Bderivatives%26aulast%3DDerabli%26aufirst%3DChamseddine%26date%3D2018%26volume%3D28%26issue%3D14%26spage%3D2481%26epage%3D2484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Ramos</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Javier  del Pino</span>, <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of gene expression profiles of CR80, a neuroprotective 1,8-Naphthyridine. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (11)
                                     , 1289-1300. <a href="https://doi.org/10.4155/fmc-2018-0004" title="DOI URL">https://doi.org/10.4155/fmc-2018-0004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0004%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DAnalysis%252Bof%252Bgene%252Bexpression%252Bprofiles%252Bof%252BCR80%25252C%252Ba%252Bneuroprotective%252B1%25252C8-Naphthyridine%26aulast%3DRamos%26aufirst%3DEva%26date%3D2018%26volume%3D10%26issue%3D11%26spage%3D1289%26epage%3D1300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Korábečný</span>, <span class="hlFld-ContribAuthor ">Eugenie  Nepovimová</span>, <span class="hlFld-ContribAuthor ">Tereza  Cikánková</span>, <span class="hlFld-ContribAuthor ">Katarína  Špilovská</span>, <span class="hlFld-ContribAuthor ">Lucie  Vašková</span>, <span class="hlFld-ContribAuthor ">Eva  Mezeiová</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuča</span>, <span class="hlFld-ContribAuthor ">Jana  Hroudová</span>. </span><span class="cited-content_cbyCitation_article-title">Newly Developed Drugs for Alzheimer’s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience</span><span> <strong>2018,</strong> <em>370 </em>, 191-206. <a href="https://doi.org/10.1016/j.neuroscience.2017.06.034" title="DOI URL">https://doi.org/10.1016/j.neuroscience.2017.06.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuroscience.2017.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuroscience.2017.06.034%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%26atitle%3DNewly%252BDeveloped%252BDrugs%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Bin%252BRelation%252Bto%252BEnergy%252BMetabolism%25252C%252BCholinergic%252Band%252BMonoaminergic%252BNeurotransmission%26aulast%3DKor%25C3%25A1be%25C4%258Dn%25C3%25BD%26aufirst%3DJan%26date%3D2018%26volume%3D370%26spage%3D191%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing-Qing  Hou</span>, <span class="hlFld-ContribAuthor ">Yi-Fei  Jing</span>, <span class="hlFld-ContribAuthor ">Xu-Sheng  Shao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and insecticidal activities of 1,8-naphthyridine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2017,</strong> <em>28 </em>
                                    (8)
                                     , 1723-1726. <a href="https://doi.org/10.1016/j.cclet.2017.05.016" title="DOI URL">https://doi.org/10.1016/j.cclet.2017.05.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2017.05.016%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DSynthesis%252Band%252Binsecticidal%252Bactivities%252Bof%252B1%25252C8-naphthyridine%252Bderivatives%26aulast%3DHou%26aufirst%3DQing-Qing%26date%3D2017%26volume%3D28%26issue%3D8%26spage%3D1723%26epage%3D1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stanton F.  McHardy</span>, <span class="hlFld-ContribAuthor ">Hua-Yu Leo  Wang</span>, <span class="hlFld-ContribAuthor ">Shelby V.  McCowen</span>, <span class="hlFld-ContribAuthor ">Matthew C.  Valdez</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 455-476. <a href="https://doi.org/10.1080/13543776.2017.1272571" title="DOI URL">https://doi.org/10.1080/13543776.2017.1272571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1272571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1272571%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRecent%252Badvances%252Bin%252Bacetylcholinesterase%252BInhibitors%252Band%252BReactivators%25253A%252Ban%252Bupdate%252Bon%252Bthe%252Bpatent%252Bliterature%252B%2525282012-2015%252529%26aulast%3DMcHardy%26aufirst%3DStanton%2BF.%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D455%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Ramos</span>, <span class="hlFld-ContribAuthor ">Paloma  Patiño</span>, <span class="hlFld-ContribAuthor ">Russel J.  Reiter</span>, <span class="hlFld-ContribAuthor ">Emilio  Gil-Martín</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Esther  Parada</span>, <span class="hlFld-ContribAuthor ">Cristobal  de los Rios</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>. </span><span class="cited-content_cbyCitation_article-title">Ischemic brain injury: New insights on the protective role of melatonin. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2017,</strong> <em>104 </em>, 32-53. <a href="https://doi.org/10.1016/j.freeradbiomed.2017.01.005" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2017.01.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2017.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2017.01.005%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DIschemic%252Bbrain%252Binjury%25253A%252BNew%252Binsights%252Bon%252Bthe%252Bprotective%252Brole%252Bof%252Bmelatonin%26aulast%3DRamos%26aufirst%3DEva%26date%3D2017%26volume%3D104%26spage%3D32%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anika  Flader</span>, <span class="hlFld-ContribAuthor ">Silvio  Parpart</span>, <span class="hlFld-ContribAuthor ">Peter  Ehlers</span>, <span class="hlFld-ContribAuthor ">Peter  Langer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of pyrrolo[1,2-a]naphthyridines by Lewis acid mediated cycloisomerization. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (15)
                                     , 3216-3231. <a href="https://doi.org/10.1039/C7OB00343A" title="DOI URL">https://doi.org/10.1039/C7OB00343A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB00343A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB00343A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bpyrrolo%25255B1%25252C2-a%25255Dnaphthyridines%252Bby%252BLewis%252Bacid%252Bmediated%252Bcycloisomerization%26aulast%3DFlader%26aufirst%3DAnika%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D15%26spage%3D3216%26epage%3D3231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. Yu.  Alekseeva</span>, <span class="hlFld-ContribAuthor ">D. L.  Mikhailov</span>, <span class="hlFld-ContribAuthor ">I. N.  Bardasov</span>, <span class="hlFld-ContribAuthor ">D. V.  Timrukova</span>, <span class="hlFld-ContribAuthor ">O. V.  Ershov</span>. </span><span class="cited-content_cbyCitation_article-title">Three-component synthesis of 5-aryl-1,8-naphthyridine-3-carbonitriles. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>52 </em>
                                    (10)
                                     , 1463-1467. <a href="https://doi.org/10.1134/S1070428016100158" title="DOI URL">https://doi.org/10.1134/S1070428016100158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428016100158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428016100158%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DThree-component%252Bsynthesis%252Bof%252B5-aryl-1%25252C8-naphthyridine-3-carbonitriles%26aulast%3DAlekseeva%26aufirst%3DA.%2BYu.%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D10%26spage%3D1463%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rocío  Lajarín-Cuesta</span>, <span class="hlFld-ContribAuthor ">Raquel L.  Arribas</span>, <span class="hlFld-ContribAuthor ">Cristóbal  De Los Ríos</span>. </span><span class="cited-content_cbyCitation_article-title">Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 389-407. <a href="https://doi.org/10.1517/13543776.2016.1135903" title="DOI URL">https://doi.org/10.1517/13543776.2016.1135903</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2016.1135903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2016.1135903%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DLigands%252Bfor%252BSer%25252FThr%252Bphosphoprotein%252Bphosphatases%25253A%252Ba%252Bpatent%252Breview%252B%2525282005-2015%252529%26aulast%3DLajar%25C3%25ADn-Cuesta%26aufirst%3DRoc%25C3%25ADo%26date%3D2016%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D389%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alka  Madaan</span>, <span class="hlFld-ContribAuthor ">Ritu  Verma</span>, <span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Anu T.  Singh</span>, <span class="hlFld-ContribAuthor ">Swatantra K.  Jain</span>, <span class="hlFld-ContribAuthor ">Manu  Jaggi</span>. </span><span class="cited-content_cbyCitation_article-title">1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2015,</strong> <em>348 </em>
                                    (12)
                                     , 837-860. <a href="https://doi.org/10.1002/ardp.201500237" title="DOI URL">https://doi.org/10.1002/ardp.201500237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201500237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201500237%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3D1%25252C8-Naphthyridine%252BDerivatives%25253A%252BA%252BReview%252Bof%252BMultiple%252BBiological%252BActivities%26aulast%3DMadaan%26aufirst%3DAlka%26date%3D2015%26date%3D2015%26volume%3D348%26issue%3D12%26spage%3D837%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aamer  Saeed</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>, <span class="hlFld-ContribAuthor ">Saba  Ashraf</span>, <span class="hlFld-ContribAuthor ">Javeria  Iftikhar</span>, <span class="hlFld-ContribAuthor ">Muhammad  Muddassar</span>, <span class="hlFld-ContribAuthor ">Kam Y.J.  Zhang</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2015,</strong> <em>63 </em>, 58-63. <a href="https://doi.org/10.1016/j.bioorg.2015.09.009" title="DOI URL">https://doi.org/10.1016/j.bioorg.2015.09.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2015.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2015.09.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcholinesterase%252Binhibition%252Band%252Bmolecular%252Bmodelling%252Bstudies%252Bof%252Bcoumarin%252Blinked%252Bthiourea%252Bderivatives%26aulast%3DSaeed%26aufirst%3DAamer%26date%3D2015%26volume%3D63%26spage%3D58%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdul  Hameed</span>, <span class="hlFld-ContribAuthor ">Syeda T.  Zehra</span>, <span class="hlFld-ContribAuthor ">Syed J. A.  Shah</span>, <span class="hlFld-ContribAuthor ">Khalid M.  Khan</span>, <span class="hlFld-ContribAuthor ">Rima D.  Alharthy</span>, <span class="hlFld-ContribAuthor ">Norbert  Furtmann</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>, <span class="hlFld-ContribAuthor ">Muhammad N.  Tahir</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses, Cholinesterases Inhibition, and Molecular Docking Studies of Pyrido[2,3-
              b
              ]pyrazine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (5)
                                     , 1115-1120. <a href="https://doi.org/10.1111/cbdd.12579" title="DOI URL">https://doi.org/10.1111/cbdd.12579</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12579%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSyntheses%25252C%252BCholinesterases%252BInhibition%25252C%252Band%252BMolecular%252BDocking%252BStudies%252Bof%252BPyrido%25255B2%25252C3-%252Bb%252B%25255Dpyrazine%252BDerivatives%26aulast%3DHameed%26aufirst%3DAbdul%26date%3D2015%26date%3D2015%26volume%3D86%26issue%3D5%26spage%3D1115%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivan N.  Bardasov</span>, <span class="hlFld-ContribAuthor ">Anastasiya U.  Alekseeva</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Ershov</span>, <span class="hlFld-ContribAuthor ">Mikhail Yu.  Belikov</span>. </span><span class="cited-content_cbyCitation_article-title">Four component DHARMA-synthesis of some densely functionalized 1,8-naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (40)
                                     , 5434-5436. <a href="https://doi.org/10.1016/j.tetlet.2015.08.013" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.08.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.08.013%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFour%252Bcomponent%252BDHARMA-synthesis%252Bof%252Bsome%252Bdensely%252Bfunctionalized%252B1%25252C8-naphthyridines%26aulast%3DBardasov%26aufirst%3DIvan%2BN.%26date%3D2015%26volume%3D56%26issue%3D40%26spage%3D5434%26epage%3D5436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehdi  Khoobi</span>, <span class="hlFld-ContribAuthor ">Farzaneh  Ghanoni</span>, <span class="hlFld-ContribAuthor ">Hamid  Nadri</span>, <span class="hlFld-ContribAuthor ">Alireza  Moradi</span>, <span class="hlFld-ContribAuthor ">Morteza  Pirali Hamedani</span>, <span class="hlFld-ContribAuthor ">Farshad  Homayouni Moghadam</span>, <span class="hlFld-ContribAuthor ">Saeed  Emami</span>, <span class="hlFld-ContribAuthor ">Mohsen  Vosooghi</span>, <span class="hlFld-ContribAuthor ">Reza  Zadmard</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>, <span class="hlFld-ContribAuthor ">Abbas  Shafiee</span>. </span><span class="cited-content_cbyCitation_article-title">New tetracyclic tacrine analogs containing pyrano[2,3-c]pyrazole: Efficient synthesis, biological assessment and docking simulation study. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>89 </em>, 296-303. <a href="https://doi.org/10.1016/j.ejmech.2014.10.049" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.10.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.10.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.10.049%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Btetracyclic%252Btacrine%252Banalogs%252Bcontaining%252Bpyrano%25255B2%25252C3-c%25255Dpyrazole%25253A%252BEfficient%252Bsynthesis%25252C%252Bbiological%252Bassessment%252Band%252Bdocking%252Bsimulation%252Bstudy%26aulast%3DKhoobi%26aufirst%3DMehdi%26date%3D2015%26volume%3D89%26spage%3D296%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xian  Feng</span>, <span class="hlFld-ContribAuthor ">Jian-Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Juan-Juan  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng-Pao  Cao</span>, <span class="hlFld-ContribAuthor ">Zhi-Bin  Huang</span>, <span class="hlFld-ContribAuthor ">Da-Qing  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective synthesis of functionalized [1,8]naphthyridine derivatives via three-component domino reaction under catalyst-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2015,</strong> <em>17 </em>
                                    (2)
                                     , 973-981. <a href="https://doi.org/10.1039/C4GC01469C" title="DOI URL">https://doi.org/10.1039/C4GC01469C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4GC01469C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4GC01469C%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DRegioselective%252Bsynthesis%252Bof%252Bfunctionalized%252B%25255B1%25252C8%25255Dnaphthyridine%252Bderivatives%252Bvia%252Bthree-component%252Bdomino%252Breaction%252Bunder%252Bcatalyst-free%252Bconditions%26aulast%3DFeng%26aufirst%3DXian%26date%3D2015%26date%3D2015%26volume%3D17%26issue%3D2%26spage%3D973%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Tenreiro</span>, <span class="hlFld-ContribAuthor ">Katrin  Eckermann</span>, <span class="hlFld-ContribAuthor ">Tiago F.  Outeiro</span>. </span><span class="cited-content_cbyCitation_article-title">Protein phosphorylation in neurodegeneration: friend or foe?. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Neuroscience</span><span> <strong>2014,</strong> <em>7 </em><a href="https://doi.org/10.3389/fnmol.2014.00042" title="DOI URL">https://doi.org/10.3389/fnmol.2014.00042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnmol.2014.00042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnmol.2014.00042%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Neuroscience%26atitle%3DProtein%252Bphosphorylation%252Bin%252Bneurodegeneration%25253A%252Bfriend%252Bor%252Bfoe%25253F%26aulast%3DTenreiro%26aufirst%3DSandra%26date%3D2014%26date%3D2014%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tamás  Kálai</span>, <span class="hlFld-ContribAuthor ">Robin  Altman</span>, <span class="hlFld-ContribAuthor ">Izumi  Maezawa</span>, <span class="hlFld-ContribAuthor ">Mária  Balog</span>, <span class="hlFld-ContribAuthor ">Christophe  Morisseau</span>, <span class="hlFld-ContribAuthor ">Jitka  Petrlova</span>, <span class="hlFld-ContribAuthor ">Bruce D.  Hammock</span>, <span class="hlFld-ContribAuthor ">Lee-Way  Jin</span>, <span class="hlFld-ContribAuthor ">James R.  Trudell</span>, <span class="hlFld-ContribAuthor ">John C.  Voss</span>, <span class="hlFld-ContribAuthor ">Kálmán  Hideg</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and functional survey of new Tacrine analogs modified with nitroxides or their precursors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>77 </em>, 343-350. <a href="https://doi.org/10.1016/j.ejmech.2014.03.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.03.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.03.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bfunctional%252Bsurvey%252Bof%252Bnew%252BTacrine%252Banalogs%252Bmodified%252Bwith%252Bnitroxides%252Bor%252Btheir%252Bprecursors%26aulast%3DK%25C3%25A1lai%26aufirst%3DTam%25C3%25A1s%26date%3D2014%26volume%3D77%26spage%3D343%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Todd J.  Eckroat</span>, <span class="hlFld-ContribAuthor ">Keith D.  Green</span>, <span class="hlFld-ContribAuthor ">Rebecca A.  Reed</span>, <span class="hlFld-ContribAuthor ">Joshua J.  Bornstein</span>, <span class="hlFld-ContribAuthor ">Sylvie  Garneau-Tsodikova</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of the role of linker moieties in bifunctional tacrine hybrids. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (12)
                                     , 3614-3623. <a href="https://doi.org/10.1016/j.bmc.2013.02.047" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.02.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.02.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.02.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DInvestigation%252Bof%252Bthe%252Brole%252Bof%252Blinker%252Bmoieties%252Bin%252Bbifunctional%252Btacrine%252Bhybrids%26aulast%3DEckroat%26aufirst%3DTodd%2BJ.%26date%3D2013%26volume%3D21%26issue%3D12%26spage%3D3614%26epage%3D3623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Ramón  Cacabelos</span>, <span class="hlFld-ContribAuthor ">María J.  Oset-Gasque</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (7)
                                     , 1916-1922. <a href="https://doi.org/10.1016/j.bmcl.2013.02.017" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.02.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.02.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Btacrine-related%252Bdrugs%252Bas%252Bpotential%252Bcandidates%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DRomero%26aufirst%3DAlejandro%26date%3D2013%26volume%3D23%26issue%3D7%26spage%3D1916%26epage%3D1922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline  Lambrecht</span>, <span class="hlFld-ContribAuthor ">Dorien  Haesen</span>, <span class="hlFld-ContribAuthor ">Ward  Sents</span>, <span class="hlFld-ContribAuthor ">Elitsa  Ivanova</span>, <span class="hlFld-ContribAuthor ">Veerle  Janssens</span>. </span><span class="cited-content_cbyCitation_article-title">Structure, Regulation, and Pharmacological Modulation of PP2A Phosphatases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 283-305. <a href="https://doi.org/10.1007/978-1-62703-562-0_17" title="DOI URL">https://doi.org/10.1007/978-1-62703-562-0_17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-62703-562-0_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-62703-562-0_17%26sid%3Dliteratum%253Aachs%26atitle%3DStructure%25252C%252BRegulation%25252C%252Band%252BPharmacological%252BModulation%252Bof%252BPP2A%252BPhosphatases%26aulast%3DLambrecht%26aufirst%3DCaroline%26date%3D2013%26date%3D2013%26spage%3D283%26epage%3D305%26pub%3DHumana%2520Press%26atitle%3DPhosphatase%252BModulators%26aulast%3DMill%25C3%25A1n%26aufirst%3DJos%25C3%25A9%2BLuis%26date%3D2013%26volume%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Chuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Cheng  Liu</span>, <span class="hlFld-ContribAuthor ">Rui  Yang</span>, <span class="hlFld-ContribAuthor ">Ji-Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective construction of 1,3-diazaheterocycle fused [1,2-a][1,8]naphthyridine derivatives via cascade reaction of quinolines with heterocyclic ketene aminals: a joint experimental–computational approach. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2013,</strong> <em>11 </em>
                                    (42)
                                     , 7276. <a href="https://doi.org/10.1039/c3ob41200h" title="DOI URL">https://doi.org/10.1039/c3ob41200h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ob41200h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ob41200h%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRegioselective%252Bconstruction%252Bof%252B1%25252C3-diazaheterocycle%252Bfused%252B%25255B1%25252C2-a%25255D%25255B1%25252C8%25255Dnaphthyridine%252Bderivatives%252Bvia%252Bcascade%252Breaction%252Bof%252Bquinolines%252Bwith%252Bheterocyclic%252Bketene%252Baminals%25253A%252Ba%252Bjoint%252Bexperimental%2525E2%252580%252593computational%252Bapproach%26aulast%3DZhang%26aufirst%3DYi-Chuan%26date%3D2013%26volume%3D11%26issue%3D42%26spage%3D7276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emna  Maalej</span>, <span class="hlFld-ContribAuthor ">Fakher  Chabchoub</span>, <span class="hlFld-ContribAuthor ">María Jesús  Oset-Gasque</span>, <span class="hlFld-ContribAuthor ">Mario  Esquivias-Pérez</span>, <span class="hlFld-ContribAuthor ">María P.  González</span>, <span class="hlFld-ContribAuthor ">Leticia  Monjas</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Ignacio  Moraleda</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>54 </em>, 750-763. <a href="https://doi.org/10.1016/j.ejmech.2012.06.038" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.06.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.06.038%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bassessment%25252C%252Band%252Bmolecular%252Bmodeling%252Bof%252Bracemic%252B7-aryl-9%25252C10%25252C11%25252C12-tetrahydro-7H-benzo%25255B7%25252C8%25255Dchromeno%25255B2%25252C3-b%25255Dquinolin-8-amines%252Bas%252Bpotential%252Bdrugs%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DMaalej%26aufirst%3DEmna%26date%3D2012%26volume%3D54%26spage%3D750%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>. </span><span class="cited-content_cbyCitation_article-title">Cholinesterase inhibitors: a patent review (2007 – 2011). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2012,</strong> <em>22 </em>
                                    (8)
                                     , 853-869. <a href="https://doi.org/10.1517/13543776.2012.701619" title="DOI URL">https://doi.org/10.1517/13543776.2012.701619</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2012.701619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2012.701619%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DCholinesterase%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282007%252B%2525E2%252580%252593%252B2011%252529%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DCrist%25C3%25B3bal%26date%3D2012%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D853%26epage%3D869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>, <span class="hlFld-ContribAuthor ">Irene  Bolea</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Ignacio  Moraleda</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Enrique  Gálvez</span>, <span class="hlFld-ContribAuthor ">Carolina  Valderas</span>, <span class="hlFld-ContribAuthor ">Mercedes  Unzeta</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>52 </em>, 251-262. <a href="https://doi.org/10.1016/j.ejmech.2012.03.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.03.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.03.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMultipotent%252BMAO%252Band%252Bcholinesterase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%25253A%252BSynthesis%25252C%252Bpharmacological%252Banalysis%252Band%252Bmolecular%252Bmodeling%252Bof%252Bheterocyclic%252Bsubstituted%252Balkyl%252Band%252Bcycloalkyl%252Bpropargyl%252Bamine%26aulast%3DSamadi%26aufirst%3DAbdelouahid%26date%3D2012%26volume%3D52%26spage%3D251%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. N.  Maksimova</span>, <span class="hlFld-ContribAuthor ">O. V.  Ershov</span>, <span class="hlFld-ContribAuthor ">K. V.  Lipin</span>, <span class="hlFld-ContribAuthor ">A. V.  Eremkin</span>, <span class="hlFld-ContribAuthor ">O. E.  Nasakin</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective reaction of 5,6-dialkyl-2-halopyridine-3,4-dicarbonitriles with ammonia. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>48 </em>
                                    (3)
                                     , 426-429. <a href="https://doi.org/10.1134/S1070428012030153" title="DOI URL">https://doi.org/10.1134/S1070428012030153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428012030153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428012030153%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252Breaction%252Bof%252B5%25252C6-dialkyl-2-halopyridine-3%25252C4-dicarbonitriles%252Bwith%252Bammonia%26aulast%3DMaksimova%26aufirst%3DV.%2BN.%26date%3D2012%26date%3D2012%26volume%3D48%26issue%3D3%26spage%3D426%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sherri C.  Young</span>, <span class="hlFld-ContribAuthor ">Karine M.  Fabio</span>, <span class="hlFld-ContribAuthor ">Mou-Tuan  Huang</span>, <span class="hlFld-ContribAuthor ">Jaya  Saxena</span>, <span class="hlFld-ContribAuthor ">Meredith P.  Harman</span>, <span class="hlFld-ContribAuthor ">Christophe D.  Guillon</span>, <span class="hlFld-ContribAuthor ">Anna M.  Vetrano</span>, <span class="hlFld-ContribAuthor ">Diane E.  Heck</span>, <span class="hlFld-ContribAuthor ">Robert A.  Flowers</span>, <span class="hlFld-ContribAuthor ">Ned D.  Heindel</span>, <span class="hlFld-ContribAuthor ">Jeffrey D.  Laskin</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of anticholinergic and non-steroidal anti-inflammatory prodrugs which reduce chemically induced skin inflammation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Applied Toxicology</span><span> <strong>2012,</strong> <em>32 </em>
                                    (2)
                                     , 135-141. <a href="https://doi.org/10.1002/jat.1645" title="DOI URL">https://doi.org/10.1002/jat.1645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jat.1645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjat.1645%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Applied%2520Toxicology%26atitle%3DInvestigation%252Bof%252Banticholinergic%252Band%252Bnon-steroidal%252Banti-inflammatory%252Bprodrugs%252Bwhich%252Breduce%252Bchemically%252Binduced%252Bskin%252Binflammation%26aulast%3DYoung%26aufirst%3DSherri%2BC.%26date%3D2012%26date%3D2011%26volume%3D32%26issue%3D2%26spage%3D135%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liupan  Yang</span>, <span class="hlFld-ContribAuthor ">Daxin  Shi</span>, <span class="hlFld-ContribAuthor ">Shu  Chen</span>, <span class="hlFld-ContribAuthor ">Hongxin  Chai</span>, <span class="hlFld-ContribAuthor ">Danfei  Huang</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiarong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted synthesis of 2,3-dihydropyrido[2,3-d]pyrimidin-4(1H)-ones catalyzed by DBU in aqueous medium. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2012,</strong> <em>14 </em>
                                    (4)
                                     , 945. <a href="https://doi.org/10.1039/c2gc16469h" title="DOI URL">https://doi.org/10.1039/c2gc16469h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2gc16469h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2gc16469h%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DMicrowave-assisted%252Bsynthesis%252Bof%252B2%25252C3-dihydropyrido%25255B2%25252C3-d%25255Dpyrimidin-4%2525281H%252529-ones%252Bcatalyzed%252Bby%252BDBU%252Bin%252Baqueous%252Bmedium%26aulast%3DYang%26aufirst%3DLiupan%26date%3D2012%26volume%3D14%26issue%3D4%26spage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>, <span class="hlFld-ContribAuthor ">Sudhakar  Manda</span>, <span class="hlFld-ContribAuthor ">Prashant  Joshi</span>, <span class="hlFld-ContribAuthor ">Baljinder  Singh</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>. </span><span class="cited-content_cbyCitation_article-title">Total synthesis and anti-cholinesterase activity of marine-derived bis-indole alkaloid fascaplysin. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2012,</strong> <em>3 </em>
                                    (9)
                                     , 1098. <a href="https://doi.org/10.1039/c2md20076g" title="DOI URL">https://doi.org/10.1039/c2md20076g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2md20076g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2md20076g%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DTotal%252Bsynthesis%252Band%252Banti-cholinesterase%252Bactivity%252Bof%252Bmarine-derived%252Bbis-indole%252Balkaloid%252Bfascaplysin%26aulast%3DBharate%26aufirst%3DSandip%2BB.%26date%3D2012%26volume%3D3%26issue%3D9%26spage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matilde  Yáñez</span>, <span class="hlFld-ContribAuthor ">Lucía  Galán</span>, <span class="hlFld-ContribAuthor ">Jorge  Matías-Guiu</span>, <span class="hlFld-ContribAuthor ">Alvaro  Vela</span>, <span class="hlFld-ContribAuthor ">Antonio  Guerrero</span>, <span class="hlFld-ContribAuthor ">Antonio G.  García</span>. </span><span class="cited-content_cbyCitation_article-title">CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: Protection by resveratrol but not riluzole. </span><span class="cited-content_cbyCitation_journal-name">Brain Research</span><span> <strong>2011,</strong> <em>1423 </em>, 77-86. <a href="https://doi.org/10.1016/j.brainres.2011.09.025" title="DOI URL">https://doi.org/10.1016/j.brainres.2011.09.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainres.2011.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainres.2011.09.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%26atitle%3DCSF%252Bfrom%252Bamyotrophic%252Blateral%252Bsclerosis%252Bpatients%252Bproduces%252Bglutamate%252Bindependent%252Bdeath%252Bof%252Brat%252Bmotor%252Bbrain%252Bcortical%252Bneurons%25253A%252BProtection%252Bby%252Bresveratrol%252Bbut%252Bnot%252Briluzole%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DMatilde%26date%3D2011%26volume%3D1423%26spage%3D77%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcos  Maroto</span>, <span class="hlFld-ContribAuthor ">Antonio M.G.  de Diego</span>, <span class="hlFld-ContribAuthor ">Elisa  Albiñana</span>, <span class="hlFld-ContribAuthor ">José C.  Fernandez-Morales</span>, <span class="hlFld-ContribAuthor ">Afonso  Caricati-Neto</span>, <span class="hlFld-ContribAuthor ">Aron  Jurkiewicz</span>, <span class="hlFld-ContribAuthor ">Matilde  Yáñez</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodriguez-Franco</span>, <span class="hlFld-ContribAuthor ">Santiago  Conde</span>, <span class="hlFld-ContribAuthor ">Mariana P.  Arce</span>, <span class="hlFld-ContribAuthor ">Jesús M.  Hernández-Guijo</span>, <span class="hlFld-ContribAuthor ">Antonio G.  García</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-target novel neuroprotective compound ITH33/IQM9.21 inhibits calcium entry, calcium signals and exocytosis. </span><span class="cited-content_cbyCitation_journal-name">Cell Calcium</span><span> <strong>2011,</strong> <em>50 </em>
                                    (4)
                                     , 359-369. <a href="https://doi.org/10.1016/j.ceca.2011.06.006" title="DOI URL">https://doi.org/10.1016/j.ceca.2011.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ceca.2011.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ceca.2011.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Calcium%26atitle%3DMulti-target%252Bnovel%252Bneuroprotective%252Bcompound%252BITH33%25252FIQM9.21%252Binhibits%252Bcalcium%252Bentry%25252C%252Bcalcium%252Bsignals%252Band%252Bexocytosis%26aulast%3DMaroto%26aufirst%3DMarcos%26date%3D2011%26volume%3D50%26issue%3D4%26spage%3D359%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, <span class="hlFld-ContribAuthor ">Irene  Bolea</span>, <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Ignacio  Moraleda</span>, <span class="hlFld-ContribAuthor ">Agatha  Bastida</span>, <span class="hlFld-ContribAuthor ">Gerard  Esteban</span>, <span class="hlFld-ContribAuthor ">Mercedes  Unzeta</span>, <span class="hlFld-ContribAuthor ">Enrique  Gálvez</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (9)
                                     , 4665-4668. <a href="https://doi.org/10.1016/j.ejmech.2011.05.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.05.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.05.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.05.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bassessment%252Band%252Bmolecular%252Bmodeling%252Bof%252Bnew%252Bmultipotent%252BMAO%252Band%252Bcholinesterase%252Binhibitors%252Bas%252Bpotential%252Bdrugs%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSamadi%26aufirst%3DAbdelouahid%26date%3D2011%26volume%3D46%26issue%3D9%26spage%3D4665%26epage%3D4668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alvin V.  Terry</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Callahan</span>, <span class="hlFld-ContribAuthor ">Brandon  Hall</span>, <span class="hlFld-ContribAuthor ">Scott J.  Webster</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer's disease and age-related memory decline (preclinical). </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Biochemistry and Behavior</span><span> <strong>2011,</strong> <em>99 </em>
                                    (2)
                                     , 190-210. <a href="https://doi.org/10.1016/j.pbb.2011.02.002" title="DOI URL">https://doi.org/10.1016/j.pbb.2011.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbb.2011.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbb.2011.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Biochemistry%2520and%2520Behavior%26atitle%3DAlzheimer%252527s%252Bdisease%252Band%252Bage-related%252Bmemory%252Bdecline%252B%252528preclinical%252529%26aulast%3DTerry%26aufirst%3DAlvin%2BV.%26date%3D2011%26volume%3D99%26issue%3D2%26spage%3D190%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Voronkov</span>, <span class="hlFld-ContribAuthor ">Steven P  Braithwaite</span>, <span class="hlFld-ContribAuthor ">Jeffry B  Stock</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (7)
                                     , 821-833. <a href="https://doi.org/10.4155/fmc.11.47" title="DOI URL">https://doi.org/10.4155/fmc.11.47</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.11.47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.11.47%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DPhosphoprotein%252Bphosphatase%252B2A%25253A%252Ba%252Bnovel%252Bdruggable%252Btarget%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DVoronkov%26aufirst%3DMichael%26date%3D2011%26volume%3D3%26issue%3D7%26spage%3D821%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emna  Maalej</span>, <span class="hlFld-ContribAuthor ">Fakher  Chabchoub</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>, <span class="hlFld-ContribAuthor ">Almudena  Perona</span>, <span class="hlFld-ContribAuthor ">Antonio  Morreale</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological assessment and molecular modeling of 14-aryl-10,11,12,14-tetrahydro-9H-benzo[5,6]chromeno[2,3-b]quinolin-13-amines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (8)
                                     , 2384-2388. <a href="https://doi.org/10.1016/j.bmcl.2011.02.094" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.02.094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.02.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.02.094%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bbiological%252Bassessment%252Band%252Bmolecular%252Bmodeling%252Bof%252B14-aryl-10%25252C11%25252C12%25252C14-tetrahydro-9H-benzo%25255B5%25252C6%25255Dchromeno%25255B2%25252C3-b%25255Dquinolin-13-amines%26aulast%3DMaalej%26aufirst%3DEmna%26date%3D2011%26volume%3D21%26issue%3D8%26spage%3D2384%26epage%3D2388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Carolina  Valderas</span>, <span class="hlFld-ContribAuthor ">Cristóbal de los  Ríos</span>, <span class="hlFld-ContribAuthor ">Agatha  Bastida</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, <span class="hlFld-ContribAuthor ">Laura  González-Lafuente</span>, <span class="hlFld-ContribAuthor ">Inés  Colmena</span>, <span class="hlFld-ContribAuthor ">Luis  Gandía</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Laura del  Barrio</span>, <span class="hlFld-ContribAuthor ">María D.  Martín-de-Saavedra</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2011,</strong> <em>19 </em>
                                    (1)
                                     , 122-133. <a href="https://doi.org/10.1016/j.bmc.2010.11.040" title="DOI URL">https://doi.org/10.1016/j.bmc.2010.11.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2010.11.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2010.11.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DCholinergic%252Band%252Bneuroprotective%252Bdrugs%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252Band%252Bneuronal%252Bvascular%252Bdiseases.%252BII.%252BSynthesis%25252C%252Bbiological%252Bassessment%25252C%252Band%252Bmolecular%252Bmodelling%252Bof%252Bnew%252Btacrine%252Banalogues%252Bfrom%252Bhighly%252Bsubstituted%252B2-aminopyridine-3-carbonitriles%26aulast%3DSamadi%26aufirst%3DAbdelouahid%26date%3D2011%26volume%3D19%26issue%3D1%26spage%3D122%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0001.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Selected Tacrine−1,4-DHP Hybrids Described in Previous Papers</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0002.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. 1,8-Naphthyridines Based on the Juxtaposition of an AChE Inhibitor (Tacrine) and a 1,4-Dihydropyridine (Nifedipine)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0003.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Naphthyridine Precursors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Me<sub>2</sub>NCH(OMe)<sub>2</sub>, DMF, room temp, 24 h; (b) Me<sub>2</sub>NCH(OEt)<sub>2</sub>, DMF, room temp, 24 h; (c) NH<sub>2</sub>COCH<sub>2</sub>CN, NaH, DMF, room temp, 24 h; (d) POCl<sub>3</sub>, reflux, 48 h; (e) benzylamine, MeOH, room temp, 4 days; (f) CF<sub>3</sub>SO<sub>3</sub>H, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 2 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0004.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the 1,8-Naphthyridine Derivatives <b>9</b>−<b>16</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Steady-state inhibition of AChE hydrolysis of acetylthiocholine (ATCh) by compound <b>14</b>. Lineweaver−Burk reciprocal plots of initial velocity and substrate concentrations (0.1−1 mM) are presented. Lines were derived from a weighted least-squares analysis of data. Inset: slope of the double reciprocal plots versus [<b>14</b>].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of compounds <b>12</b> and <b>14</b> on [Ca<sup>2+</sup>]<sub>c</sub> increase induced by high K<sup>+</sup> in SH-SY5Y neuroblastoma cells. Experiments were performed in Fluo-4-loaded cells (<i>n</i> = 4). The curves are representative examples of the averaged time course of [Ca<sup>2+</sup>]<sub>c</sub> in control conditions and in the presence of <b>12</b>, <b>14</b> (at 1 μM), or nifedipine at 3 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. LDH release assay with rotenone/oligomycin A stimulated SH-SY5Y cells in the presence of compounds <b>9</b>−<b>16</b> or the 4-phenyl-substituted analogue <b>17</b>. SH-SY5Y neuroblastoma cells were treated with 1 μM drugs 24 h before and during the incubation period with the toxic stimulus (30 μM rotenone plus 10 μM oligomycin-A, Rot/Olig). The 10 nM melatonin (Mel) and 1 mM <i>N</i>-acetylcysteine (NAC) were used as reference compounds. After exposure to Rot/Olig, cell death was quantified by measuring the LDH released to the media and normalized in each individual experiment as percentage with respect to the maximum LDH released, considered as 100% cell death, and LDH released by nontreated cells, considered as 0% cell death. Data are the means ± SEM of triplicates of seven different cell batches: (∗) <i>p</i> < 0.05 in comparison to control cell death.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. MTT reduction assay in okadaic acid stimulated SH-SY5Y cells in the presence of compounds <b>9</b>−<b>16</b> and the 4-phenyl-substituted analogue <b>17</b>. SH-SY5Y neuroblastoma cells were treated with 1 μM compounds or 0.3 μM galantamine (used as reference compound) 24 h before and during the incubation period with the toxic stimulus (30 nM okadaic acid, 24 h). After this period, cell viability was quantified by evaluating MTT reduction to a formazan salt. Control group was considered as 100% of viability and represents cell viability of cells incubated only with cell culture medium. Data are the mean ± SEM of triplicates of seven different cell batches: (###) <i>p</i> < 0.001, comparing control and okadaic acid-lesioned cells; (∗∗) <i>p</i> < 0.01, comparing to okadaic acid lesioned cells in the absence of drug.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0009.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Tautomeric Equilibrium for Compound <b>14</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0010.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Structure of Okadaic Acid and Tautomer <b>14d</b> Showing the Regions and the Selected Atoms To Be Aligned</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Superposition of tautomer <b>14d</b> and okadaic acid. Hydrogen atoms are omitted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Molecular electrostatic potential surfaces for tautomer <b>14d</b> (left) and okadaic acid (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>14</b> on the inhibition of PP2A-derived phosphatase activity induced by OA, measured with the malachite green assay. Immunoprecipitated PP2A from rat brain lysates was treated with vehicle (control), 30 nM OA (maximal inhibition), and 30 nM OA plus <b>14</b> (1 or 10 μM), before adding the threonine phosphopeptide (Lys-Arg-pThr-Ile-Arg-Arg) used as enzymatic substrate. After 10 min, malachite green was added and the enzymatic reaction was allowed 15 min more for color development. After this period, PP2A activity was quantified by measuring color generation at 620 nm. Control group represents the maximal phosphatase activity. Data are the mean ± SEM of triplicates of two different brain lysates: (###) <i>p</i> < 0.001 versus control; (∗) <i>p</i> < 0.05 and (∗∗∗) <i>p</i> < 0.001 in comparison to OA in the absence of drug.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0014.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (a, left) Molecular docking model of <b>14d</b>−PP2A complex. Yellow portions indicate positions of the pocket. (b, right) Molecular docking model of <b>14d</b>−PP2A complex including okadaic acid (zoom): <b>14d</b> (blue), okadaic acid (red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0015.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Binding mode of the most stable docked orientation of <b>14d</b> with PP2A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0016.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. MTT reduction assay in Aβ-lesioned SH-SY5Y neuroblastoma cells in the presence of compound <b>14</b>. Neuroblastoma cells were treated with <b>14</b> (0.1−3 μM) or 10 nM of melatonin (Mel, used as reference) 24 h before and during a 24 h incubation period with 30 μM Aβ<sub>1−42</sub>. After this period, cell viability was quantified by measuring MTT reduction. Control group was considered as 100% and represents cell viability of cells incubated only in culture medium. Data are the mean ± SEM of triplicates of four different cell batches: (##) <i>p</i> < 0.01 versus control; (∗∗) <i>p</i> < 0.01 and (∗∗∗) <i>p</i> < 0.001 in comparison to Aβ<sub>1−42</sub> lesioned cells in the absence of drug.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/medium/jm-2009-01902w_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0017.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. MTT reduction assay in rat hippocampal slices subjected to 15 min of OGD and 120 min of reoxygenation in absence (OGD bar) or presence of increasing concentrations (1, 3, 10, and 30 μM) of compound <b>14</b> (see protocol at the top of the figure). Galantamine (GAL, 15 μM) was used as reference. Slices, kept during the same period of time with oxygen and glucose, were run in parallel to define the control condition (Control). MTT reduction in control slices was taken as 100% of tissue viability. Data are the mean ± SEM of six experiments: (###) <i>p</i> < 0.001 comparing control respect to OGD; (∗∗∗) <i>p</i> < 0.001 in comparison to OGD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm901902w/production/images/large/jm-2009-01902w_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901902w&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71503" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71503" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 74 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span> </span><span class="NLM_article-title">A century of Alzheimer’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+century+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520century%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4377</span><span class="NLM_x">–</span> <span class="NLM_lpage">4387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.2174%2F138161206778792985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=17105433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4377-4387&author=A.+Castroauthor=A.+Martinez&title=Targeting+beta-amyloid+pathogenesis+through+acetylcholinesterase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span></div><div class="casAuthors">Castro, Ana; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4377-4387</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Although the hallmarks of neurodegeneration in Alzheimer's brains are well known, one of the current difficulties is related to the lack of solid evidence about the ultimate factors that give rise to the pathogenesis of this disease, creating a great challenge for the definition of efficient treatments for Alzheimer's disease (AD).  Current therapeutic option for AD patients is the use of acetylcholinesterase (AChE) inhibitors, which gives only a symptomatic relief.  However, recent studies show a long-lasting effect in a certain percentage of patients.  In fact, there is accumulating evidence that an AChE has secondary non-cholinergic functions including the processing and deposition of β-amyloid (Aβ).  AChE could play a role in the Aβ metab. and during an early step in the development of the senile plaque, as revealed by the finding that AChE accelerates Aβ deposition.  Considering the non-classical AChE functions, their relationships with AD hallmarks, and the putative role of peripheral anionic site in all these functions, the dual binding site AChE inhibitors may acquire importance for AD treatment.  On the other hand, the interference of AChE inhibitors with Aβ processing is not a general rule for this class of compds. with the involvement of other features such as chem. structure and/or genetic regulation.  This review highlights the collection of several compds. with an outstanding profile against AChE-induced amyloid aggregation and potent AChE inhibitory activity, indicating the possibility of targeting Aβ through the inhibition of AChE and reveals the emergence of a new generation of AChE inhibitors aiming to be excellent candidate drugs for the future cure of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrisn7G_dIHxrVg90H21EOLACvtfcHk0lj5j1zncJY_4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI&md5=fd41eca56c6433d9ee6a3989908ff2c5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F138161206778792985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778792985%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DTargeting%2520beta-amyloid%2520pathogenesis%2520through%2520acetylcholinesterase%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4377%26epage%3D4387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gong, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span> </span><span class="NLM_article-title">Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2321</span><span class="NLM_x">–</span> <span class="NLM_lpage">2328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.2174%2F092986708785909111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=18855662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2321-2328&author=C.+X.+Gongauthor=K.+Iqbal&title=Hyperphosphorylation+of+microtubule-associated+protein+tau%3A+a+promising+therapeutic+target+for+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease</span></div><div class="casAuthors">Gong, C.-X.; Iqbal, K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2321-2328</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease (AD) is the most common cause of dementia in adults.  The current therapy for AD has only moderate efficacy in controlling symptoms, and it does not cure the disease.  Recent studies have suggested that abnormal hyperphosphorylation of tau in the brain plays a vital role in the mol. pathogenesis of AD and in neurodegeneration.  This article reviews the current advances in understanding of tau protein, regulation of tau phosphorylation, and the role of its abnormal hyperphosphorylation in neurofibrillary degeneration.  Furthermore, several therapeutic strategies for treating AD on the basis of the important role of tau hyperphosphorylation in the pathogenesis of the disease are described.  These strategies include (1) inhibition of glycogen synthase kinase-3β (GSK-3β), cyclin-dependent kinase 5 (cdk5), and other tau kinases; (2) restoration of PP2A activity; and (3) targeting tau O-GlcNAcylation.  Development of drugs on the basis of these strategies is likely to lead to disease-modifying therapies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYsNnpBYEpr7Vg90H21EOLACvtfcHk0lhgMMIBpOoM3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsb7F&md5=8b860e765e134fa7eeb471026d40d90b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F092986708785909111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785909111%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DHyperphosphorylation%2520of%2520microtubule-associated%2520protein%2520tau%253A%2520a%2520promising%2520therapeutic%2520target%2520for%2520Alzheimer%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2321%26epage%3D2328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Pratico, D.</span><span> </span><span class="NLM_article-title">Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1147</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1147&publication_year=2008&pages=70-78&author=D.+Pratico&title=Evidence+of+oxidative+stress+in+Alzheimer%E2%80%99s+disease+brain+and+antioxidant+therapy%3A+lights+and+shadows"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPratico%26aufirst%3DD.%26atitle%3DEvidence%2520of%2520oxidative%2520stress%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%2520and%2520antioxidant%2520therapy%253A%2520lights%2520and%2520shadows%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2008%26volume%3D1147%26spage%3D70%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Treatment of Alzheimer’s disease: current and future therapeutic approaches</span> <span class="citation_source-journal">Rev. Neurol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=16400259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FhslSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=60-69&author=J.+L.+Cummings&title=Treatment+of+Alzheimer%E2%80%99s+disease%3A+current+and+future+therapeutic+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Alzheimer's disease: current and future therapeutic approaches</span></div><div class="casAuthors">Cummings Jeffrey L</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in neurological diseases</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">60-9</span>
        ISSN:<span class="NLM_cas:issn">1545-2913</span>.
    </div><div class="casAbstract">The pathophysiology of Alzheimer's disease (AD) includes the deposition of amyloid beta protein (Abeta) and the ensuing initiation of a variety of secondary processes, including tau hyperphosphorylation, excitotoxicity, oxidation, and inflammation.  Nerve cell loss in structures responsible for manufacturing neurotransmitters results in a variety of neurochemical deficits.  Current therapeutic approaches to the treatment of AD include cholinesterase inhibitors for mild to moderate disease, memantine for moderate to severe disease, and vitamin E or selegiline.  Reduction of Abeta generation or aggregation, enhancement of Abeta removal, interruption of tau hyperphosphorylation, and the use of more efficacious antioxidant or anti-inflammatory agents represent promising therapeutic strategies currently being investigated.  Improved methodologies for clinical trial design and analysis and the development of biological markers may hasten the identification of effective treatments for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7-rxo5VUM0rHHuJhbyicZfW6udTcc2ea7Rt5z4l-81bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FhslSisA%253D%253D&md5=b88c53187ff8cadf0a0e58f0f1015d1a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DTreatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520current%2520and%2520future%2520therapeutic%2520approaches%26jtitle%3DRev.%2520Neurol.%2520Dis.%26date%3D2004%26volume%3D1%26spage%3D60%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Rafii, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span> </span><span class="NLM_article-title">Recent developments in Alzheimer’s disease therapeutics</span> <span class="citation_source-journal">BMC Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1186%2F1741-7015-7-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=19228370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADC%252BD1M7nsVKksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=7&author=M.+S.+Rafiiauthor=P.+S.+Aisen&title=Recent+developments+in+Alzheimer%E2%80%99s+disease+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in Alzheimer's disease therapeutics</span></div><div class="casAuthors">Rafii Michael S; Aisen Paul S</div><div class="citationInfo"><span class="NLM_cas:title">BMC medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease is a devastating neurological disorder that affects more than 37 million people worldwide.  The economic burden of Alzheimer's disease is massive; in the United States alone, the estimated direct and indirect annual cost of patient care is at least $100 billion.  Current FDA-approved drugs for Alzheimer's disease do not prevent or reverse the disease, and provide only modest symptomatic benefits.  Driven by the clear unmet medical need and a growing understanding of the molecular pathophysiology of Alzheimer's disease, the number of agents in development has increased dramatically in recent years.  Truly *'disease-modifying' therapies that target the underlying mechanisms of Alzheimer's disease have now reached late stages of human clinical trials.  Primary targets include beta-amyloid, whose presence and accumulation in the brain is thought to contribute to the development of Alzheimer's disease, and tau protein which, when hyperphosphorylated, results in the self-assembly of tangles of paired helical filaments also believed to be involved in the pathogenesis of Alzheimer's disease.  In this review, we briefly discuss the current status of Alzheimer's disease therapies under study, as well the scientific context in which they have been developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQBqsOYVNCvy6Ufuk_1xoTfW6udTcc2ea7Rt5z4l-81bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7nsVKksA%253D%253D&md5=fddd28d862a1be10ae4a10cc2769c3a4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-7-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-7-7%26sid%3Dliteratum%253Aachs%26aulast%3DRafii%26aufirst%3DM.%2BS.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26atitle%3DRecent%2520developments%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DBMC%2520Med.%26date%3D2009%26volume%3D7%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">van Marum, R. J.</span><span> </span><span class="NLM_article-title">Current and future therapy in Alzheimer’s disease</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1472-8206.2008.00578.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=18485144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=265-274&author=R.+J.+van+Marum&title=Current+and+future+therapy+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Current and future therapy in Alzheimer's disease</span></div><div class="casAuthors">van Marum, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-274</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Dementia is increasingly being recognized as one of the most important medical problems in the elderly.  As most pharmacol. research within the field of dementia is focused on Alzheimer's dementia (AD), this review will focus on pharmacol. interventions in AD.  Most disease-modifying therapies are based on the amyloid hypothesis.  In this hypothesis, the pathol. accumulation of Aβ in the brain leads to oxidative stress, neuronal destruction and finally the clin. syndrome of AD.  Following this hypothesis, secondary prevention of AD can be made by: decreasing the prodn. of Aβ, stimulation of clearance of Aβ formed or prevention of aggregation of Aβ into amyloid plaques.  First a short overview on current approved therapies for AD is given.  The main part of the review will focus on potential disease-modifying therapies for AD that are currently being studied in phase I to phase III trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYSu96SxTqLVg90H21EOLACvtfcHk0ljZ__Ck_RGjnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D&md5=0813e575e9440a3e1ffc0e0ee79c5e7a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.2008.00578.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.2008.00578.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMarum%26aufirst%3DR.%2BJ.%26atitle%3DCurrent%2520and%2520future%2520therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D22%26spage%3D265%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Fillit, H. M.; Doody, R. S.; Binaso, K.; Crooks, G. M.; Ferris, S. H.; Farlow, M. R.; Leifer, B.; Mills, C.; Minkoff, N.; Orland, B.; Reichman, W. E.; Salloway, S.</span><span> </span><span class="NLM_article-title">Recommendations for best practices in the treatment of Alzheimer's disease in managed care</span>.  <span class="citation_source-journal">Am. J. Geriatr. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. A</span>),  <span class="NLM_fpage">S9</span>− <span class="NLM_lpage">S24</span>; quiz S25−S28.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=S9-S24&issue=Suppl.+A&author=H.+M.+Fillit&author=R.+S.+Doody&author=K.+Binaso&author=G.+M.+Crooks&author=S.+H.+Ferris&author=M.+R.+Farlow&author=B.+Leifer&author=C.+Mills&author=N.+Minkoff&author=B.+Orland&author=W.+E.+Reichman&author=S.+Salloway&title=Recommendations+for+best+practices+in+the+treatment+of+Alzheimer%27s+disease+in+managed+care"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFillit%26aufirst%3DH.%2BM.%26atitle%3DRecommendations%2520for%2520best%2520practices%2520in%2520the%2520treatment%2520of%2520Alzheimer%2527s%2520disease%2520in%2520managed%2520care%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Pharmacother.%26date%3D2006%26volume%3D4%26issue%3DSuppl.%2520A%26spage%3DS9%26epage%3DS24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzucchelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porrello, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govoni, S.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors: novel activities of old molecules</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2Fj.phrs.2003.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=15304241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVCqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=441-451&author=M.+Racchiauthor=M.+Mazzucchelliauthor=E.+Porrelloauthor=C.+Lanniauthor=S.+Govoni&title=Acetylcholinesterase+inhibitors%3A+novel+activities+of+old+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors: novel activities of old molecules</span></div><div class="casAuthors">Racchi, Marco; Mazzucchelli, Michela; Porrello, Emanuela; Lanni, Cristina; Govoni, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-451</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The therapeutic approach for improving the cognitive function in patients with Alzheimer's disease (AD) is mainly based on the potentiation of central cholinergic activity and is achieved clin. by the use of acetylcholinesterase (AChE) inhibitors such as tacrine, donepezil, rivastigmine, galantamine and other drugs currently in clin. trials.  These are, by their pharmacol., only symptomatic drugs yet recently these mols. have shown some potential also in the modulation of amyloid precursor protein (APP) processing.  We explore in this review the exptl. evidence that suggests a role for AChEIs in APP processing and point to multiple complex mechanisms involving either a cholinergic agonist effect, coupled to multiple signal transduction pathways, or post-transcriptional effects that modulate the expression of cellular APP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVpOo04QwYy7Vg90H21EOLACvtfcHk0ljZ__Ck_RGjnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVCqsr8%253D&md5=7f81d066fa285380f75c36d18ec46313</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2003.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2003.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DMazzucchelli%26aufirst%3DM.%26aulast%3DPorrello%26aufirst%3DE.%26aulast%3DLanni%26aufirst%3DC.%26aulast%3DGovoni%26aufirst%3DS.%26atitle%3DAcetylcholinesterase%2520inhibitors%253A%2520novel%2520activities%2520of%2520old%2520molecules%26jtitle%3DPharmacol.%2520Res.%26date%3D2004%26volume%3D50%26spage%3D441%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Talesa, V. N.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase in Alzheimer’s disease</span> <span class="citation_source-journal">Mech. Ageing Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2001&pages=1961-1969&author=V.+N.+Talesa&title=Acetylcholinesterase+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalesa%26aufirst%3DV.%2BN.%26atitle%3DAcetylcholinesterase%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMech.%2520Ageing%2520Dev.%26date%3D2001%26volume%3D122%26spage%3D1961%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">O’Neill, M. F.</span><span> </span><span class="NLM_article-title">Difficult times for Alzheimer’s treatments</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1333-1335&author=M.+F.+O%E2%80%99Neill&title=Difficult+times+for+Alzheimer%E2%80%99s+treatments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BF.%26atitle%3DDifficult%2520times%2520for%2520Alzheimer%25E2%2580%2599s%2520treatments%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D1333%26epage%3D1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bullock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touchon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapatz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, R.</span><span> </span><span class="NLM_article-title">Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer’s disease over a 2-year period</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1185%2F030079905X56565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=16083542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGltrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=1317-1327&author=R.+Bullockauthor=J.+Touchonauthor=H.+Bergmanauthor=G.+Gambinaauthor=Y.+Heauthor=G.+Rapatzauthor=J.+Nagelauthor=R.+Lane&title=Rivastigmine+and+donepezil+treatment+in+moderate+to+moderately-severe+Alzheimer%E2%80%99s+disease+over+a+2-year+period"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period</span></div><div class="casAuthors">Bullock, Roger; Touchon, Jacques; Bergman, Howard; Gambina, Giuseppe; He, Yunsheng; Rapatz, Gunter; Nagel, Jennifer; Lane, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1317-1327</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">Randomized controlled trials that directly compare cholinesterase inhibitors for the treatment of Alzheimer's disease have been characterized by significant methodol. limitations.  As a consequence, they have failed to establish whether there are differences between agents in this class.  A double-blind, randomized, controlled, multicenter trial was designed to evaluate the efficacy and tolerability of cholinesterase inhibitor treatment in patients with moderate to moderately-severe Alzheimer's disease over a 2-yr period.  Patients were randomly assigned to rivastigmine 3-12 mg/day or donepezil 5-10 mg/day.  Efficacy measures comprised assessments of cognition, activities of daily living, global functioning and behavioral symptoms.  Safety and tolerability assessments included adverse events and measurement of vital signs.  In total, 994 patients received cholinesterase inhibitor treatment (rivastigmine, n = 495; donepezil, n = 499), and 57.9% of patients completed the study.  The most frequent reason for premature discontinuation in both treatment groups was adverse events, primarily gastrointestinal.  Adverse events were more frequent in the rivastigmine group during the titrn. phase, but similar in the maintenance phase.  Serious adverse events were reported by 31.7% of rivastigmine- and 32.5% of donepezil-treated patients, resp.  Rivastigmine and donepezil had similar effects on measures of cognition and behavior, but rivastigmine showed a statistically significant advantage on measures of activities of daily living and global functioning in the ITT-LOCF population.  However, this was not maintained in the non-ITT-LOCF populations.  In secondary subgroup analyses, AD patients who had genotypes that encoded for full expression of the butyrylcholinesterase enzyme (BuChE wt/wt; n = 226/340), who were < 75 years of age (n = 362/994) or who had symptoms suggestive of concomitant Lewy body disease (n = 49/994) showed significantly greater benefits from rivastigmine treatment.  Cholinesterase inhibitor treatment may offer continued therapeutic benefit for up to 2 years in patients with moderate AD.  Although both drugs performed similarly on cognition and behavior, rivastigmine may provide greater benefit in activities of daily living and global functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxRLhcjewR27Vg90H21EOLACvtfcHk0li333bBZ4214Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGltrrM&md5=27e399adae3f407b7ea4e9b092f6634c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1185%2F030079905X56565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079905X56565%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DR.%26aulast%3DTouchon%26aufirst%3DJ.%26aulast%3DBergman%26aufirst%3DH.%26aulast%3DGambina%26aufirst%3DG.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DRapatz%26aufirst%3DG.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DLane%26aufirst%3DR.%26atitle%3DRivastigmine%2520and%2520donepezil%2520treatment%2520in%2520moderate%2520to%2520moderately-severe%2520Alzheimer%25E2%2580%2599s%2520disease%2520over%2520a%25202-year%2520period%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2005%26volume%3D21%26spage%3D1317%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span> </span><span class="NLM_article-title">Novel anti-Alzheimer’s dimer bis(7)-cognitin: cellular and molecular mechanisms of neuroprotection through multiple targets</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=187-201&author=W.+Liauthor=M.+Makauthor=H.+Jiangauthor=Q.+Wangauthor=Y.+Pangauthor=K.+Chenauthor=Y.+Han&title=Novel+anti-Alzheimer%E2%80%99s+dimer+bis%287%29-cognitin%3A+cellular+and+molecular+mechanisms+of+neuroprotection+through+multiple+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMak%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DY.%26atitle%3DNovel%2520anti-Alzheimer%25E2%2580%2599s%2520dimer%2520bis%25287%2529-cognitin%253A%2520cellular%2520and%2520molecular%2520mechanisms%2520of%2520neuroprotection%2520through%2520multiple%2520targets%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D187%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Lorrio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobrado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arias, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span> </span><span class="NLM_article-title">Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1124%2Fjpet.107.122747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=17526807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=591-599&author=S.+Lorrioauthor=M.+Sobradoauthor=E.+Ariasauthor=J.+M.+Rodaauthor=A.+G.+Garciaauthor=M.+G.+Lopez&title=Galantamine+postischemia+provides+neuroprotection+and+memory+recovery+against+transient+global+cerebral+ischemia+in+gerbils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils</span></div><div class="casAuthors">Lorrio, Silvia; Sobrado, Monica; Arias, Esperanza; Roda, Jose M.; Garcia, Antonio G.; Lopez, Manuela G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">591-599</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Galantamine, currently used in Alzheimer's patients, has shown neuroprotection in hippocampal slices subjected to oxygen-glucose deprivation.  Here, we present an in vivo study to evaluate the potential neuroprotective effects of galantamine in a transient global cerebral ischemia model in gerbils.  Three treatment protocols were used.  In the pretreatment protocol, gerbils were treated before ischemia and for 3 consecutive days thereafter.  Eight groups of animals were included: sham operation plus placebo, 10 mg/kg mecamylamine and 10 mg/kg galantamine, resp.; and ischemia plus placebo, 10 mg/kg mecamylamine, 1 mg/kg galantamine, and 10 mg/kg galantamine and 10 mg/kg mecamylamine plus galantamine, resp.  Postischemia protocols included three groups of animals: sham operation, ischemia plus placebo, and ischemia plus 10 mg/kg galantamine; substances were administered 3 or 6 h after ischemia and for 2 consecutive days thereafter.  Pyramidal neurons surviving in the cornus ammonis 1 region of the hippocampus were evaluated 72 h after reperfusion, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) histochem., caspase-3 and superoxide dismutase (SOD)-2 immunohistochemistries, and Western blottings were performed, and object placement tests were carried out.  Galantamine significantly increased the no. of living pyramidal neurons after ischemia-reperfusion injury.  Galantamine significantly reduced TUNEL, active caspase-3, and SOD-2 immunoreactivity.  The nicotinic antagonist mecamylamine blocked the protective effects of galantamine.  The neuroprotective effects of galantamine were preserved even when first administered at 3 h postischemia.  These results correlated with the performance in the object placement test.  This study shows that galantamine provides in vivo neuroprotection and memory recovery against global cerebral ischemia, even when administration begins 3 h postischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMjXG-BDErbVg90H21EOLACvtfcHk0li333bBZ4214Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSjtLk%253D&md5=d9bff0788463da058533e1af0c3efe46</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.122747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.122747%26sid%3Dliteratum%253Aachs%26aulast%3DLorrio%26aufirst%3DS.%26aulast%3DSobrado%26aufirst%3DM.%26aulast%3DArias%26aufirst%3DE.%26aulast%3DRoda%26aufirst%3DJ.%2BM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26atitle%3DGalantamine%2520postischemia%2520provides%2520neuroprotection%2520and%2520memory%2520recovery%2520against%2520transient%2520global%2520cerebral%2520ischemia%2520in%2520gerbils%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D591%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Arias, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ales, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabilan, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano-Abad, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span> </span><span class="NLM_article-title">Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2004&pages=103-114&author=E.+Ariasauthor=E.+Alesauthor=N.+H.+Gabilanauthor=M.+F.+Cano-Abadauthor=M.+Villarroyaauthor=A.+G.+Garciaauthor=M.+G.+Lopez&title=Galantamine+prevents+apoptosis+induced+by+beta-amyloid+and+thapsigargin%3A+involvement+of+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArias%26aufirst%3DE.%26aulast%3DAles%26aufirst%3DE.%26aulast%3DGabilan%26aufirst%3DN.%2BH.%26aulast%3DCano-Abad%26aufirst%3DM.%2BF.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26atitle%3DGalantamine%2520prevents%2520apoptosis%2520induced%2520by%2520beta-amyloid%2520and%2520thapsigargin%253A%2520involvement%2520of%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D46%26spage%3D103%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Melo, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostinho, P.</span><span> </span><span class="NLM_article-title">Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1460-9568.2009.06612.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=19222556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ltlSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=455-464&author=J.+B.+Meloauthor=C.+Sousaauthor=P.+Garcaoauthor=C.+R.+Oliveiraauthor=P.+Agostinho&title=Galantamine+protects+against+oxidative+stress+induced+by+amyloid-beta+peptide+in+cortical+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons</span></div><div class="casAuthors">Melo Joana B; Sousa Carla; Garcao Pedro; Oliveira Catarina R; Agostinho Paula</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Galantamine is currently used in the treatment of patients with mild-to-moderate Alzheimer's disease (AD).  Although its action is mostly directed at the regulation of cholinergic transmission, galantamine can also afford neuroprotection against amyloid-beta peptide (Abeta), which is involved in AD pathogenesis.  In this study, we used cultured rat cortical neurons treated with two forms of Abeta(1-40), fresh and previously aged (enriched in fibrils).  First, we confirmed that galantamine prevented neurodegeneration induced by both peptide forms in a concentration-dependent manner.  Moreover, we observed that when neurons were co-incubated with fresh Abeta(1-40) plus galantamine, the amount of amyloid aggregates was reduced.  As oxidative conditions influence Abeta aggregation, we investigated whether galantamine prevents oxidative stress induced by this peptide.  The data show that either fresh or aged Abeta(1-40) significantly increased the amount of reactive oxygen species and lipoperoxidation, these effects being prevented by galantamine.  In Abeta(1-40)-treated neurons, the depletion of reduced glutathione (GSH) seems to be related to the decrease in glutathione peroxidase and glutathione reductase activities(.) These alterations in the GSH antioxidant system were prevented by galantamine.  Overall, these results constitute the first evidence that galantamine can prevent the neuronal oxidative damage induced by Abeta, providing an in vitro basis for the beneficial actions of galantamine in the AD neurodegenerative process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJ45F6z1jQI8ULxIEhxUjPfW6udTcc2eazUFKNVVuQfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ltlSmsA%253D%253D&md5=2c73855b5b7334bcf926d97afa39ae93</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2009.06612.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2009.06612.x%26sid%3Dliteratum%253Aachs%26aulast%3DMelo%26aufirst%3DJ.%2BB.%26aulast%3DSousa%26aufirst%3DC.%26aulast%3DGarcao%26aufirst%3DP.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26aulast%3DAgostinho%26aufirst%3DP.%26atitle%3DGalantamine%2520protects%2520against%2520oxidative%2520stress%2520induced%2520by%2520amyloid-beta%2520peptide%2520in%2520cortical%2520neurons%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D455%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Noh, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1471-4159.2008.05837.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=19077054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFelsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2009&pages=1116-1125&author=M.+Y.+Nohauthor=S.+H.+Kohauthor=Y.+Kimauthor=H.+Y.+Kimauthor=G.+W.+Choauthor=S.+H.+Kim&title=Neuroprotective+effects+of+donepezil+through+inhibition+of+GSK-3+activity+in+amyloid-beta-induced+neuronal+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-β-induced neuronal cell death</span></div><div class="casAuthors">Noh, Min-Young; Koh, Seong-Ho; Kim, Youngchul; Kim, Hyun Young; Cho, Goang Won; Kim, Seung Hyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1116-1125</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Acetylcholinesterase inhibitors (AChE-inhibitors) are used for the treatment of Alzheimer's disease.  Recently, the AChE-inhibitor donepezil was found to have neuroprotective effects.  However, the protective mechanisms of donepezil have not yet been clearly identified.  We investigated the neuroprotective effects of donepezil and other AChE-inhibitors against amyloid-β1-42 (Aβ42)-induced neurotoxicity in rat cortical neurons.  To evaluate the neuroprotective effects of AChE-inhibitors, primary cultured cortical neurons were pre-treated with several concns. of AChE-inhibitors for 24 h and then treated with 20 μM Aβ42 for 6 h.  In addn. to donepezil, other AChE-inhibitors (galantamine and huperzine A) also showed increased neuronal cell viability against Aβ42 toxicity in a concn.-dependent manner.  However, we demonstrated that donepezil has a more potent effect in inhibiting glycogen synthase kinase-3 (GSK-3) activity compared with other AChE-inhibitors.  The neuroprotective effects of donepezil were blocked by LY294002 (10 μM), a phosphoinositide 3 kinase inhibitor, but only partially by mecamylamine (10 μM), a blocker of nicotinic acetylcholine receptors.  Addnl., donepezil's neuroprotective mechanism was related to the enhanced phosphorylation of Akt and GSK-3β and reduced phosphorylation of tau and glycogen synthase.  These results suggest that donepezil prevents Aβ42-induced neurotoxicity through the activation of phosphoinositide 3 kinase/Akt and inhibition of GSK-3, as well as through the activation of nicotinic acetylcholine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAlKKJMgtliLVg90H21EOLACvtfcHk0lgt3gVc_dXn0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFelsrs%253D&md5=574ac70d2b0d533599b4c11a11332d55</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05837.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05837.x%26sid%3Dliteratum%253Aachs%26aulast%3DNoh%26aufirst%3DM.%2BY.%26aulast%3DKoh%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DCho%26aufirst%3DG.%2BW.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DNeuroprotective%2520effects%2520of%2520donepezil%2520through%2520inhibition%2520of%2520GSK-3%2520activity%2520in%2520amyloid-beta-induced%2520neuronal%2520cell%2520death%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D108%26spage%3D1116%26epage%3D1125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanueva, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=881-891&author=N.+C.+Inestrosaauthor=A.+Alvarezauthor=C.+A.+Perezauthor=R.+D.+Morenoauthor=M.+Vicenteauthor=C.+Linkerauthor=O.+I.+Casanuevaauthor=C.+Sotoauthor=J.+Garrido&title=Acetylcholinesterase+accelerates+assembly+of+amyloid-beta-peptides+into+Alzheimer%E2%80%99s+fibrils%3A+possible+role+of+the+peripheral+site+of+the+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%2BA.%26aulast%3DMoreno%26aufirst%3DR.%2BD.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DLinker%26aufirst%3DC.%26aulast%3DCasanueva%26aufirst%3DO.%2BI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520accelerates%2520assembly%2520of%2520amyloid-beta-peptides%2520into%2520Alzheimer%25E2%2580%2599s%2520fibrils%253A%2520possible%2520role%2520of%2520the%2520peripheral%2520site%2520of%2520the%2520enzyme%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D881%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2FS0006-2952%2802%2901514-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=12527333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=407-416&author=M.+Bartoliniauthor=C.+Bertucciauthor=V.+Cavriniauthor=V.+Andrisano&title=beta-Amyloid+aggregation+induced+by+human+acetylcholinesterase%3A+inhibition+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span></div><div class="casAuthors">Bartolini, Manuela; Bertucci, Carlo; Cavrini, Vanni; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The aggregation of β-amyloid (1-40) (Aβ) induced by human recombinant acetylcholinesterase (HuAChE) was studied by means of CD (CD) and by thioflavin T fluorescence spectroscopy.  Aβ was incubated alone and with HuAChE.  The kinetic of fibrils formation was followed for 48 h.  The increasing β-conformation content induced by HuAChE, preliminary to the formation of Aβ fibrils, was detd. by CD.  This phenomenon was found to be related to the thioflavin T emission of fluorescence at 490 nm.  Incubation expts. were performed in the presence of known AChE inhibitors (physostigmine, edrophonium, decamethonium, propidium) and drugs used for Alzheimer's disease (AD) (tacrine, donepezil), to test their capability of preventing the HuAChE-induced Aβ aggregation.  The non-competitive or mixed mode of AChE inhibition was confirmed to be an essential feature.  At 100 μM propidium, decamethonium, donepezil and physostigmine were found to inhibit the HuAChE-induced Aβ aggregation by 82, 25, 22 and 30%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2eDGIBesVCbVg90H21EOLACvtfcHk0lgt3gVc_dXn0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D&md5=51d1021e8be93014f0b15a61db241392</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901514-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901514-9%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3Dbeta-Amyloid%2520aggregation%2520induced%2520by%2520human%2520acetylcholinesterase%253A%2520inhibition%2520studies%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D65%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Espinoza-Fonseca, L. M.</span><span> </span><span class="NLM_article-title">The benefits of the multi-target approach in drug design and discovery</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">896</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2Fj.bmc.2005.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=16203151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=896-897&author=L.+M.+Espinoza-Fonseca&title=The+benefits+of+the+multi-target+approach+in+drug+design+and+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The benefits of the multi-target approach in drug design and discovery</span></div><div class="casAuthors">Espinoza-Fonseca, L. Michel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">896-897</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Promiscuous binding has been considered to be a problem in the design and development of new drugs against a given disease.  However, promiscuity in mol. recognition is not all bad news, and scientists are currently taking advantage of the emerging promiscuous binding' or multi-target approach' in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocGqPWnEVzk7Vg90H21EOLACvtfcHk0livlqompdMiJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOjuw%253D%253D&md5=3daf3304b9bc2c60575b5e3003e89897</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DEspinoza-Fonseca%26aufirst%3DL.%2BM.%26atitle%3DThe%2520benefits%2520of%2520the%2520multi-target%2520approach%2520in%2520drug%2520design%2520and%2520discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D896%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0livlqompdMiJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpellini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estelrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lizondo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3588</span><span class="NLM_x">–</span> <span class="NLM_lpage">3598</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8001313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3588-3598&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=T.+Gomezauthor=D.+Munoz-Torreroauthor=M.+Scarpelliniauthor=E.+Viaynaauthor=A.+Badiaauthor=M.+V.+Closauthor=A.+Caminsauthor=M.+Pallasauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=J.+Estelrichauthor=M.+Lizondoauthor=A.+Bidon-Chanalauthor=F.+J.+Luque&title=Novel+donepezil-based+inhibitors+of+acetyl-+and+butyrylcholinesterase+and+acetylcholinesterase-induced+beta-amyloid+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm8001313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001313%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DGomez%26aufirst%3DT.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26aulast%3DScarpellini%26aufirst%3DM.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPallas%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DEstelrich%26aufirst%3DJ.%26aulast%3DLizondo%26aufirst%3DM.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNovel%2520donepezil-based%2520inhibitors%2520of%2520acetyl-%2520and%2520butyrylcholinesterase%2520and%2520acetylcholinesterase-induced%2520beta-amyloid%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3588%26epage%3D3598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colizzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2Fj.bmcl.2007.09.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=17998161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1WgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=423-426&author=L.+Piazziauthor=A.+Cavalliauthor=F.+Colizziauthor=F.+Bellutiauthor=M.+Bartoliniauthor=F.+Manciniauthor=M.+Recanatiniauthor=V.+Andrisanoauthor=A.+Rampa&title=Multi-target-directed+coumarin+derivatives%3A+hAChE+and+BACE1+inhibitors+as+potential+anti-Alzheimer+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds</span></div><div class="casAuthors">Piazzi, Lorna; Cavalli, Andrea; Colizzi, Francesco; Belluti, Federica; Bartolini, Manuela; Mancini, Francesca; Recanatini, Maurizio; Andrisano, Vincenza; Rampa, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">423-426</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The complex etiol. of Alzheimer's disease (AD) prompts scientists to develop multifunctional compds. to combat causes and symptoms of such neurodegeneration.  A series of compds., e.g., I, has been designed, synthesized, and tested by introducing halophenylalkylamidic functions on the scaffold of AP2238 (II), which is a dual binding site acetylcholinesterase inhibitor.  The inhibitory activity was successfully extended to the beta-site amyloid precursor protein cleavage enzyme, leading to the discovery of a potent inhibitor of this enzyme and affording multifunctional compds. for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQZP5TwhQKrVg90H21EOLACvtfcHk0livlqompdMiJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1WgtA%253D%253D&md5=f97fcfe0199fced046a876d98ed481bc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.100%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DColizzi%26aufirst%3DF.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DMulti-target-directed%2520coumarin%2520derivatives%253A%2520hAChE%2520and%2520BACE1%2520inhibitors%2520as%2520potential%2520anti-Alzheimer%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D423%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dafni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Pyrano[3,2-<i>c</i>]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5365</span><span class="NLM_x">–</span> <span class="NLM_lpage">5379</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900859q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5365-5379&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=D.+Munoz-Torreroauthor=L.+Ramirezauthor=E.+Gomezauthor=N.+Isambertauthor=R.+Lavillaauthor=A.+Badiaauthor=M.+V.+Closauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodriguez-Francoauthor=O.+Huertasauthor=T.+Dafniauthor=F.+J.+Luque&title=Pyrano%5B3%2C2-c%5Dquinoline-6-chlorotacrine+hybrids+as+a+novel+family+of+acetylcholinesterase-+and+beta-amyloid-directed+anti-Alzheimer+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm900859q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900859q%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26aulast%3DRamirez%26aufirst%3DL.%26aulast%3DGomez%26aufirst%3DE.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DDafni%26aufirst%3DT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DPyrano%255B3%252C2-c%255Dquinoline-6-chlorotacrine%2520hybrids%2520as%2520a%2520novel%2520family%2520of%2520acetylcholinesterase-%2520and%2520beta-amyloid-directed%2520anti-Alzheimer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5365%26epage%3D5379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Weinstock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschbaum-Slager, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarovici, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bejar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoham, S.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">939</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=939&publication_year=2001&pages=148-161&author=M.+Weinstockauthor=N.+Kirschbaum-Slagerauthor=P.+Lazaroviciauthor=C.+Bejarauthor=M.+B.+Youdimauthor=S.+Shoham&title=Neuroprotective+effects+of+novel+cholinesterase+inhibitors+derived+from+rasagiline+as+potential+anti-Alzheimer+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstock%26aufirst%3DM.%26aulast%3DKirschbaum-Slager%26aufirst%3DN.%26aulast%3DLazarovici%26aufirst%3DP.%26aulast%3DBejar%26aufirst%3DC.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DShoham%26aufirst%3DS.%26atitle%3DNeuroprotective%2520effects%2520of%2520novel%2520cholinesterase%2520inhibitors%2520derived%2520from%2520rasagiline%2520as%2520potential%2520anti-Alzheimer%2520drugs%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2001%26volume%3D939%26spage%3D148%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinchon, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Novel tacrine derivatives that block neuronal calcium channels</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2088</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2077-2088&author=C.+de+los+Riosauthor=J.+L.+Marcoauthor=M.+D.+Carreirasauthor=P.+M.+Chinchonauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Novel+tacrine+derivatives+that+block+neuronal+calcium+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3DCarreiras%26aufirst%3DM.%2BD.%26aulast%3DChinchon%26aufirst%3DP.%2BM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNovel%2520tacrine%2520derivatives%2520that%2520block%2520neuronal%2520calcium%2520channels%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2077%26epage%3D2088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banos, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivas, N. M.</span><span> </span><span class="NLM_article-title">Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=727-732&author=J.+L.+Marcoauthor=C.+de+los+Riosauthor=M.+C.+Carreirasauthor=J.+E.+Banosauthor=A.+Badiaauthor=N.+M.+Vivas&title=Synthesis+and+acetylcholinesterase%2Fbutyrylcholinesterase+inhibition+activity+of+new+tacrine-like+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DCarreiras%26aufirst%3DM.%2BC.%26aulast%3DBanos%26aufirst%3DJ.%2BE.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26atitle%3DSynthesis%2520and%2520acetylcholinesterase%252Fbutyrylcholinesterase%2520inhibition%2520activity%2520of%2520new%2520tacrine-like%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D727%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglietta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terencio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Novel multipotent tacrine−dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7607</span><span class="NLM_x">–</span> <span class="NLM_lpage">7610</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061047j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7607-7610&author=J.+Marco-Contellesauthor=R.+Leonauthor=C.+de+Los+Riosauthor=A.+Gugliettaauthor=J.+Terencioauthor=M.+G.+Lopezauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Novel+multipotent+tacrine%E2%88%92dihydropyridine+hybrids+with+improved+acetylcholinesterase+inhibitory+and+neuroprotective+activities+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm061047j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061047j%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3Dde%2BLos%2BRios%26aufirst%3DC.%26aulast%3DGuglietta%26aufirst%3DA.%26aulast%3DTerencio%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNovel%2520multipotent%2520tacrine%25E2%2588%2592dihydropyridine%2520hybrids%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520neuroprotective%2520activities%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7607%26epage%3D7610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras Mdo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Tacripyrines, the first tacrine−dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2724</span><span class="NLM_x">–</span> <span class="NLM_lpage">2732</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801292b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2724-2732&author=J.+Marco-Contellesauthor=R.+Leonauthor=C.+de+los+Riosauthor=A.+Samadiauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=O.+Huertasauthor=X.+Barrilauthor=F.+J.+Luqueauthor=M.+I.+Rodriguez-Francoauthor=B.+Lopezauthor=M.+G.+Lopezauthor=A.+G.+Garciaauthor=C.+Carreiras+Mdoauthor=M.+Villarroya&title=Tacripyrines%2C+the+first+tacrine%E2%88%92dihydropyridine+hybrids%2C+as+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm801292b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801292b%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DLopez%26aufirst%3DB.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DCarreiras%2BMdo%26aufirst%3DC.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DTacripyrines%252C%2520the%2520first%2520tacrine%25E2%2588%2592dihydropyridine%2520hybrids%252C%2520as%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2724%26epage%3D2732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Summers, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majovski, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachiki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, A.</span><span> </span><span class="NLM_article-title">Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">1241</span><span class="NLM_x">–</span> <span class="NLM_lpage">1245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1056%2FNEJM198611133152001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=2430180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADyaL2s%252FjvFahsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=1986&pages=1241-1245&author=W.+K.+Summersauthor=L.+V.+Majovskiauthor=G.+M.+Marshauthor=K.+Tachikiauthor=A.+Kling&title=Oral+tetrahydroaminoacridine+in+long-term+treatment+of+senile+dementia%2C+Alzheimer+type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type</span></div><div class="casAuthors">Summers W K; Majovski L V; Marsh G M; Tachiki K; Kling A</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1241-5</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">We treated 17 patients who had moderate to severe Alzheimer's disease with oral tetrahydroaminoacridine (THA), a centrally active anticholinesterase, in a three-phase study.  In the nonblinded first phase of the study, significant improvement occurred in subjects who received the drug, as compared with their pretreatment status, on the global assessment (P = 0.001), the Orientation Test (P = 0.001), and the more sophisticated Names Learning Test (P = 0.001).  During the second phase, the subjects served as their own controls in a double-blind, placebo-controlled, cross-over study in which the order of administration of the drug and placebo was randomly assigned.  Among the 14 subjects completing Phase II, THA treatment produced significantly better results than placebo on the global assessment (P = 0.003), the Orientation Test (P = 0.004), the Alzheimer's Deficit Scale (P = 0.003), and the Names Learning Test (P = 0.001).  Twelve subjects have entered Phase III, which involves long-term administration of oral THA.  The average duration of treatment in these subjects at present is 12.6 months; symptomatic improvements have occurred, and no serious side effects attributable to THA have been observed.  These encouraging initial results suggest that THA may be at least temporarily useful in the long-term palliative treatment of patients with Alzheimer's disease.  We stress that further observations will be required before a clear assessment of the role of this agent can be made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXMwVWLd0gLpp6t8nS6Nc3fW6udTcc2eZf-MbDcA9DeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s%252FjvFahsA%253D%253D&md5=cdb2761ff58c436d8e12d9a9ab219ccd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1056%2FNEJM198611133152001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198611133152001%26sid%3Dliteratum%253Aachs%26aulast%3DSummers%26aufirst%3DW.%2BK.%26aulast%3DMajovski%26aufirst%3DL.%2BV.%26aulast%3DMarsh%26aufirst%3DG.%2BM.%26aulast%3DTachiki%26aufirst%3DK.%26aulast%3DKling%26aufirst%3DA.%26atitle%3DOral%2520tetrahydroaminoacridine%2520in%2520long-term%2520treatment%2520of%2520senile%2520dementia%252C%2520Alzheimer%2520type%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1986%26volume%3D315%26spage%3D1241%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Mori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varadi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakamori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, A.</span><span> </span><span class="NLM_article-title">Molecular pharmacology of voltage-dependent calcium channels</span> <span class="citation_source-journal">Jpn. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1254%2Fjjp.72.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=8912911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaK28XmsVCrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1996&pages=83-109&author=Y.+Moriauthor=G.+Mikalaauthor=G.+Varadiauthor=T.+Kobayashiauthor=S.+Kochauthor=M.+Wakamoriauthor=A.+Schwartz&title=Molecular+pharmacology+of+voltage-dependent+calcium+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology of voltage-dependent calcium channels</span></div><div class="casAuthors">Mori, Yasuo; Mikala, Gabor; Varadi, Gyula; Kobayashi, Tsutomu; Koch, Sheryl; Wakamori, Minoru; Schwartz, Arnold</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-109</span>CODEN:
                <span class="NLM_cas:coden">JJPAAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-5198</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A review, with 262 refs., describing recent progress in understanding the interactions between Ca2+ channels and their blockers, i.e., Ca2+ antagonists, from a mol. and structural point of view.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmtvN84D43hrVg90H21EOLACvtfcHk0liy7IHNGvSkUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsVCrsbc%253D&md5=09045dbbe2aa4799b15a21e0ec5883c8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1254%2Fjjp.72.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjjp.72.83%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DY.%26aulast%3DMikala%26aufirst%3DG.%26aulast%3DVaradi%26aufirst%3DG.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DKoch%26aufirst%3DS.%26aulast%3DWakamori%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DA.%26atitle%3DMolecular%2520pharmacology%2520of%2520voltage-dependent%2520calcium%2520channels%26jtitle%3DJpn.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D72%26spage%3D83%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, Y.</span><span> </span><span class="NLM_article-title">Ca<sup>2+</sup> channel antagonists and neuroprotection from cerebral ischemia</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2FS0014-2999%2898%2900774-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=9877076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaK1cXotFWjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=1998&pages=1-15&author=T.+Kobayashiauthor=Y.+Mori&title=Ca2%2B+channel+antagonists+and+neuroprotection+from+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ channel antagonists and neuroprotection from cerebral ischemia</span></div><div class="casAuthors">Kobayashi, Tsutomu; Mori, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 114 refs. Stroke is the 3rd leading cause of death and the main disabling neurol. disease.  The finding in exptl. studies that neuronal death does not occur immediately after ischemic injury has encouraged the development of neuroprotective agents.  Various Ca2+ channel antagonists, i.e., L-type-selective or nonselective derivs. of classical Ca2+ channel antagonists, have been examd. for their ability to produce neuroprotection through improvement of cerebral blood circulation or inhibition of Ca2+ overload induced by excessive glutamate release.  Although some of the antagonists gave efficient neuroprotection in animal models, systemic hypotension limited the utility of these drugs, and none of the compds. had beneficial effects in treatments for acute ischemic stroke in clin. trials.  Drugs other than Ca2+ channel antagonists which have been developed on the basis of the glutamate-Ca2+ overload hypothesis also lack clin. benefit.  Recently, some mechanisms have been proposed to interpret neuronal death in relation to hyperexcitability or apoptosis after ischemic insult.  In these hypotheses, activation of the Ca2+ channel types selectively expressed in neuronal tissues is proposed as a crit. step of the pathways toward neurodegeneration.  Thus, it is increasingly recognized that developing highly selective compds. for interacting with neuronal Ca2+ channels is not only important for treatment of stroke but also for elucidation of mechanisms that underlie neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoET9ON4I4zw7Vg90H21EOLACvtfcHk0liy7IHNGvSkUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotFWjtLw%253D&md5=7c76108499474a770d09bc7ae48f7993</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2898%2900774-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252898%252900774-2%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DY.%26atitle%3DCa2%252B%2520channel%2520antagonists%2520and%2520neuroprotection%2520from%2520cerebral%2520ischemia%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D363%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lukic-Panin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span> </span><span class="NLM_article-title">Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1176</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2Fj.brainres.2007.07.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=17904110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2ht7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1176&publication_year=2007&pages=143-150&author=V.+Lukic-Paninauthor=T.+Kamiyaauthor=H.+Zhangauthor=T.+Hayashiauthor=A.+Tsuchiyaauthor=Y.+Seharaauthor=K.+Deguchiauthor=T.+Yamashitaauthor=K.+Abe&title=Prevention+of+neuronal+damage+by+calcium+channel+blockers+with+antioxidative+effects+after+transient+focal+ischemia+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats</span></div><div class="casAuthors">Lukic-Panin, Violeta; Kamiya, Tatsushi; Zhang, HanZhe; Hayashi, Takeshi; Tsuchiya, Atsushi; Sehara, Yoshihide; Deguchi, Kentaro; Yamashita, Toru; Abe, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-150</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Background:: Cerebral ischemia is a major leading cause of death and at the first place cause of disability all over the world.  There are a lot of drugs that are in exptl. stage for treatment of stroke.  Among them are calcium channel blockers (CCBs) that have, in animal models, different effectiveness in healing of ischemic damage in brain.  Mechanism of CCBs' action in cerebral ischemia is still unclear, but antioxidative property is supposed to be implicated.  In the present study, we investigated antioxidative and neuroprotective properties of two CCBs, azelnidipine and amlodipine.  Methods:: Male Wistar Kyoto rats were subjected to 90 min of transient middle cerebral artery occlusion (MCAO) by a nylon thread.  Animals were divided into 3 groups, vehicle, azelnidipine and amlodipine group.  In the azelnidipine and amlodipine groups, rats were treated with azelnidipine (1 mg/kg) and amlodipine (1 mg/kg) by gastric gavage for 2 wk before MCAO.  Vehicle group was treated by soln. of Me cellulose for 2 wk.  Rats were killed 24 h after MCAO.  Physiol. parameters (mean arterial pressure, heart rate, body wt.), infarct vol., brain edema index, cerebral blood flow (CBF), oxidative stress markers which are HEL, 4-HNE, AGE and 8-OHdG, and evidence of apoptosis by TUNEL, were investigated.  Results:: There were no significant differences among groups in mean arterial pressure, heart rate and body wt.  Treatment with azelnidipine and amlodipine reduced infarct vol. and brain edema.  Azelnidipine treated group showed more marked redn. of infarct vol. and cerebral edema than amlodipine group.  There was no attenuation of CBF in CCBs groups.  The no. of HEL, 4-HNE, AGE and 8-OHdG pos. cells were significantly decreased in the CCBs treated groups.  These mols. were again fewer in the azelnidipine group than in the amlodipine group.  In TUNEL staining, the nos. of pos. cells was smaller in the CCBs treated groups, esp. in the azelnidipine group.  Conclusions:: Pretreatment of azelnidipine and amlodipine had a neuroprotective effect in ischemic brain.  Antioxidative property is one of the important profiles of CCBs that is implicated in brain protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo13EnmF33kpbVg90H21EOLACvtfcHk0lg6TXtowmL-Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2ht7fK&md5=68e558261bf27445603b3f8b8a029e45</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.07.038%26sid%3Dliteratum%253Aachs%26aulast%3DLukic-Panin%26aufirst%3DV.%26aulast%3DKamiya%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DTsuchiya%26aufirst%3DA.%26aulast%3DSehara%26aufirst%3DY.%26aulast%3DDeguchi%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DK.%26atitle%3DPrevention%2520of%2520neuronal%2520damage%2520by%2520calcium%2520channel%2520blockers%2520with%2520antioxidative%2520effects%2520after%2520transient%2520focal%2520ischemia%2520in%2520rats%26jtitle%3DBrain%2520Res.%26date%3D2007%26volume%3D1176%26spage%3D143%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleuterio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morreale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca<sup>2+</sup> channels and nicotinic receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2199-2218&author=J.+L.+Marcoauthor=C.+de+los+Riosauthor=A.+G.+Garciaauthor=M.+Villarroyaauthor=M.+C.+Carreirasauthor=C.+Martinsauthor=A.+Eleuterioauthor=A.+Morrealeauthor=M.+Orozcoauthor=F.+J.+Luque&title=Synthesis%2C+biological+evaluation+and+molecular+modelling+of+diversely+functionalized+heterocyclic+derivatives+as+inhibitors+of+acetylcholinesterase%2Fbutyrylcholinesterase+and+modulators+of+Ca2%2B+channels+and+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DCarreiras%26aufirst%3DM.%2BC.%26aulast%3DMartins%26aufirst%3DC.%26aulast%3DEleuterio%26aufirst%3DA.%26aulast%3DMorreale%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520molecular%2520modelling%2520of%2520diversely%2520functionalized%2520heterocyclic%2520derivatives%2520as%2520inhibitors%2520of%2520acetylcholinesterase%252Fbutyrylcholinesterase%2520and%2520modulators%2520of%2520Ca2%252B%2520channels%2520and%2520nicotinic%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2199%26epage%3D2218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Orozco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arias, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span> </span><span class="NLM_article-title">ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with “calcium promotor” and neuroprotective properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1124%2Fjpet.104.068189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=15111641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1eqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=987-994&author=C.+Orozcoauthor=C.+de+Los+Riosauthor=E.+Ariasauthor=R.+Leonauthor=A.+G.+Garciaauthor=J.+L.+Marcoauthor=M.+Villarroyaauthor=M.+G.+Lopez&title=ITH4012+%28ethyl+5-amino-6%2C7%2C8%2C9-tetrahydro-2-methyl-4-phenylbenzol%5B1%2C8%5Dnaphthyridine-3-carboxylate%29%2C+a+novel+acetylcholinesterase+inhibitor+with+%E2%80%9Ccalcium+promotor%E2%80%9D+and+neuroprotective+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with "calcium promotor" and neuroprotective properties</span></div><div class="casAuthors">Orozco, Camilo; de los Rios, Cristobal; Arias, Esperanza; Leon, Rafael; Garcia, Antonio G.; Marco, Jose L.; Villarroya, Mercedes; Lopez, Manuela G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">987-994</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">ITH4012 is a novel tacrine deriv. that can reduce cell death induced by various compds. with different mechanisms of action, such as thapsigargin (reticular stress), H2O2 (free radicals), and veratridine (calcium overload), in bovine chromaffin cell.  Cell viability, quantified as lactic dehydrogenase release, was significantly reduced by ITH4012 at concns. ranging from 0.01 to 3 μM.  In the human neuroblastoma cell line SH-SY5Y, ITH4012 also reduced amyloid β25-35-induced apoptosis, detd. by flow cytometry.  ITH4012 caused a slight elevation in the cytosolic concn. of Ca2+ in fura 2-loaded bovine chromaffin cells, which could be related to the induction of protein synthesis relevant for cell survival.  Blockade of protein synthesis by cycloheximide or blockade of Bcl-2's active site with HA14-1 (Et 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate) reversed the cytoprotective action of ITH4012.  Furthermore, exposure of bovine chromaffin cells for 24 or 48 h to neuroprotective concns. of this compd. enhanced, nearly 3-fold, the expression of the antiapoptotic protein Bcl-2.  In conclusion, ITH4012 is a tacrine deriv. that maintains acetylcholinesterase-inhibiting activity (IC50 = 0.8 μM) but has the addnl. property of acting as a calcium promotor, a property leading to neuroprotection through the induction of antiapoptotic proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSWEJ4AXfFlbVg90H21EOLACvtfcHk0lg6TXtowmL-Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1eqtLo%253D&md5=68e7e0669459ddf4721c550ef301535a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.068189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.068189%26sid%3Dliteratum%253Aachs%26aulast%3DOrozco%26aufirst%3DC.%26aulast%3Dde%2BLos%2BRios%26aufirst%3DC.%26aulast%3DArias%26aufirst%3DE.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26atitle%3DITH4012%2520%2528ethyl%25205-amino-6%252C7%252C8%252C9-tetrahydro-2-methyl-4-phenylbenzol%255B1%252C8%255Dnaphthyridine-3-carboxylate%2529%252C%2520a%2520novel%2520acetylcholinesterase%2520inhibitor%2520with%2520%25E2%2580%259Ccalcium%2520promotor%25E2%2580%259D%2520and%2520neuroprotective%2520properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26spage%3D987%26epage%3D994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Abushanab, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aly, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakefield, B. J.</span><span> </span><span class="NLM_article-title">Synthesis of substituted nicotinamides from enamines derived from <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1055%2Fs-1995-4039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=923-925&author=F.+A.+Abushanabauthor=F.+M.+Alyauthor=B.+J.+Wakefield&title=Synthesis+of+substituted+nicotinamides+from+enamines+derived+from+N%2CN-dimethylformamide+dimethyl+acetal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1055%2Fs-1995-4039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1995-4039%26sid%3Dliteratum%253Aachs%26aulast%3DAbushanab%26aufirst%3DF.%2BA.%26aulast%3DAly%26aufirst%3DF.%2BM.%26aulast%3DWakefield%26aufirst%3DB.%2BJ.%26atitle%3DSynthesis%2520of%2520substituted%2520nicotinamides%2520from%2520enamines%2520derived%2520from%2520N%252CN-dimethylformamide%2520dimethyl%2520acetal%26jtitle%3DSynthesis%26date%3D1995%26spage%3D923%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Crey-Desbiolles, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotera, M.</span><span> </span><span class="NLM_article-title">Synthesis of 3-deaza-3-nitro-2′-deoxyadenosine</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1935-1941&author=C.+Crey-Desbiollesauthor=M.+Kotera&title=Synthesis+of+3-deaza-3-nitro-2%E2%80%B2-deoxyadenosine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrey-Desbiolles%26aufirst%3DC.%26aulast%3DKotera%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25203-deaza-3-nitro-2%25E2%2580%25B2-deoxyadenosine%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1935%26epage%3D1941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Sunthankar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidya, S. D.</span><span> </span><span class="NLM_article-title">Some reactions of 5-carbethoxy-3-cyano-6-methyl-2-pyridone</span> <span class="citation_source-journal">Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaE2sXls1OrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1977&pages=187-188&author=S.+V.+Sunthankarauthor=S.+D.+Vaidya&title=Some+reactions+of+5-carbethoxy-3-cyano-6-methyl-2-pyridone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Some reactions of 5-carbethoxy-3-cyano-6-methyl-2-pyridone</span></div><div class="casAuthors">Sunthankar, S. V.; Vaidya, S. D.</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">15B</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-8</span>CODEN:
                <span class="NLM_cas:coden">IJSBDB</span>;
        ISSN:<span class="NLM_cas:issn">0376-4699</span>.
    </div><div class="casAbstract">5-Carbethoxy-3-cyano-6-methyl-2-pyridone, obtained by the reaction of Et ethoxymethyleneacetoacetate with cyanoacetamide, is converted to 5-carbethoxy-2-chloro-3-cyano-6-methylpyridine (I) with POCl3-PCl5.  I reacts readily with aniline and NaOEt to give 2-anilino-5-carbethoxy-3-cyano-6-methyl- and 5-carbethoxy-3-cyano-2-ethoxy-6-methylpyridines, resp.  I also reacts with hydrazine hydrate and PhNHNH2 to give pyrazolopyridines II and III, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1xuaBRX9Q1LVg90H21EOLACvtfcHk0lh4VUqO9N-iTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXls1OrsbY%253D&md5=879f28fcf1d910b274a9b3c12476c71c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSunthankar%26aufirst%3DS.%2BV.%26aulast%3DVaidya%26aufirst%3DS.%2BD.%26atitle%3DSome%2520reactions%2520of%25205-carbethoxy-3-cyano-6-methyl-2-pyridone%26jtitle%3DIndian%2520J.%2520Chem.%252C%2520Sect.%2520B%253A%2520Org.%2520Chem.%2520Incl.%2520Med.%2520Chem.%26date%3D1977%26volume%3D15%26spage%3D187%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Minetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinti, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carminati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castorina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cesare, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Serio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghirardi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoccini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span> </span><span class="NLM_article-title">2-<i>n</i>-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9<i>H</i>-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">–</span> <span class="NLM_lpage">6896</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058018d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6887-6896&author=P.+Minettiauthor=M.+O.+Tintiauthor=P.+Carminatiauthor=M.+Castorinaauthor=M.+A.+Di+Cesareauthor=S.+Di+Serioauthor=G.+Galloauthor=O.+Ghirardiauthor=F.+Giorgiauthor=L.+Giorgiauthor=G.+Piersantiauthor=F.+Bartocciniauthor=G.+Tarzia&title=2-n-Butyl-9-methyl-8-%5B1%2C2%2C3%5Dtriazol-2-yl-9H-purin-6-ylamine+and+analogues+as+A2A+adenosine+receptor+antagonists.+Design%2C+synthesis%2C+and+pharmacological+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm058018d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058018d%26sid%3Dliteratum%253Aachs%26aulast%3DMinetti%26aufirst%3DP.%26aulast%3DTinti%26aufirst%3DM.%2BO.%26aulast%3DCarminati%26aufirst%3DP.%26aulast%3DCastorina%26aufirst%3DM.%26aulast%3DDi%2BCesare%26aufirst%3DM.%2BA.%26aulast%3DDi%2BSerio%26aufirst%3DS.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGhirardi%26aufirst%3DO.%26aulast%3DGiorgi%26aufirst%3DF.%26aulast%3DGiorgi%26aufirst%3DL.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DBartoccini%26aufirst%3DF.%26aulast%3DTarzia%26aufirst%3DG.%26atitle%3D2-n-Butyl-9-methyl-8-%255B1%252C2%252C3%255Dtriazol-2-yl-9H-purin-6-ylamine%2520and%2520analogues%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists.%2520Design%252C%2520synthesis%252C%2520and%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6887%26epage%3D6896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Cheng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. J.</span><span> </span><span class="NLM_article-title">The Friedlander synthesis of quinolines</span> <span class="citation_source-journal">Org. React.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaL38XlvVais74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1982&pages=37-201&author=C.+C.+Chengauthor=S.+J.+Yan&title=The+Friedlander+synthesis+of+quinolines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The Friedlander synthesis of quinolines</span></div><div class="casAuthors">Cheng, Chia Chung; Yan, Shou Jen</div><div class="citationInfo"><span class="NLM_cas:title">Organic Reactions (New York)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-201</span>CODEN:
                <span class="NLM_cas:coden">ORREAW</span>;
        ISSN:<span class="NLM_cas:issn">0078-6179</span>.
    </div><div class="casAbstract">A review with 176 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL7kAe6I0n-7Vg90H21EOLACvtfcHk0lh4VUqO9N-iTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlvVais74%253D&md5=8f57bdc36e8a0db0df6d2212a27e0df2</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DC.%2BC.%26aulast%3DYan%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520Friedlander%2520synthesis%2520of%2520quinolines%26jtitle%3DOrg.%2520React.%26date%3D1982%26volume%3D28%26spage%3D37%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feather-Stone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Feather-Stone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0lh4VUqO9N-iTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeather-Stone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Bourne, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bougis, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchot, P.</span><span> </span><span class="NLM_article-title">Conformational flexibility of the acetylcholinesterase tetramer suggested by X-ray crystallography</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">30370</span><span class="NLM_x">–</span> <span class="NLM_lpage">30376</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=30370-30376&author=Y.+Bourneauthor=J.+Grassiauthor=P.+E.+Bougisauthor=P.+Marchot&title=Conformational+flexibility+of+the+acetylcholinesterase+tetramer+suggested+by+X-ray+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DY.%26aulast%3DGrassi%26aufirst%3DJ.%26aulast%3DBougis%26aufirst%3DP.%2BE.%26aulast%3DMarchot%26aufirst%3DP.%26atitle%3DConformational%2520flexibility%2520of%2520the%2520acetylcholinesterase%2520tetramer%2520suggested%2520by%2520X-ray%2520crystallography%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D30370%26epage%3D30376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Ott, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lustig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbusch, J. P.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase from human erythrocytes membranes: dimers as functional units</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1982&pages=187-189&author=P.+Ottauthor=A.+Lustigauthor=U.+Brodbeckauthor=J.+P.+Rosenbusch&title=Acetylcholinesterase+from+human+erythrocytes+membranes%3A+dimers+as+functional+units"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DP.%26aulast%3DLustig%26aufirst%3DA.%26aulast%3DBrodbeck%26aufirst%3DU.%26aulast%3DRosenbusch%26aufirst%3DJ.%2BP.%26atitle%3DAcetylcholinesterase%2520from%2520human%2520erythrocytes%2520membranes%253A%2520dimers%2520as%2520functional%2520units%26jtitle%3DFEBS%2520Lett.%26date%3D1982%26volume%3D138%26spage%3D187%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heider, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, U.</span><span> </span><span class="NLM_article-title">Different glycosylation in acetylcholinesterases from mammalian brain and erythrocytes</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1471-4159.1992.tb11333.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=1548461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaK38XhvFSit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1992&pages=1230-1238&author=J.+Liaoauthor=H.+Heiderauthor=M.+C.+Sunauthor=U.+Brodbeck&title=Different+glycosylation+in+acetylcholinesterases+from+mammalian+brain+and+erythrocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Different glycosylation in acetylcholinesterases from mammalian brain and erythrocytes</span></div><div class="casAuthors">Liao, Jian; Heider, Harald; Sun, Man Chi; Brodbeck, Urs</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1230-8</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Acetylcholinesterases (EC 3.1.1.7, AChE) have varying amts. of carbohydrates attached to the core protein.  Sequence anal. of the known primary structures gives evidence for several asparagine-linked carbohydrates.  From the differences in mol. wt. detd. by SDS-PAGE before and after deglycosylation with N-glycosidase F (EC 3.2.2.18), it was seen that dimeric AChE from red cell membranes was more heavily glycosylated than the tetrameric brain enzyme.  Furthermore, dimeric and tetrameric forms of bovine AChE were more heavily glycosylated than the corresponding human enzymes.  Monoclonal antibodies 2E6, 1H11, and 2G8 raised against detergent-sol. AChE from elec. organs of Torpedo nacline timilei as well as Elec-39 raised against AChE from Electrophorus electricus cross-reacted with AChE from bovine and human brain but not with AChE from erythrocytes.  Treatment of the enzyme with N-glycosidase F abolished binding of monoclonal antibodies, suggesting that the epitope, or part of it, consists of N-linked carbohydrates.  Anal. of N-acetylglucosamine sugars revealed the presence of N-acetylglucosamine in all forms of cholinesterases investigated, giving evidence for N-linked glycosylation.  On the other hand, N-acetylgalactosamine was not found in AChE from human and bovine brain or in butyrylcholinesterase (EC 3.1.1.8) from human serum, indicating that these forms of cholinesterase did not contain O-linked carbohydrates.  Despite the notion that within 1 species, the different forms of AChE arise from 1 gene by different splicing, the present results showed that dimeric erythrocyte and tetrameric brain AChE must undergo different postsynthetic modifications leading to differences in their glycosylation patterns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5UlwcyS7xVbVg90H21EOLACvtfcHk0lhoVv5NlmI7jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhvFSit7s%253D&md5=11af6f373d3ec13bd0296469e66e0fdb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1992.tb11333.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1992.tb11333.x%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DHeider%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DM.%2BC.%26aulast%3DBrodbeck%26aufirst%3DU.%26atitle%3DDifferent%2520glycosylation%2520in%2520acetylcholinesterases%2520from%2520mammalian%2520brain%2520and%2520erythrocytes%26jtitle%3DJ.%2520Neurochem.%26date%3D1992%26volume%3D58%26spage%3D1230%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Acheson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, D. M.</span><span> </span><span class="NLM_article-title">Anatomy of acetylcholinesterase catalysis: reaction dynamics analogy for human erythrocyte and electric eel enzymes</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">1040</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1040&publication_year=1990&pages=199-205&author=S.+A.+Achesonauthor=D.+M.+Quinn&title=Anatomy+of+acetylcholinesterase+catalysis%3A+reaction+dynamics+analogy+for+human+erythrocyte+and+electric+eel+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAcheson%26aufirst%3DS.%2BA.%26aulast%3DQuinn%26aufirst%3DD.%2BM.%26atitle%3DAnatomy%2520of%2520acetylcholinesterase%2520catalysis%253A%2520reaction%2520dynamics%2520analogy%2520for%2520human%2520erythrocyte%2520and%2520electric%2520eel%2520enzymes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1990%26volume%3D1040%26spage%3D199%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Atack, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncrant, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapoport, S. I.</span><span> </span><span class="NLM_article-title">Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">249</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=2709330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaL1MXkslSgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=1989&pages=194-202&author=J.+R.+Atackauthor=Q.+S.+Yuauthor=T.+T.+Soncrantauthor=A.+Brossiauthor=S.+I.+Rapoport&title=Comparative+inhibitory+effects+of+various+physostigmine+analogs+against+acetyl-+and+butyrylcholinesterases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases</span></div><div class="casAuthors">Atack, John R.; Yu, Qian Sheng; Soncrant, Timothy T.; Brossi, Arnold; Rapoport, Stanley I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">249</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Carbamoyl- and N1-substituted analogs of physostigmine (I) were synthesized and their in vitro potencies (IC50 values) vs. human erythrocyte and brain (cerebral cortex and caudate nucleus) acetylcholinesterase (AChE) and elec. eel AChE and against human brain and plasma butyrylcholinesterase (BChE) were compared to the potencies of physostigmine and other traditional anticholinesterases.  In general, increasingly hydrophobic, simple nonbranching carbamoyl groups (as in octyl-, butyl- and benzylcarbamoyleseroline) did not generally alter potency vs. AChE whereas increasingly hydrophobic N1-substitutions [i.e., N1-allyl-, -phenethyl and -benzylphysostigmines] decreased potency vs. AChE.  In contrast, increasing the hydrophobicity of both the carbamoyl and N1 groups increased the potency of the compd. against BChE.  Furthermore, quaternization at the N1 position (physostigmine methosulfate) increased potency vs. AChE but reduced potency vs. BChE.  Bulky, branched carbamoyl groups (e.g., N-benzyl-N-benzylallophanyleseroline) were all poor anticholinesterases.  N-Phenylcarbamoyleseroline was as potent as benzylcarbamoyleseroline against AChE yet was 50-100-fold less potent than the benzyl analog vs. BChE.  Therefore, the Ph substitution appears to increase greatly the selectivity of the compd. for AChE.  Although it is not possible to det. whether physostigmine analogs that are potent in vitro might be of interest in vivo, these results do show that the structure of physostigmine can be changed significantly while retaining biol. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWLiNmZ2ZAH7Vg90H21EOLACvtfcHk0lhoVv5NlmI7jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkslSgs70%253D&md5=27e81ef90357c2bae1b6b6573f02176e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26aulast%3DYu%26aufirst%3DQ.%2BS.%26aulast%3DSoncrant%26aufirst%3DT.%2BT.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DRapoport%26aufirst%3DS.%2BI.%26atitle%3DComparative%2520inhibitory%2520effects%2520of%2520various%2520physostigmine%2520analogs%2520against%2520acetyl-%2520and%2520butyrylcholinesterases%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1989%26volume%3D249%26spage%3D194%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Andersen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aaraas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaare, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonnum, F.</span><span> </span><span class="NLM_article-title">Inhibition of acetylcholinesterase from different species by organophosphorus compounds, carbamates and methylsulphonyfluoride</span> <span class="citation_source-journal">Gen. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2F0306-3623%2877%2990009-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=564313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaE1cXktVWgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1977&pages=331-334&author=R.+A.+Andersenauthor=I.+Aaraasauthor=G.+Gaareauthor=F.+Fonnum&title=Inhibition+of+acetylcholinesterase+from+different+species+by+organophosphorus+compounds%2C+carbamates+and+methylsulphonyfluoride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acetylcholinesterase from different species by organophosphorus compounds, carbamates and methylsulfonylfluoride</span></div><div class="casAuthors">Andersen, R. A.; Aaraas, I.; Gaare, G.; Fonnum, F.</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">331-4</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    </div><div class="casAbstract">Acetylcholinesterase  [9000-81-1] from frog brain was more resistant to inhibition by organophosphorus compds. or carbamate than were the enzymes from chicken brain or rat brain, but only a slight species difference occurred in the inhibition of acetylcholinesterase by methylsulfonylfluoride  [558-25-8].  The insensitivity of the frog enzyme to many of these inhibitors apparently involved a diminished affinity for the acetylcholinesterase, and did not involve species differences in phosphorylation rates or enzyme conformation.  Steric hindrance at the active site of the mol. was the most probable explanation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTk4IcUZAw5rVg90H21EOLACvtfcHk0lgLBV68fvC8Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXktVWgtLk%253D&md5=ad92eb1098af8aba58361614d5333580</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2877%2990009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252877%252990009-X%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DR.%2BA.%26aulast%3DAaraas%26aufirst%3DI.%26aulast%3DGaare%26aufirst%3DG.%26aulast%3DFonnum%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520acetylcholinesterase%2520from%2520different%2520species%2520by%2520organophosphorus%2520compounds%252C%2520carbamates%2520and%2520methylsulphonyfluoride%26jtitle%3DGen.%2520Pharmacol.%26date%3D1977%26volume%3D8%26spage%3D331%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Chan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirachi, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhargava, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevor, A. J.</span><span> </span><span class="NLM_article-title">Purifcation and properties of multiple forms of brain acetylcholinesterase (EC 3.1.1.7)</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2747</span><span class="NLM_x">–</span> <span class="NLM_lpage">2758</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1471-4159.1972.tb03812.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=4652627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaE3sXpsVWksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1972&pages=2747-2758&author=S.+L.+Chanauthor=D.+Y.+Shirachiauthor=H.+N.+Bhargavaauthor=E.+Gardnerauthor=A.+J.+Trevor&title=Purifcation+and+properties+of+multiple+forms+of+brain+acetylcholinesterase+%28EC+3.1.1.7%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and properties of multiple forms of brain acetylcholinesterase (EC 3.1.1.7)</span></div><div class="casAuthors">Chan, S. L.; Shirachi, D. Y.; Bhargava, H. N.; Gardner, E.; Trevor, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2747-58</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Approx. 70% of the total AChE(acetylcholinesterase) of bovine brain tissue was solubilized by repeated homogenization and centrifugation in 0.32M sucrose containing EDTA.  After (NH4)2SO4 fractionation, application of the enzyme preparation to an agarose affinity gel column effected a 700-fold purification.  Subsequent mol. filtration separated 3 active forms of AChE with mol. wts. of 13,000, 270,000, and 290,000 with an av. sp. activity of 575 mmoles of acetylthiocholine hydrolyzed/mg of protein/hr.  The complete procedure represented an approx. 23,000-fold purification of the enzyme from that in the original tissue homogenate.  The 3 forms of AChE exhibited certain differences in properties, including apparent Km values, pH optima, and sensitivity to inhibitory agents.  Ancillary studies on less purified enzyme preparations by use of polyacrylamide gel electrophoresis and isoelectric focusing techniques also suggested that brain AChE exists in multiple forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogXdNLPoa7WLVg90H21EOLACvtfcHk0lgLBV68fvC8Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXpsVWksw%253D%253D&md5=5dbfce8e1acc1be347bde24580947186</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1972.tb03812.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1972.tb03812.x%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DS.%2BL.%26aulast%3DShirachi%26aufirst%3DD.%2BY.%26aulast%3DBhargava%26aufirst%3DH.%2BN.%26aulast%3DGardner%26aufirst%3DE.%26aulast%3DTrevor%26aufirst%3DA.%2BJ.%26atitle%3DPurifcation%2520and%2520properties%2520of%2520multiple%2520forms%2520of%2520brain%2520acetylcholinesterase%2520%2528EC%25203.1.1.7%2529%26jtitle%3DJ.%2520Neurochem.%26date%3D1972%26volume%3D19%26spage%3D2747%26epage%3D2758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors for potential use in Alzheimer’s disease: molecular modeling, synthesis and kinetic evaluation of 11<i>H</i>-indeno-[1,2-<i>b</i>]-quinolin-10-ylamine derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=497-506&author=A.+Rampaauthor=A.+Bisiauthor=F.+Bellutiauthor=S.+Gobbiauthor=P.+Valentiauthor=V.+Andrisanoauthor=V.+Cavriniauthor=A.+Cavalliauthor=M.+Recanatini&title=Acetylcholinesterase+inhibitors+for+potential+use+in+Alzheimer%E2%80%99s+disease%3A+molecular+modeling%2C+synthesis+and+kinetic+evaluation+of+11H-indeno-%5B1%2C2-b%5D-quinolin-10-ylamine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520for%2520potential%2520use%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520molecular%2520modeling%252C%2520synthesis%2520and%2520kinetic%2520evaluation%2520of%252011H-indeno-%255B1%252C2-b%255D-quinolin-10-ylamine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2000%26volume%3D8%26spage%3D497%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallender, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szegletes, T.</span><span> </span><span class="NLM_article-title">A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">119−120</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2FS0009-2797%2899%2900017-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=10421442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaK1MXkvVKit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119%E2%88%92120&publication_year=1999&pages=85-97&author=T.+L.+Rosenberryauthor=W.+D.+Mallenderauthor=P.+J.+Thomasauthor=T.+Szegletes&title=A+steric+blockade+model+for+inhibition+of+acetylcholinesterase+by+peripheral+site+ligands+and+substrate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate</span></div><div class="casAuthors">Rosenberry, Terrone L.; Mallender, William D.; Thomas, Patrick J.; Szegletes, Tivadar</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">119-120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-97</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The active site gorge of acetylcholinesterase (AChE) contains two sites of ligand binding, an acylation site near the base of the gorge and a peripheral site at its mouth.  We recently introduced a steric blockade model which demonstrated that small peripheral site ligands like propidium can inhibit substrate hydrolysis simply by decreasing the substrate assocn. and dissocn. rate consts. without altering the equil. const. for substrate binding to the acylation site.  We now employ our nonequil. kinetic anal. to extend this model to include blockade of the dissocn. of substrate hydrolysis products by bound peripheral site ligand.  We also report here that acetylthiocholine can bind to the AChE peripheral site with an equil. dissocn. const. KS of about 1 mM.  This value was detd. from the effect of the acetylthiocholine concn. on the rate at which fasciculin assocs. with the peripheral site.  When substrate binding to the peripheral site is incorporated into our steric blockade model, hydrolysis rates at low substrate concn. appear to be accelerated while substrate inhibition of hydrolysis occurs at high substrate concn.  The model predicts that hydrolysis rates for substrates which equilibrate with the acylation site prior to the acylation step should not be inhibited by bound peripheral site ligand.  Organophosphates equilibrate with AChE prior to phosphorylating the active site serine residue, and as predicted propidium had little effect on the phosphorylation rate consts. for the fluorogenic organophosphate ethylmethyl-phosphonylcoumarin (EMPC).  The 2nd-order phosphorylation rate const. kOP/KOP was decreased 3-fold by a high concn. of propidium and the 1st-order rate const. kOP increased somewhat.  In contrast to propidium, when the neurotoxin fasciculin bound to the AChE peripheral site both a steric blockade and a conformational change in the acylation site appeared to occur.  With satg. fasciculin, kOP/KOP decreased by a factor of more than 750 and kOP decreased 300-fold.  These data suggest that new peripheral site ligands may be designed to have selective effects on AChE phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvzXlkBuOvcLVg90H21EOLACvtfcHk0lgLBV68fvC8Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvVKit7Y%253D&md5=8731b3e4e833a42870412dbcffa71c25</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2899%2900017-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252899%252900017-4%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DMallender%26aufirst%3DW.%2BD.%26aulast%3DThomas%26aufirst%3DP.%2BJ.%26aulast%3DSzegletes%26aufirst%3DT.%26atitle%3DA%2520steric%2520blockade%2520model%2520for%2520inhibition%2520of%2520acetylcholinesterase%2520by%2520peripheral%2520site%2520ligands%2520and%2520substrate%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D1999%26volume%3D119%25E2%2588%2592120%26spage%3D85%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Berridge, M. J.</span><span> </span><span class="NLM_article-title">Calcium hypothesis of Alzheimer's disease</span>.  <span class="citation_source-journal">Pfluegers Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">459</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span>− <span class="NLM_lpage">449</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1007%2Fs00424-009-0736-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=19795132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Wqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2010&pages=441-449&author=M.+J.+Berridge&title=Calcium+hypothesis+of+Alzheimer%27s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Berridge, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-449</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by an increase in amyloid metab.  The ca hypothesis of AD explores how activation of the amyloidogenic pathway may function to remodel the neuronal Ca2+ signaling pathways responsible for cognition.  Hydrolysis of the β-amyloid precursor protein (APP) yields two products that can influence Ca2+ signaling.  Firstly, the amyloids released to the outside form oligomers that enhance the entry of Ca2+ that is pumped into the endoplasmic reticulum (ER).  An increase in the luminal level of Ca2+ within the ER enhances the sensitivity of the ryanodine receptors (RYRs) to increase the amt. of Ca2+ being released from the internal stores.  Secondly, the APP intracellular domain may alter the expression of key signaling components such as the RYR.  It is proposed that this remodeling of Ca2+ signaling will result in the learning and memory deficits that occur early during the onset of AD.  In particular, the Ca2+ signaling remodeling may erase newly acquired memories by enhancing the mechanism of long-term depression that depends on activation of the Ca2+-dependent protein phosphatase calcineurin.  The alteration in Ca2+ signaling will also contribute to the neurodegeneration that characterizes the later stages of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbH6HJhWPHCbVg90H21EOLACvtfcHk0li254BedOPJkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Wqsw%253D%253D&md5=fa22a8338ae0819c41fad684e4bb5839</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs00424-009-0736-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-009-0736-1%26sid%3Dliteratum%253Aachs%26aulast%3DBerridge%26aufirst%3DM.%2BJ.%26atitle%3DCalcium%2520hypothesis%2520of%2520Alzheimer%2527s%2520disease%26jtitle%3DPfluegers%2520Arch.%26date%3D2010%26volume%3D459%26spage%3D441%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuadrado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span> </span><span class="NLM_article-title">Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1852</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1111%2Fj.1471-4159.2007.04665.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=17540012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVyksLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=1842-1852&author=J.+Egeaauthor=A.+O.+Rosaauthor=A.+Cuadradoauthor=A.+G.+Garciaauthor=M.+G.+Lopez&title=Nicotinic+receptor+activation+by+epibatidine+induces+heme+oxygenase-1+and+protects+chromaffin+cells+against+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress</span></div><div class="casAuthors">Egea, Javier; Rosa, Angelo O.; Cuadrado, Antonio; Garcia, Antonio G.; Lopez, Manuela G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1842-1852</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Activation of neuronal nicotinic acetylcholine receptors (nAChR) provides neuroprotection against different toxic stimuli that often lead to overprodn. of reactive oxygen species (ROS) and cell death.  ROS prodn. has been related with disease progression in several neurodegenerative pathologies such as Alzheimer's or Parkinson's diseases.  In this context, we investigated here if the exposure of bovine chromaffin cells to the potent nAChR agonist epibatidine protected against rotenone (30 μmol/L) plus oligomycin (10 μmol/L) (rot/oligo) toxicity, an in vitro model of mitochondrial ROS prodn.  Epibatidine induced a concn.- and time-dependent protection, which was maximal at 3 μmol/L after 24 h.  Pre-incubation with dantrolene (100 μmol/L) (a blocker of the ryanodine receptor channel), chelerythrine (1 μmol/L) (a protein kinase C inhibitor), or PD98059 (50 μmol/L) (a MEK inhibitor), aborted epibatidine-elicited cytoprotection.  Mitochondrial depolarization, ROS, and caspase 3 active produced by rot/oligo were also prevented by epibatidine.  Epibatidine doubled the amt. of heme oxygenase-1 (HO-1), a crit. cell defense enzyme against oxidative stress.  Furthermore, the HO-1 inhibitor Sn(IV) protoporphyrin IX dichloride reversed the epibatidine protecting effects and HO-1 inducer Co (III) protoporphyrin IX dichloride exhibited neuroprotective effects by itself.  The results of this study point to HO-1 as the cytoprotective target of nAChR activation through the following pathway: endoplasmic reticulum Ca2+-induced Ca2+-release activates the protein kinase C/extracellular regulated kinase/HO-1 axis to mitigate mitochondrial depolarization and ROS prodn.  This study provides a mechanistic insight on how nAChR activation translates into an antioxidant and antiapoptotic signal through up-regulation of HO-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3XG5b3a4IOLVg90H21EOLACvtfcHk0li254BedOPJkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVyksLbF&md5=689683073dac18206961fec581367cd9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.04665.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.04665.x%26sid%3Dliteratum%253Aachs%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRosa%26aufirst%3DA.%2BO.%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26atitle%3DNicotinic%2520receptor%2520activation%2520by%2520epibatidine%2520induces%2520heme%2520oxygenase-1%2520and%2520protects%2520chromaffin%2520cells%2520against%2520oxidative%2520stress%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D102%26spage%3D1842%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Koh, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D. W.</span><span> </span><span class="NLM_article-title">Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2F0165-0270%2887%2990041-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=2884353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaL2sXktF2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1987&pages=83-90&author=J.+Y.+Kohauthor=D.+W.+Choi&title=Quantitative+determination+of+glutamate+mediated+cortical+neuronal+injury+in+cell+culture+by+lactate+dehydrogenase+efflux+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay</span></div><div class="casAuthors">Koh, Jae Young; Choi, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-90</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">Measurement of lactate dehydrogenase (LDH) activity released to the extracellular bathing media was a simple yet quant. method for assessing glutamate-mediated central neuronal cell injury in cortical cell culture.  Extracellular LDH is both chem. and biol. stable; the magnitude of LDH efflux in the cultures correlates in a linear fashion with the no. of neurons damaged by glutamate exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc5CWdojkmkLVg90H21EOLACvtfcHk0li254BedOPJkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktF2is74%253D&md5=8f9806e0deff8d482c25c1fb50c6992a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2887%2990041-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252887%252990041-0%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DJ.%2BY.%26aulast%3DChoi%26aufirst%3DD.%2BW.%26atitle%3DQuantitative%2520determination%2520of%2520glutamate%2520mediated%2520cortical%2520neuronal%2520injury%2520in%2520cell%2520culture%2520by%2520lactate%2520dehydrogenase%2520efflux%2520assay%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1987%26volume%3D20%26spage%3D83%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Dodd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copolov, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berk, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-Acetylcysteine for antioxidant therapy: pharmacology and clinical utility</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1955</span><span class="NLM_x">–</span> <span class="NLM_lpage">1962</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1517%2F14728220802517901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=18990082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlCjt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1955-1962&author=S.+Doddauthor=O.+Deanauthor=D.+L.+Copolovauthor=G.+S.+Malhiauthor=M.+Berk&title=N-Acetylcysteine+for+antioxidant+therapy%3A+pharmacology+and+clinical+utility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility</span></div><div class="casAuthors">Dodd, Seetal; Dean, Olivia; Copolov, David L.; Malhi, Gin S.; Berk, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1955-1962</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Glutathione is an endogenous antioxidant and has a ubiquitous role in many of the body's defences.  Treatment with N-acetylcysteine (NAC) has been shown to increase levels of glutathione.  NAC has been proposed as a treatment for several illnesses.  Objectives: The efficacy and tolerability of NAC was examd. across a range of conditions to evaluate the evidence supporting the use of NAC for each indication.  Methods: A literature search was conducted using PubMed.  Information was also collected from other online sources including the websites of the Therapeutic Goods Administration of Australia and the FDA.  Results: Reports ranged from case studies to clin. trials.  There is strong evidence to support the use of NAC for the treatment of paracetamol overdose and emerging evidence suggesting it has utility in psychiatric disorders, particularly schizophrenia and bipolar disorder.  NAC is safe and well tolerated when administered orally but has documented risks with i.v. administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDamUPmW8CgLVg90H21EOLACvtfcHk0lgKjPOPZIcG_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlCjt7vO&md5=cf8679acd667b7cd1a7d22a0cefd73f7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1517%2F14728220802517901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220802517901%26sid%3Dliteratum%253Aachs%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DDean%26aufirst%3DO.%26aulast%3DCopolov%26aufirst%3DD.%2BL.%26aulast%3DMalhi%26aufirst%3DG.%2BS.%26aulast%3DBerk%26aufirst%3DM.%26atitle%3DN-Acetylcysteine%2520for%2520antioxidant%2520therapy%253A%2520pharmacology%2520and%2520clinical%2520utility%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2008%26volume%3D8%26spage%3D1955%26epage%3D1962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Arendt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruckner, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartner, U.</span><span> </span><span class="NLM_article-title">The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer’s disease</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1998&pages=1337-1340&author=T.+Arendtauthor=M.+Holzerauthor=M.+K.+Brucknerauthor=C.+Jankeauthor=U.+Gartner&title=The+use+of+okadaic+acid+in+vivo+and+the+induction+of+molecular+changes+typical+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DBruckner%26aufirst%3DM.%2BK.%26aulast%3DJanke%26aufirst%3DC.%26aulast%3DGartner%26aufirst%3DU.%26atitle%3DThe%2520use%2520of%2520okadaic%2520acid%2520in%2520vivo%2520and%2520the%2520induction%2520of%2520molecular%2520changes%2520typical%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuroscience%26date%3D1998%26volume%3D85%26spage%3D1337%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Z.</span><span> </span><span class="NLM_article-title">Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2003&pages=1175-1182&author=L.+Sunauthor=S.+Y.+Liuauthor=X.+W.+Zhouauthor=X.+C.+Wangauthor=R.+Liuauthor=Q.+Wangauthor=J.+Z.+Wang&title=Inhibition+of+protein+phosphatase+2A-+and+protein+phosphatase+1-induced+tau+hyperphosphorylation+and+impairment+of+spatial+memory+retention+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%2BY.%26aulast%3DZhou%26aufirst%3DX.%2BW.%26aulast%3DWang%26aufirst%3DX.%2BC.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26atitle%3DInhibition%2520of%2520protein%2520phosphatase%25202A-%2520and%2520protein%2520phosphatase%25201-induced%2520tau%2520hyperphosphorylation%2520and%2520impairment%2520of%2520spatial%2520memory%2520retention%2520in%2520rats%26jtitle%3DNeuroscience%26date%3D2003%26volume%3D118%26spage%3D1175%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Denizot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, R.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2F0022-1759%2886%2990368-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=3486233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1986&pages=271-277&author=F.+Denizotauthor=R.+Lang&title=Rapid+colorimetric+assay+for+cell+growth+and+survival.+Modifications+to+the+tetrazolium+dye+procedure+giving+improved+sensitivity+and+reliability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span></div><div class="casAuthors">Denizot F; Lang R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-7</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A convenient way to estimate the number of viable cells growing in microtitre tray wells is to use a colorimetric assay and an automatic microplate scanning spectrophotometer.  One such assay, developed by Mosmann, depends on the reduction by living cells of tetrazolium salt, MTT, to form a blue formazan product.  However the original technique has several technical limitations, namely a less than optimal sensitivity, a variable background due to protein precipitation on adding an organic solvent to dissolve the blue formazan product, and a low solubility of the product.  These problems have been overcome by the following modifications: avoidance of serum in the incubation medium, thus overcoming precipitation problems in the organic solvent; avoidance of phenol red in the incubation medium, thus avoiding the use of acid in the final solvent which altered the spectral properties of the formazan; elimination of the medium containing MTT after the reaction and subsequent use of pure propanol or ethanol to rapidly solubilize the formazan; use of a higher concentration of MTT; use of half-area microtitre trays to increase the spectrophotometer readings from a given amount of formazan; use of a more judicious reference wavelength in a dual wavelength spectrophotometer.  With these modifications the reliability and sensitivity of the test have been increased to the point where it can in many cases replace the [3H]thymidine uptake assay to measure cell proliferation or survival in growth factor or cytotoxicity assays.  Examples of its use in IL-2 assays are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpURYu5ihmxO98rul4nhSdfW6udTcc2ebA31PWBJwbZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D&md5=9e5506f28a0b29b20046b7e21bb5527e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2886%2990368-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252886%252990368-6%26sid%3Dliteratum%253Aachs%26aulast%3DDenizot%26aufirst%3DF.%26aulast%3DLang%26aufirst%3DR.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cell%2520growth%2520and%2520survival.%2520Modifications%2520to%2520the%2520tetrazolium%2520dye%2520procedure%2520giving%2520improved%2520sensitivity%2520and%2520reliability%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1986%26volume%3D89%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Arias, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallego-Sandin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span> </span><span class="NLM_article-title">Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">1346</span><span class="NLM_x">–</span> <span class="NLM_lpage">1353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1124%2Fjpet.105.090365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=16144975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlalurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=1346-1353&author=E.+Ariasauthor=S.+Gallego-Sandinauthor=M.+Villarroyaauthor=A.+G.+Garciaauthor=M.+G.+Lopez&title=Unequal+neuroprotection+afforded+by+the+acetylcholinesterase+inhibitors+galantamine%2C+donepezil%2C+and+rivastigmine+in+SH-SY5Y+neuroblastoma+cells%3A+role+of+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: Role of nicotinic receptors</span></div><div class="casAuthors">Arias, Esperanza; Gallego-Sandin, Sonia; Villarroya, Mercedes; Garcia, Antonio G.; Lopez, Manuela G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1346-1353</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Donepezil, rivastigmine, and galantamine are three drugs with acetylcholinesterase (AChE)-inhibiting activity that are currently being used to treat patients suffering from Alzheimer's disease.  We have studied the neuroprotective effects of these drugs, in comparison with nicotine, on cell death caused by β-amyloid (Aβ) and okadaic acid, two models that are relevant to Alzheimer's pathol., in the human neuroblastoma cell line SH-SY5Y.  Galantamine and donepezil showed a U-shaped neuroprotective curve against okadaic acid toxicity; max. protection was achieved at 0.3 μM galantamine and at 1 μM donepezil; at higher concns., protection was diminished.  Rivastigmine showed a concn.-dependent effect; max. protection was achieved at 3 μM.  When apoptosis was induced by Aβ25-35, galantamine, donepezil, and rivastigmine showed max. protection at the same concns.: 0.3, 1, and 3 μM, resp.  Nicotine also afforded protection against Aβ- and okadaic acid-induced toxicity.  The neuroprotective effects of galantamine, donepezil, and nicotine were reversed by the α7 nicotinic antagonist methyllycaconitine but not by the α4β2 nicotinic antagonist dihydro-β-erythroidine.  The phosphoinositide 3-kinase (PI3K)-Akt blocker 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY294002) reversed the protective effects of galantamine, donepezil, and nicotine but not that of rivastigmine.  In contrast, the bcl-2 antagonist ethyl[2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)]-4H-chromene-3- carboxylate (HA 14-1) reversed the protective effects of the three AChE inhibitors and that of nicotine.  Our results show that galantamine, donepezil, and rivastigmine afford neuroprotection through a mechanism that is likely unrelated to AChE inhibition.  Such neuroprotection seemed to be linked to α7 nicotinic receptors and the PI3K-Akt pathway in the case of galantamine and donepezil but not for rivastigmine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomaPp9wSWEeLVg90H21EOLACvtfcHk0lgKjPOPZIcG_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlalurbL&md5=a51e42bf1bef8009f760299c7e389cbd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.090365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.090365%26sid%3Dliteratum%253Aachs%26aulast%3DArias%26aufirst%3DE.%26aulast%3DGallego-Sandin%26aufirst%3DS.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26atitle%3DUnequal%2520neuroprotection%2520afforded%2520by%2520the%2520acetylcholinesterase%2520inhibitors%2520galantamine%252C%2520donepezil%252C%2520and%2520rivastigmine%2520in%2520SH-SY5Y%2520neuroblastoma%2520cells%253A%2520role%2520of%2520nicotinic%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D1346%26epage%3D1353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Sheppeck, J. E.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauss, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlin, A. R.</span><span> </span><span class="NLM_article-title">Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1750</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=1739-1750&author=J.+E.+Sheppeckauthor=C.+M.+Gaussauthor=A.+R.+Chamberlin&title=Inhibition+of+the+Ser-Thr+phosphatases+PP1+and+PP2A+by+naturally+occurring+toxins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DChamberlin%26aufirst%3DA.%2BR.%26atitle%3DInhibition%2520of%2520the%2520Ser-Thr%2520phosphatases%2520PP1%2520and%2520PP2A%2520by%2520naturally%2520occurring%2520toxins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1997%26volume%3D5%26spage%3D1739%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Harder, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark-Lewis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirik, F. R.</span><span> </span><span class="NLM_article-title">Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=1994&pages=395-401&issue=Part+2&author=K.+W.+Harderauthor=P.+Owenauthor=L.+K.+Wongauthor=R.+Aebersoldauthor=I.+Clark-Lewisauthor=F.+R.+Jirik&title=Characterization+and+kinetic+analysis+of+the+intracellular+domain+of+human+protein+tyrosine+phosphatase+beta+%28HPTP+beta%29+using+synthetic+phosphopeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DK.%2BW.%26aulast%3DOwen%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DL.%2BK.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DClark-Lewis%26aufirst%3DI.%26aulast%3DJirik%26aufirst%3DF.%2BR.%26atitle%3DCharacterization%2520and%2520kinetic%2520analysis%2520of%2520the%2520intracellular%2520domain%2520of%2520human%2520protein%2520tyrosine%2520phosphatase%2520beta%2520%2528HPTP%2520beta%2529%2520using%2520synthetic%2520phosphopeptides%26jtitle%3DBiochem.%2520J.%26date%3D1994%26volume%3D298%26issue%3DPart%25202%26spage%3D395%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Begum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragolia, L.</span><span> </span><span class="NLM_article-title">cAMP counter-regulates insulin-mediated protein phosphatase-2A inactivation in rat skeletal muscle cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">31166</span><span class="NLM_x">–</span> <span class="NLM_lpage">31171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=31166-31171&author=N.+Begumauthor=L.+Ragolia&title=cAMP+counter-regulates+insulin-mediated+protein+phosphatase-2A+inactivation+in+rat+skeletal+muscle+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBegum%26aufirst%3DN.%26aulast%3DRagolia%26aufirst%3DL.%26atitle%3DcAMP%2520counter-regulates%2520insulin-mediated%2520protein%2520phosphatase-2A%2520inactivation%2520in%2520rat%2520skeletal%2520muscle%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D31166%26epage%3D31171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Jarrett, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.,  Jr.</span><span> </span><span class="NLM_article-title">The C-terminus of the beta protein is critical in amyloidogenesis</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">695</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=695&publication_year=1993&pages=144-148&author=J.+T.+Jarrettauthor=E.+P.+Bergerauthor=P.+T.+Lansbury&title=The+C-terminus+of+the+beta+protein+is+critical+in+amyloidogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJarrett%26aufirst%3DJ.%2BT.%26aulast%3DBerger%26aufirst%3DE.%2BP.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DThe%2520C-terminus%2520of%2520the%2520beta%2520protein%2520is%2520critical%2520in%2520amyloidogenesis%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1993%26volume%3D695%26spage%3D144%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Pappolla, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bick, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson-Bick, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efthimiopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robakis, N. K.</span><span> </span><span class="NLM_article-title">Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1523%2FJNEUROSCI.17-05-01683.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=9030627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADyaK2sXhtlOms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=1683-1690&author=M.+A.+Pappollaauthor=M.+Sosauthor=R.+A.+Omarauthor=R.+J.+Bickauthor=D.+L.+Hickson-Bickauthor=R.+J.+Reiterauthor=S.+Efthimiopoulosauthor=N.+K.+Robakis&title=Melatonin+prevents+death+of+neuroblastoma+cells+exposed+to+the+Alzheimer+amyloid+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide</span></div><div class="casAuthors">Pappolla, Miguel A.; Sos, Melisa; Omar, Rawhi A.; Bick, Roger J.; Hickson-Bick, Diane L. M.; Reiter, Russel J.; Efthimiopoulos, Spiros; Robakis, Nickolaos K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1683-1690</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Studies from several labs. have generated evidence suggesting that oxidative stress is involved in the pathogenesis of Alzheimer's disease (AD).  The finding that the amyloid β protein (Aβ) has neurotoxic properties and that such effects are, in part, mediated by free radicals has provided insights into mechanisms of cell death in AD and an avenue to explore new therapeutic approaches.  In this study melatonin, a pineal hormone with recently established antioxidant properties, is remarkably effective in preventing death of cultured neuroblastoma cells as well as oxidative damage and intracellular Ca2+ increases induced by a cytotoxic fragment of Aβ.  The effects of melatonin were extremely reproducible and corroborated by multiple quant. methods, including cell viability studies by confocal laser microscopy, electron microscopy, and measurements of intracellular calcium levels.  The importance of this finding is that, in contrast to conventional antioxidants, melatonin has a proposed physiol. role in the aging process.  Secretion levels of this hormone are decreased in aging and more severely reduced in AD.  The reported phenomenon may be of therapeutic relevance in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq8o3cVyfX4rVg90H21EOLACvtfcHk0ljQMksGoyt2GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtlOms7s%253D&md5=f9f078c4a30661c0ef9645118efa5a9f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.17-05-01683.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.17-05-01683.1997%26sid%3Dliteratum%253Aachs%26aulast%3DPappolla%26aufirst%3DM.%2BA.%26aulast%3DSos%26aufirst%3DM.%26aulast%3DOmar%26aufirst%3DR.%2BA.%26aulast%3DBick%26aufirst%3DR.%2BJ.%26aulast%3DHickson-Bick%26aufirst%3DD.%2BL.%26aulast%3DReiter%26aufirst%3DR.%2BJ.%26aulast%3DEfthimiopoulos%26aufirst%3DS.%26aulast%3DRobakis%26aufirst%3DN.%2BK.%26atitle%3DMelatonin%2520prevents%2520death%2520of%2520neuroblastoma%2520cells%2520exposed%2520to%2520the%2520Alzheimer%2520amyloid%2520peptide%26jtitle%3DJ.%2520Neurosci.%26date%3D1997%26volume%3D17%26spage%3D1683%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Masilamoni, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesudason, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhandayuthapani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashok, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jebaraj, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayakumar, R.</span><span> </span><span class="NLM_article-title">The neuroprotective role of melatonin against amyloid beta peptide injected mice</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1080%2F10715760802277388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=18654881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFWktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2008&pages=661-673&author=J.+G.+Masilamoniauthor=E.+P.+Jesudasonauthor=S.+Dhandayuthapaniauthor=B.+S.+Ashokauthor=S.+Vigneshauthor=W.+C.+Jebarajauthor=S.+F.+Paulauthor=R.+Jayakumar&title=The+neuroprotective+role+of+melatonin+against+amyloid+beta+peptide+injected+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The neuroprotective role of melatonin against amyloid β peptide injected mice</span></div><div class="casAuthors">Masilamoni, J. Gunasingh; Jesudason, E. Philip; Dhandayuthapani, S.; Ashok, Ben S.; Vignesh, S.; Jebaraj, W. Charles E.; Paul, Solomon F. D.; Jayakumar, Rajadas</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-673</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Widespread cerebral deposition of a 40-42 amino acid peptide called amyloid β peptide (Aβ) in the form of amyloid fibrils is one of the most prominent neuropathol. features of Alzheimer's disease (AD).  The clin. study provides evidence that accumulation of protofibrils due to the Arctic mutation (E22G) causes early AD onset.  Melatonin showed beneficial effects in an AD mouse model.  Mice were divided into four different groups (n=8 per group): (i) control group, (ii) scrambled Aβ-injected group, (iii) Aβ protofibril-injected group and (iv) melatonin-treated group.  A single dose of (5 μg) Aβ protofibril was administered to the Aβ protofibril-injected and melatonin-treated groups via intracerebroventricular injections.  The results demonstrate that melatonin treatment significantly reduces Aβ protofibril-induced reactive oxygen species (ROS) prodn., intracellular calcium levels and acetylcholinesterase activity in the neocortex and hippocampus regions.  Based on these findings it is suggested that melatonin therapy might be a useful treatment for AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX8RU_qDKPH7Vg90H21EOLACvtfcHk0ljQMksGoyt2GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFWktLs%253D&md5=24553739fb84a1c65a1d75ac6fd01eac</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1080%2F10715760802277388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760802277388%26sid%3Dliteratum%253Aachs%26aulast%3DMasilamoni%26aufirst%3DJ.%2BG.%26aulast%3DJesudason%26aufirst%3DE.%2BP.%26aulast%3DDhandayuthapani%26aufirst%3DS.%26aulast%3DAshok%26aufirst%3DB.%2BS.%26aulast%3DVignesh%26aufirst%3DS.%26aulast%3DJebaraj%26aufirst%3DW.%2BC.%26aulast%3DPaul%26aufirst%3DS.%2BF.%26aulast%3DJayakumar%26aufirst%3DR.%26atitle%3DThe%2520neuroprotective%2520role%2520of%2520melatonin%2520against%2520amyloid%2520beta%2520peptide%2520injected%2520mice%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2008%26volume%3D42%26spage%3D661%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Sobrado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span> </span><span class="NLM_article-title">Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen−glucose deprivation</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2004&pages=132-136&author=M.+Sobradoauthor=J.+M.+Rodaauthor=M.+G.+Lopezauthor=J.+Egeaauthor=A.+G.+Garcia&title=Galantamine+and+memantine+produce+different+degrees+of+neuroprotection+in+rat+hippocampal+slices+subjected+to+oxygen%E2%88%92glucose+deprivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSobrado%26aufirst%3DM.%26aulast%3DRoda%26aufirst%3DJ.%2BM.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26atitle%3DGalantamine%2520and%2520memantine%2520produce%2520different%2520degrees%2520of%2520neuroprotection%2520in%2520rat%2520hippocampal%2520slices%2520subjected%2520to%2520oxygen%25E2%2588%2592glucose%2520deprivation%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D365%26spage%3D132%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrilova, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachurin, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seely, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, D.</span><span> </span><span class="NLM_article-title">Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer’s disease: a randomised, double-blind, placebo-controlled study</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=207-215&author=R.+S.+Doodyauthor=S.+I.+Gavrilovaauthor=M.+Sanoauthor=R.+G.+Thomasauthor=P.+S.+Aisenauthor=S.+O.+Bachurinauthor=L.+Seelyauthor=D.+Hung&title=Effect+of+dimebon+on+cognition%2C+activities+of+daily+living%2C+behaviour%2C+and+global+function+in+patients+with+mild-to-moderate+Alzheimer%E2%80%99s+disease%3A+a+randomised%2C+double-blind%2C+placebo-controlled+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DGavrilova%26aufirst%3DS.%2BI.%26aulast%3DSano%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DBachurin%26aufirst%3DS.%2BO.%26aulast%3DSeely%26aufirst%3DL.%26aulast%3DHung%26aufirst%3DD.%26atitle%3DEffect%2520of%2520dimebon%2520on%2520cognition%252C%2520activities%2520of%2520daily%2520living%252C%2520behaviour%252C%2520and%2520global%2520function%2520in%2520patients%2520with%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520study%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26spage%3D207%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Bachurin, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsova, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireeva, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxenkrug, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sablin, S. O.</span><span> </span><span class="NLM_article-title">Mitochondria as a target for neurotoxins and neuroprotective agents</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">993</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><div class="note"><p class="first last">; discussion 345−339</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=993&publication_year=2003&pages=334-344&author=S.+O.+Bachurinauthor=E.+P.+Shevtsovaauthor=E.+G.+Kireevaauthor=G.+F.+Oxenkrugauthor=S.+O.+Sablin&title=Mitochondria+as+a+target+for+neurotoxins+and+neuroprotective+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBachurin%26aufirst%3DS.%2BO.%26aulast%3DShevtsova%26aufirst%3DE.%2BP.%26aulast%3DKireeva%26aufirst%3DE.%2BG.%26aulast%3DOxenkrug%26aufirst%3DG.%2BF.%26aulast%3DSablin%26aufirst%3DS.%2BO.%26atitle%3DMitochondria%2520as%2520a%2520target%2520for%2520neurotoxins%2520and%2520neuroprotective%2520agents%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D993%26spage%3D334%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Lermontova, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkozubov, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsova, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serkova, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireeva, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachurin, S. O.</span><span> </span><span class="NLM_article-title">Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channels</span> <span class="citation_source-journal">Bull. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1023%2FA%3A1017972709652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=11865327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFOhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=1079-1083&author=N.+N.+Lermontovaauthor=A.+E.+Redkozubovauthor=E.+F.+Shevtsovaauthor=T.+P.+Serkovaauthor=E.+G.+Kireevaauthor=S.+O.+Bachurin&title=Dimebon+and+tacrine+inhibit+neurotoxic+action+of+beta-amyloid+in+culture+and+block+L-type+Ca%282%2B%29+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Dimebon and tacrine inhibit neurotoxic action of β-amyloid in culture and block L-type Ca2+ channels</span></div><div class="casAuthors">Lermontova, N. N.; Redkozubov, A. E.; Shevtsova, E. F.; Serkova, T. P.; Kireeva, E. G.; Bachurin, S. O.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of Experimental Biology and Medicine (Translation of Byulleten Eksperimental'noi Biologii i Meditsiny)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1079-1083</span>CODEN:
                <span class="NLM_cas:coden">BEXBAN</span>;
        ISSN:<span class="NLM_cas:issn">0007-4888</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">Dimebon, a Russian-made drug, inhibited toxic effects of β-amyloid on cultured neurons.  Excessive accumulation of β-amyloid in the brain is characteristic of Alzheimer dementias.  Anti-Alzheimer prepns. tacrine and dimebon improve survival of cerebellar granule cells during long-term incubation with Aβ25-35, the neurotoxic fragment of β-amyloid.  Both prepns. can block potential-dependent Ca2+ entry into neurons by about 20%, which is explained by their selective action on L-type Ca2+ channels.  It was assumed that the neuroprotective effect of dimebon and tacrine against Aβ25-35 partially depends on inhibition of potential-dependent Ca2+ entry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGST_I29hTtbVg90H21EOLACvtfcHk0lhQyo_2SyS5pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFOhtbk%253D&md5=da716770f509333da85cab7e45988edf</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1023%2FA%3A1017972709652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1017972709652%26sid%3Dliteratum%253Aachs%26aulast%3DLermontova%26aufirst%3DN.%2BN.%26aulast%3DRedkozubov%26aufirst%3DA.%2BE.%26aulast%3DShevtsova%26aufirst%3DE.%2BF.%26aulast%3DSerkova%26aufirst%3DT.%2BP.%26aulast%3DKireeva%26aufirst%3DE.%2BG.%26aulast%3DBachurin%26aufirst%3DS.%2BO.%26atitle%3DDimebon%2520and%2520tacrine%2520inhibit%2520neurotoxic%2520action%2520of%2520beta-amyloid%2520in%2520culture%2520and%2520block%2520L-type%2520Ca%25282%252B%2529%2520channels%26jtitle%3DBull.%2520Exp.%2520Biol.%2520Med.%26date%3D2001%26volume%3D132%26spage%3D1079%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Brooks, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruccoleri, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olafson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">States, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karplus, M.</span><span> </span><span class="NLM_article-title">Charmm, a program for macromolecular energy, minimization, and dynamics calculations</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1983&pages=187-217&author=B.+R.+Brooksauthor=R.+E.+Bruccoleriauthor=B.+D.+Olafsonauthor=D.+J.+Statesauthor=S.+Swaminathanauthor=M.+Karplus&title=Charmm%2C+a+program+for+macromolecular+energy%2C+minimization%2C+and+dynamics+calculations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26aulast%3DBruccoleri%26aufirst%3DR.%2BE.%26aulast%3DOlafson%26aufirst%3DB.%2BD.%26aulast%3DStates%26aufirst%3DD.%2BJ.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DKarplus%26aufirst%3DM.%26atitle%3DCharmm%252C%2520a%2520program%2520for%2520macromolecular%2520energy%252C%2520minimization%252C%2520and%2520dynamics%2520calculations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1983%26volume%3D4%26spage%3D187%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Morreale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maseras, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvez, E.</span><span> </span><span class="NLM_article-title">Ligand−receptor interaction at the neural nicotinic acetylcholine binding site: a theoretical model</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2FS1093-3263%2802%2900127-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1yks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=111-118&author=A.+Morrealeauthor=F.+Maserasauthor=I.+Iriepaauthor=E.+Galvez&title=Ligand%E2%88%92receptor+interaction+at+the+neural+nicotinic+acetylcholine+binding+site%3A+a+theoretical+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-receptor interaction at the neural nicotinic acetylcholine binding site: a theoretical model</span></div><div class="casAuthors">Morreale, A.; Maseras, F.; Iriepa, I.; Galvez, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-118</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Recent mutagenesis expts. have identified some of the functional amino acids that are essential in the interaction of nicotinic agents with the binding site of the neural nicotinic acetylcholine receptor (nAChR).  Although this receptor is one of the best studied and characterized the lack of detailed exptl. information regarding its quaternary structure has turned it into a challenge for computational chem.  The authors have previously reported a computational protocol based on mol. mechanics and mol. dynamics (MD) where SER82, ASP83, TRP86, ASP89, TYR93, TYR190, TYR198 and ARG209 were placed around selected agonists and antagonists aided by stereoelectronic criteria.  Explicit water mols. were used with the double goal of simulating aq. environment and keeping the system from falling apart.  The protocol was stable enough to allow the ligands to evolve to their thermodynamically most probable structure while maintaining the key interactions.  In this communication the authors use the av. model for the agonists (one av. structure for each agonist) to calc. quantum mech. the interactions of the binding site with one neurotransmitter acetylcholine (ACh) (1), as well as with two of the most potent agonists described so far [nicotine (2) and epibatidine (3)] and the modeled binding site.  A wide variety of methods as well as basis sets were used to rationalize the best way to treat the problem.  In this limited set of compds., a good correlation between total interaction energies and biol. affinity is obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroGwEJdEu4NbVg90H21EOLACvtfcHk0lhQyo_2SyS5pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1yks7s%253D&md5=1f670a0505e526eabe9264d81a41152b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2FS1093-3263%2802%2900127-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1093-3263%252802%252900127-4%26sid%3Dliteratum%253Aachs%26aulast%3DMorreale%26aufirst%3DA.%26aulast%3DMaseras%26aufirst%3DF.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DGalvez%26aufirst%3DE.%26atitle%3DLigand%25E2%2588%2592receptor%2520interaction%2520at%2520the%2520neural%2520nicotinic%2520acetylcholine%2520binding%2520site%253A%2520a%2520theoretical%2520model%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2002%26volume%3D21%26spage%3D111%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0ljcB-uHLImjlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Segel, I. H.</span> <span class="citation_source-book">Enzyme Kinetics</span>; <span class="NLM_publisher-name">John Wiley</span>: <span class="NLM_publisher-loc">Toronto, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">1975</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1975&author=I.+H.+Segel&title=Enzyme+Kinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSegel%26aufirst%3DI.%2BH.%26btitle%3DEnzyme%2520Kinetics%26pub%3DJohn%2520Wiley%26date%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobrado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span> </span><span class="NLM_article-title">Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2007&pages=866-872&author=J.+Egeaauthor=A.+O.+Rosaauthor=M.+Sobradoauthor=L.+Gandiaauthor=M.+G.+Lopezauthor=A.+G.+Garcia&title=Neuroprotection+afforded+by+nicotine+against+oxygen+and+glucose+deprivation+in+hippocampal+slices+is+lost+in+alpha7+nicotinic+receptor+knockout+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRosa%26aufirst%3DA.%2BO.%26aulast%3DSobrado%26aufirst%3DM.%26aulast%3DGandia%26aufirst%3DL.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26atitle%3DNeuroprotection%2520afforded%2520by%2520nicotine%2520against%2520oxygen%2520and%2520glucose%2520deprivation%2520in%2520hippocampal%2520slices%2520is%2520lost%2520in%2520alpha7%2520nicotinic%2520receptor%2520knockout%2520mice%26jtitle%3DNeuroscience%26date%3D2007%26volume%3D145%26spage%3D866%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Mosmann, T.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm901902w&amp;key=10.1016%2F0022-1759%2883%2990303-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm901902w&amp;key=6606682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm901902w&amp;key=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1983&pages=55-63&author=T.+Mosmann&title=Rapid+colorimetric+assay+for+cellular+growth+and+survival%3A+application+to+proliferation+and+cytotoxicity+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span></div><div class="casAuthors">Mosmann T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A tetrazolium salt has been used to develop a quantitative colorimetric assay for mammalian cell survival and proliferation.  The assay detects living, but not dead cells and the signal generated is dependent on the degree of activation of the cells.  This method can therefore be used to measure cytotoxicity, proliferation or activation.  The results can be read on a multiwell scanning spectrophotometer (ELISA reader) and show a high degree of precision.  No washing steps are used in the assay.  The main advantages of the colorimetric assay are its rapidity and precision, and the lack of any radioisotope.  We have used the assay to measure proliferative lymphokines, mitogen stimulations and complement-mediated lysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBbRLMWf0dI3thwrmtH4OBfW6udTcc2ebjF82UtiChUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D&md5=c1116f4ca7a7d2b79fab2a0bd2c2d439</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2883%2990303-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252883%252990303-4%26sid%3Dliteratum%253Aachs%26aulast%3DMosmann%26aufirst%3DT.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cellular%2520growth%2520and%2520survival%253A%2520application%2520to%2520proliferation%2520and%2520cytotoxicity%2520assays%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1983%26volume%3D65%26spage%3D55%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IE4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IE4','PDB','2IE4'); return false;">PDB: 2IE4</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i60"><a href="/doi/suppl/10.1021/jm901902w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_35751"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis results for compounds <b>9</b>−<b>16</b>, results and experimental details of the propidium displacement assay, full data of Ca<sup>2+</sup> channel blocking activity of <b>9</b>−<b>16</b>, tables of results for all neuroprotection experiments, protocol of animal usage, and references. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901902w/suppl_file/jm901902w_si_001.pdf">jm901902w_si_001.pdf (70.91 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901902w&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm901902w%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-14%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901902w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799869bf87d2440","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
